TW201605800A - Pyridine compound and use thereof - Google Patents

Pyridine compound and use thereof Download PDF

Info

Publication number
TW201605800A
TW201605800A TW104120127A TW104120127A TW201605800A TW 201605800 A TW201605800 A TW 201605800A TW 104120127 A TW104120127 A TW 104120127A TW 104120127 A TW104120127 A TW 104120127A TW 201605800 A TW201605800 A TW 201605800A
Authority
TW
Taiwan
Prior art keywords
group
substituted
unsubstituted
alkyl
alkoxy
Prior art date
Application number
TW104120127A
Other languages
Chinese (zh)
Inventor
岩田淳
加登一成
佐藤元亮
植薄信也
藤井聡
小林朝巳
幸堀伸哉
寺西貴昭
Original Assignee
日本曹達股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日本曹達股份有限公司 filed Critical 日本曹達股份有限公司
Publication of TW201605800A publication Critical patent/TW201605800A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/541,3-Diazines; Hydrogenated 1,3-diazines
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/561,2-Diazoles; Hydrogenated 1,2-diazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/581,2-Diazines; Hydrogenated 1,2-diazines
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/02Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having no bond to a nitrogen atom
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/02Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having no bond to a nitrogen atom
    • A01N47/06Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having no bond to a nitrogen atom containing —O—CO—O— groups; Thio analogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • A61K31/502Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/68One oxygen atom attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/056Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

The present invention provides a compound represented by formula (I) (in the formula, R1, R2, R3 and R4 each represent a hydrogen atom, a C1-6 alkyl group or the like, R1 and R2 may bond to form a 5- to 6-membered ring together with the carbon atoms bonded with R1 and R2, Q represents an organic group represented by formula (II) or the like (in formula (II), Ar1 represents a C6-10 aryl group or the like, R<SP>a</SP> represents a hydrogen atom, a C1-6 alkyl group or the like, * represents the bonding position of the organic group represented by formula (II))) or salt thereof, and also provides a fungicide for agricultural and horticultural use, a harmful organism control agent, and an insecticide or acaricide including at least one selected from the group consisting of the compound represented by formula (I) and salt thereof as an active ingredient.

Description

吡啶化合物及其用途 Pyridine compound and its use

本發明係關於一種吡啶化合物、以及農園藝用殺菌劑、有害生物防除劑、及殺蟲或殺蟎劑等之用途。 The present invention relates to a pyridine compound, and an agricultural and horticultural fungicide, a pest control agent, and an insecticidal or acaricidal agent.

於栽培農園藝作物時,針對作物之病害提出有許多防除藥劑,但該等中因如下原因而難以稱為可充分令人滿意之防除藥劑者不在少數:其防除效力不充分;或由於出現藥劑耐性之病原菌,其使用受到限制;或會對植物體產生藥害或污染;或者對人畜魚類之毒性或對環境之影響較大等。因此,強烈希望出現該缺陷較少之可安全使用之藥劑。 When cultivating agricultural and horticultural crops, there are many control agents for crop diseases, but it is difficult to call them a sufficiently satisfactory anti-drug for the following reasons: their control effect is insufficient; or due to the presence of drugs The pathogenic bacteria of tolerance are limited in their use; they may cause phytotoxicity or pollution to plants; or they may have toxicity to human and animal fish or have a greater impact on the environment. Therefore, it is strongly desired to have a drug that is less safe to use.

且說,於專利文獻1中揭示有一種式(A)或式(B)所表示之吡啶化合物。根據專利文獻1,該吡啶化合物似乎作為電子傳遞系統之複合體II抑制劑是有用的。 Further, Patent Document 1 discloses a pyridine compound represented by the formula (A) or the formula (B). According to Patent Document 1, the pyridine compound appears to be useful as a complex II inhibitor of an electron transport system.

[專利文獻1]WO 2003/103667A [Patent Document 1] WO 2003/103667A

本發明之課題在於提供一種新穎之吡啶化合物、以及農園藝用殺菌劑、有害生物防除劑、及殺蟲或殺蟎劑。 An object of the present invention is to provide a novel pyridine compound, an agricultural and horticultural fungicide, a pest control agent, and an insecticidal or acaricidal agent.

為了解決上述課題而進行了研究,結果完成包含以下之態樣之本發明。 In order to solve the above problems, research has been conducted, and as a result, the present invention including the following aspects has been completed.

[1]一種化合物或其鹽,該化合物係以式(I)表示。 [1] A compound or a salt thereof, which is represented by the formula (I).

[式(I)中,R1表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1 取代之C1~6烷氧基、未經取代或經G2取代之C6~10芳基、未經取代或經G2取代之3~6員雜環基、氰基或鹵素基。 [In the formula (I), R 1 represents a hydrogen atom, unsubstituted or substituted. 1 G of C1 ~ 6 alkyl, unsubstituted or substituted. 1 G of C1 ~ 6 alkoxy, unsubstituted or G 2 substituted C6~10 aryl, unsubstituted or G 2 substituted 3-6 membered heterocyclic group, cyano group or halogen group.

R2及R3分別獨立地表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C3~8環烷基、未經取代或經G1取代之C1~6烷氧基、甲醯基、甲醯氧基、未經取代或經G1取代之C1~6烷基羰基、未經取代或經G1取代之C1~6烷基羰氧基、未經取代或經G2取代之C6~10芳基、(未經取代或經G1取代之C1~6烷氧基亞胺基)-C1~6烷基、氰基、或鹵素基。 R 2 and R 3 each independently represent a hydrogen atom, an unsubstituted or G 1 -substituted C 1-6 alkyl group, an unsubstituted or G 1 -substituted C 3 -8 cycloalkyl group, unsubstituted or via G 1 the substituted C1 ~ 6 alkoxy, methyl acyl, carboxylic acyl group, unsubstituted or substituted with G 1 of C1 ~ 6 alkyl carbonyl, unsubstituted or substituted with G 1 of C1 ~ 6 alkyl carbonyloxy a C6-10 aryl group which is unsubstituted or substituted by G 2 , (unsubstituted or substituted by a G 1 C1-6 alkoxyimino group)-C1~6 alkyl group, a cyano group, or a halogen group .

此處,R1與R2亦可一併與R1及R2各自所鍵結之碳原子共同形成5~6員環。 Here, R 1 and R 2 may together form a 5- to 6-membered ring together with the carbon atoms to which each of R 1 and R 2 are bonded.

R4表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C2~6烯基、未經取代或經G1取代之C2~6炔基、未經取代或經G1取代之C3~8環烷基、未經取代或經G2取代之C6~10芳基C1~6烷基、未經取代或經G2取代之3~6員雜環基、未經取代或經G2取代之3~6員雜環基C1~6烷基、甲醯基、未經取代或經G1取代之C1~6烷基羰基、未經取代或經G1取代之C3~8環烷基羰基、未經取代或經G1取代之C1~6烯基羰基、未經取代或經G2取代之C6~10芳基羰基、未經取代或經G1取代之C1~6烷氧基羰基、未經取代或經G1取代之C2~6烯氧基羰基、未經取代或經G1取代之C1~6烷基磺醯基、未經取代或經G1取代之C1~6烷基胺基羰基、未經取代或經G1取代之(C1~6烷硫基)羰基、未經取代或經G1取代之C1~6烷基胺基(硫羰基)、或者式(IV)所表示之基。 R 4 represents a hydrogen atom, an unsubstituted or G 1 -substituted C 1-6 alkyl group, an unsubstituted or G 1 -substituted C 2 -6 alkenyl group, an unsubstituted or G 1 -substituted C 2 -6 alkynyl group. , unsubstituted or substituted by G 1 C 3-8 cycloalkyl, unsubstituted or G 2 substituted C 6-10 aryl C 1-6 alkyl, unsubstituted or substituted by G 2 3-6 members heterocyclyl, unsubstituted or substituted with G 2 of the 3 to 6-membered heterocyclic group a C1 to 6 alkyl, methyl acyl, unsubstituted or substituted with G 1 of a C1 to 6 alkyl carbonyl, unsubstituted or G 1 via the C3 ~ 8 cycloalkyl substituted alkylcarbonyl, unsubstituted or substituted with G 1 group of C1 ~ 6 alkenyl carbonyl group, unsubstituted or substituted with G 2 of the C6 ~ 10 aryl-carbonyl group, an unsubstituted or G 1 -substituted alkoxycarbonyl group substituted by G 1 , unsubstituted or substituted C 2 6 alkenyloxycarbonyl group by G 1 , unsubstituted or substituted C 1 6 alkylsulfonyl group by G 1 , unsubstituted or one of C1 ~ 6 alkyl substituted aminocarbonyl through G, unsubstituted or substituted with 1 G of (C1 ~ 6 alkylthio) carbonyl, unsubstituted or substituted with 1 G of C1 ~ 6 alkyl group (thiocarbonyl) or a group represented by the formula (IV).

式(IV)中,Ga分別獨立地表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C2~6烯基、未經取代或經G1取代之C2~6炔基、未經取代或經G1取代之C3~8環烷基、或者未經取代或經G2取代之C6~10芳基。 In the formula (IV), G a each independently represents a hydrogen atom, an unsubstituted or G 1 -substituted C 1 - 6 alkyl group, an unsubstituted or G 1 -substituted C 2 - 6 alkenyl group, unsubstituted or via G 1 substituents of C2 ~ 6 alkynyl, unsubstituted or substituted with G 1 of C3 ~ 8 cycloalkyl, or unsubstituted or substituted G 2 of the C6 ~ 10 aryl group.

式(IV)中,Gb表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C2~6烯基、未經取代或經G1取代之C2~6炔基、未經取代或經G1取代之C3~8環烷基、未經取代或經G2取代之C6~10芳基、或者未經取代或經G2取代之3~6員雜環基。 In the formula (IV), G b represents a hydrogen atom, an unsubstituted or G 1 -substituted C 1-6 alkyl group, an unsubstituted or G 1 -substituted C 2 -6 alkenyl group, unsubstituted or substituted by G 1 the C2 ~ 6 alkynyl, unsubstituted or substituted with G 1 of C3 ~ 8 cycloalkyl, unsubstituted or substituted with G 2 of the C6 ~ 10 aryl group, or an unsubstituted or substituted by G 2 of 3 ~ 6-membered heterocyclic group.

式(IV)中,T表示氧原子、氧基羰基、羰氧基、氧基羰氧基、硫原子、(硫基)羰基、羰基(硫基)、(硫基)羰氧基、氧基羰基(硫基)、或-O-C(=O)-N(Gb)-所表示之二價基。 In the formula (IV), T represents an oxygen atom, an oxycarbonyl group, a carbonyloxy group, an oxycarbonyloxy group, a sulfur atom, a (thio)carbonyl group, a carbonyl group (thio group), a (thio)carbonyloxy group, an oxy group. a divalent group represented by a carbonyl group (thio group) or -OC(=O)-N(G b )-.

*表示式(IV)所表示之基之鍵結位置。 * indicates the bonding position of the base represented by the formula (IV).

Q表示式(II)或式(III)所表示之有機基中之任一者。 Q represents any one of the organic groups represented by the formula (II) or the formula (III).

[式(II)及式(III)中, Ar1表示未經取代或經G2取代之C6~10芳基、或者未經取代或經G2取代之3~10員雜環基。 [In the formulae (II) and (III), Ar 1 represents an unsubstituted or G 2 -substituted C 6 -10 aryl group, or a 3 - 10 membered heterocyclic group which is unsubstituted or substituted with G 2 .

Ar2表示未經取代或經G2取代之C6~10芳基、未經取代或經G2取代之C6~10芳氧基、未經取代或經G2取代之C6~10芳硫基、未經取代或經G2取代之C6~10芳基亞磺醯基、未經取代或經G2取代之C6~10芳基磺醯基、未經取代或經G2取代之3~10員雜環基、未經取代或經G2取代之3~10員雜環氧基、未經取代或經G2取代之3~10員雜環硫基或二茂鐵基。 Ar 2 represents an unsubstituted or G 2 -substituted C 6 -10 aryl group, an unsubstituted or G 2 -substituted C 6 -10 aryloxy group, an unsubstituted or G 2 -substituted C 6 -10 arylthio group, Unsubstituted or G 2 substituted C6-10 sulfinyl, unsubstituted or G 2 substituted C6-10 sulfonyl, unsubstituted or substituted by G 2 3~10 members Heterocyclic group, unsubstituted or G 2 substituted 3-10 membered heterocyclic oxy group, unsubstituted or G 2 substituted 3-10 membered heterocyclic thio or ferrocene group.

Ra表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C3~8環烷基、胺基、C1~6烷基羰基胺基、或者未經取代或經G2取代之C6~10芳基。 R a represents a hydrogen atom, an unsubstituted or G 1 -substituted C 1-6 alkyl group, an unsubstituted or G 1 -substituted C 3 -8 cycloalkyl group, an amine group, a C 1-6 alkylcarbonylamino group, or C6~10 aryl group which is unsubstituted or substituted by G 2 .

Ba表示未經取代或經G4取代之C1~C6伸烷基(alkylene group)、未經取代或經G4取代之C2~C6伸烯基(alkenylene group)、未經取代或經G4取代之C2~C6伸炔基(alkynylene group)、未經取代或經G4取代之C1~C6伸烷氧基C1~6伸烷基、未經取代或經G4取代之C3~C6伸環烷基(cycloalkylene group)、未經取代或經G4取代之C1~C6伸烷基C3~6伸環烷基、未經取代或經G4取代之C1~C6伸烷氧基C3~6伸環烷基、未經取代或經G4取代之C4~C6伸環烯基(cycloalkenylene group)、或者未經取代或經G4取代之3~6員伸雜環基(heterocyclylene group)。 B a represents an unsubstituted or G 4 -substituted C 1 -C 6 alkylene group, an unsubstituted or G 4 -substituted C 2 -C 6 alkenylene group, unsubstituted or via G 4 Substituted C2~C6 alkynylene group, unsubstituted or G 4 substituted C1~C6 alkoxy C1~6 alkyl, unsubstituted or substituted by G 4 C3~C6 Cycloalkylene group, unsubstituted or G 4 substituted C1~C6 alkylene C3~6 cycloalkylene group, unsubstituted or substituted by C 4 C1~C6 alkoxy C3~6 cycloalkyl, unsubstituted or substituted with G 4 of extending C4 ~ C6 cycloalkenyl group (cycloalkenylene group), or G 4 unsubstituted or substituted 3 to 6-membered extension of heterocyclic group (heterocyclylene group).

又,Ba之碳原子或Ba上之取代基G4之一部分亦可與Ar2上之碳原子鍵結而形成5~6員環。 Further, a carbon atom of B a or a part of the substituent G 4 on B a may be bonded to a carbon atom on Ar 2 to form a 5- to 6-membered ring.

*表示式(II)或式(III)所表示之有機基之鍵結位置] * indicates the bonding position of the organic group represented by the formula (II) or the formula (III)]

G1表示羥基、C1~6烷氧基、C1~6烷氧基C1~6烷氧基、 C1~6烷氧基羰基、甲醯氧基、C1~6烷基羰氧基、C1~6烷氧基羰氧基、氰基、或鹵素基。於R1、R2、R3、R4或Ra中之兩者以上為經G1取代之上述基之情形時,該G1互相可相同,亦可不同。 G 1 represents a hydroxyl group, a C1-6 alkoxy group, a C1-6 alkoxy C1-6 alkyloxy group, a C1-6 alkyloxycarbonyl group, a methyloxy group, a C1-6 alkyloxy group, a C1~6 group. Alkoxycarbonyloxy, cyano, or halogen. When two or more of R 1 , R 2 , R 3 , R 4 or R a is a group substituted with G 1 , the G 1 's may be the same or different.

G2表示C1~6烷基、羥基C1~6烷基、C2~6烯基、C2~6炔基、C3~8環烷基、C1~6鹵化烷基、C1~6烷氧基C1~6烷基、C1~6烷氧基C1~6鹵化烷基、C2~6鹵化烯基、C2~6鹵化炔基、羥基、C1~6烷氧基、C3~8環烷基C1~6烷氧基、C1~6烷氧基C1~6烷氧基、C1~6鹵化烷氧基、C1~6鹵化烷氧基C1~6鹵化烷氧基、甲醯基、C1~6烷基羰基、C1~6烷氧基羰基、甲醯氧基、C1~6烷基羰氧基、C1~6烷氧基羰氧基、C1~6烷氧基羰基胺基、未經取代或經G21取代之C6~10芳基、未經取代或經G21取代之C6~10芳基C1~6烷基、未經取代或經G21取代之C6~10芳氧基、未經取代或經G21取代之3~6員雜環基、未經取代或經G21取代之3~6員雜環氧基、C1~6烷硫基、C1~6烷基亞磺醯基、C1~6烷基磺醯基、C1~6鹵化烷硫基、C1~6鹵化烷基亞磺醯基、C1~6鹵化烷基磺醯基、五氟硫基(pentafluorosulfanyl group)、未經取代或經G21取代之C6~10芳硫基、未經取代或經G21取代之C6~10芳基亞磺醯基、未經取代或經G21取代之C6~10芳基磺醯基、硝基、氰基、鹵素基、C1~6伸烷基、C1~6伸烷基二氧基、或C1~6鹵化伸烷基二氧基。於R1、R2、R3、R4、Ra、G4、Ar1或Ar2中之兩者以上為經G2取代之上述基之情形時,該G2互相可相同,亦可不同。 G 2 represents a C1~6 alkyl group, a hydroxyl group C1~6 alkyl group, a C2~6 alkenyl group, a C2~6 alkynyl group, a C3~8 cycloalkyl group, a C1~6 halogenated alkyl group, a C1~6 alkoxy group C1~ 6 alkyl, C1~6 alkoxy C1~6 halogenated alkyl, C2-6 halogenated alkenyl, C2-6 halogenated alkynyl, hydroxy, C1-6 alkoxy, C3~8 cycloalkyl C1~6 alkane Oxy group, C1~6 alkoxy C1~6 alkoxy group, C1~6 halogenated alkoxy group, C1~6 halogenated alkoxy C1~6 halogenated alkoxy group, formyl group, C1~6 alkylcarbonyl group, C1 ~ 6 alkoxycarbonyl group, carboxylic acyl group, C1 ~ 6 alkylcarbonyloxy, C1 ~ 6 alkoxycarbonyl group, C1 ~ 6 alkoxycarbonyl group, unsubstituted or substituted with G 21 the C6 ~ 10 aryl group, unsubstituted or substituted with G 21 C6 ~ 10 aryl group of C1 ~ 6 alkyl, unsubstituted or substituted with the G 21 C6 ~ 10 aryloxy, unsubstituted or G 21 Substituted 3-6 membered heterocyclic group, unsubstituted or substituted by G 21 3-6 membered heterocyclic oxy group, C1~6 alkylthio group, C1-6 alkyl sulfinyl group, C1~6 alkyl group Sulfonyl, C1~6 halogenated alkylthio, C1~6 halogenated alkylsulfinyl, C1-6 halogenated alkylsulfonyl, pentafluorosulfanyl group, unsubstituted or substituted by G 21 the C6 ~ 10 aryl group, unsubstituted or substituted with G 21 C6 ~ 10 aryl methylsulfoximide acyl, unsubstituted or substituted with the G 21 C6 ~ 10 aryl sulfonic acyl group, a nitro group, a cyano group, a halogen group, C1 ~ 6 alkylene, C1 ~ 6 alkylene group Dioxy, or C1~6 halogenated alkyldioxy. When two or more of R 1 , R 2 , R 3 , R 4 , R a , G 4 , Ar 1 or Ar 2 are the above-mentioned groups substituted by G 2 , the G 2 may be the same as each other, or different.

G21表示C1~6烷基、C1~6鹵化烷基、C1~6烷氧基、C1~6鹵化烷氧基、或鹵素基。於G2或G4中之兩者以上為經G21取代之上述基 之情形時,該G21互相可相同,亦可不同。 G 21 represents a C1-6 alkyl group, a C1-6 alkyl halide, a C1-6 alkyloxy group, a C1-6 alkyl alkoxy group, or a halogen group. In the case where two or more of G 2 or G 4 are the above-mentioned groups substituted by G 21 , the G 21 may be the same or different from each other.

G4表示C1~6烷基、C3~8環烷基、C1~6鹵化烷基、C1~6烷氧基C1~6烷基、C2~6烯氧基C1~6烷基、羥基、C1~6烷氧基、C1~6烷氧基C1~6烷氧基、C2~6烯氧基、C1~6烷氧基羰基、未經取代或經G21取代之C6~10芳基、未經取代或經G21取代之3~6員雜環基、氰基、鹵素基、C1~6伸烷基、C1~6伸烷基二氧基、側氧基、C3~8環烷基C1~6烷基、未經取代或經G21取代之C6~10芳基C1~6烷基、未經取代或經G21取代之3~6員雜環基C1~6烷基、C3~8環烷氧基C1~6烷基、未經取代或經G21取代之C6~10芳氧基C1~6烷基、未經取代或經G21取代之3~6員雜環氧基C1~6烷基、C1~6亞烷基(alkylidene group)、C1~6烷氧基亞胺基、未經取代或經G21取代之C6~10芳基C1~6烷氧基亞胺基、或C1~6烷基肼基] G 4 represents a C1~6 alkyl group, a C3~8 cycloalkyl group, a C1~6 halogenated alkyl group, a C1~6 alkoxy C1~6 alkyl group, a C2~6 alkenyloxy C1~6 alkyl group, a hydroxyl group, a C1 group. ~ 6 alkoxy group, a C1 to C6 alkoxy group a C1 ~ 6 alkoxy, C2 ~ 6 alkenyl group, a C1 ~ 6 alkoxycarbonyl, unsubstituted or substituted with the G 21 C6 ~ 10 aryl group, an 3- to 6-membered heterocyclic group substituted by or substituted with G 21 , cyano group, halogen group, C1~6 alkylene group, C1~6 alkylenedioxy group, pendant oxy group, C3-8 cycloalkyl group C1 ~ 6 alkyl, unsubstituted or substituted with G 21 C6 ~ 10 aryl group of a C1 ~ 6 alkyl, unsubstituted or substituted with the G 21-membered heterocyclic group having 3 to 6 a C1 ~ 6 alkyl, C3 ~ 8 cycloalkoxy group having a C1 to 6 alkyl, unsubstituted or substituted with G 21 C6 ~ 10 aryloxy group of a C1 to 6 alkyl, unsubstituted or substituted with the 3 G 21 ~ ~ 6-membered heterocyclic group having a C1 6 alkyl, C1 ~ 6 alkylene (alkylidene group), C1 ~ 6 alkoxyimino group, unsubstituted or substituted with G 21 C6 ~ 10 aryl group of C1 ~ 6 alkoxyimino group, or C1~6 alkyl fluorenyl]

[2]一種農園藝用殺菌劑,其含有選自由上述[1]所記載之化合物及其鹽所組成之群中之至少一者作為有效成分。 [2] A bactericidal agent for agricultural and horticultural, comprising at least one selected from the group consisting of the compound of the above [1] and a salt thereof as an active ingredient.

[3]一種有害生物防除劑,其含有選自由上述[1]所記載之化合物及其鹽所組成之群中之至少一者作為有效成分。 [3] A pest control agent comprising at least one selected from the group consisting of the compound of the above [1] and a salt thereof as an active ingredient.

[4]一種殺蟲或殺蟎劑,其含有選自由上述[1]所記載之化合物及其鹽所組成之群中之至少一者作為有效成分。 [4] An insecticidal or acaricidal agent comprising at least one selected from the group consisting of the compound of the above [1] and a salt thereof as an active ingredient.

本發明之吡啶化合物係具有有害生物防除、殺菌、殺蟎、殺蟲等效果,不會對植物體產生藥害,對人畜魚類之毒性或對環境之影響較少之新穎化合物。尤其是對麥類病害表現出優異之防除效果。本發明之吡 啶化合物作為農園藝用殺菌劑、有害生物防除劑、及殺蟲或殺蟎劑之有效成分而有用。 The pyridine compound of the present invention is a novel compound which has the effects of pest control, sterilization, acaricidal killing, insecticidal action, and the like, does not cause phytotoxicity to plants, and has little toxicity to human or animal fish or has little influence on the environment. In particular, it exhibits excellent control effects against wheat diseases. Pyridine of the present invention The pyridine compound is useful as an active ingredient for agricultural and horticultural fungicides, pest control agents, and insecticides or acaricides.

本發明之吡啶化合物係式(I)所表示之化合物(以下有時記作化合物(I))及其鹽。 The pyridine compound of the present invention is a compound represented by the formula (I) (hereinafter sometimes referred to as the compound (I)) and a salt thereof.

[R1] [R 1 ]

R1表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C1~6烷氧基、未經取代或經G2取代之C6~10芳基、3~6員雜環基、氰基或鹵素基。 R 1 represents a hydrogen atom, an unsubstituted or G 1 -substituted C 1-6 alkyl group, an unsubstituted or G 1 -substituted C 1-6 alkoxy group, an unsubstituted or G 2 -substituted C 6 ~ 10 aryl group. a group, a 3 to 6 membered heterocyclic group, a cyano group or a halogen group.

C1~6烷基可為直鏈,若碳數為3以上,則亦可為支鏈。作為C1~6烷基,可列舉:甲基、乙基、正丙基、異丙基、正丁基、第二丁基、異丁基、第三丁基、正戊基、正己基、異戊基、新戊基、2-甲基丁基、2,2-二甲基丙基、異己基等。 The C1~6 alkyl group may be a straight chain, and if the carbon number is 3 or more, it may be a branched chain. Examples of the C1-6 alkyl group include a methyl group, an ethyl group, a n-propyl group, an isopropyl group, a n-butyl group, a second butyl group, an isobutyl group, a t-butyl group, a n-pentyl group, a n-hexyl group, and a different one. Butyl, neopentyl, 2-methylbutyl, 2,2-dimethylpropyl, isohexyl and the like.

作為C1~6烷氧基,可列舉:甲氧基、乙氧基、正丙氧基、正丁氧基、 正戊氧基、正己氧基、異丙氧基、異丁氧基、第二丁氧基、第三丁氧基、異己氧基等。 Examples of the C1-6 alkoxy group include a methoxy group, an ethoxy group, a n-propoxy group, and a n-butoxy group. N-pentyloxy, n-hexyloxy, isopropoxy, isobutoxy, second butoxy, tert-butoxy, isohexyloxy and the like.

作為C6~10芳基,可列舉:苯基、萘基、薁基、茚基、二氫茚基、萘滿基(tetralinyl group)等。 Examples of the C6-10 aryl group include a phenyl group, a naphthyl group, an anthracenyl group, an anthracenyl group, a dihydroindenyl group, and a tetralinyl group.

3~6員雜環基係含有選自由氮原子、氧原子及硫原子所組成之群中之1~4個雜原子作為環之構成原子者。雜環基可為單環及多環中之任一種。若多環雜環基中至少一個環為雜環基,則其餘環可為飽和脂環、不飽和脂環或芳香環中之任一種。作為3~6員雜環基,可列舉:3~6員飽和雜環基、5~6員雜芳基、5~6員部分不飽和雜環基等。 The 3-6 membered heterocyclic group contains one to four hetero atoms selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom as a constituent atom of the ring. The heterocyclic group may be any of a monocyclic ring and a polycyclic ring. If at least one of the polycyclic heterocyclic groups is a heterocyclic group, the remaining ring may be any of a saturated alicyclic ring, an unsaturated alicyclic ring or an aromatic ring. Examples of the 3-6 membered heterocyclic group include a 3 to 6 membered saturated heterocyclic group, a 5 to 6 membered heteroaryl group, and a 5 to 6 membered partially unsaturated heterocyclic group.

作為3~6員飽和雜環基,可列舉:氮丙啶基、環氧乙烷基、氮雜環丁基(azetidinyl group)、氧雜環丁基(oxetanyl group)、吡咯啶基、四氫呋喃基、四氫噻唑基、哌啶基、哌基、啉基、四氫吡喃基、二氧雜環戊基(dioxolanyl group)、二氧雜環己基(dioxanyl group)等。 Examples of the 3-6 membered saturated heterocyclic group include aziridine group, oxiranyl group, azetidinyl group, oxetanyl group, pyrrolidinyl group, and tetrahydrofuranyl group. , tetrahydrothiazolyl, piperidinyl, piperidine base, A phenyl group, a tetrahydropyranyl group, a dioxolanyl group, a dioxanyl group, or the like.

作為5員雜芳基,可列舉:吡咯基、呋喃基、噻吩基、咪唑基、吡唑基、唑基、異唑基、噻唑基、異噻唑基、三唑基、二唑基、噻二唑基、四唑基等。 Examples of the 5-membered heteroaryl group include a pyrrolyl group, a furyl group, a thienyl group, an imidazolyl group, and a pyrazolyl group. Azolyl, different Azyl, thiazolyl, isothiazolyl, triazolyl, A oxazolyl group, a thiadiazolyl group, a tetrazolyl group or the like.

作為6員雜芳基,可列舉:吡啶基、吡基、嘧啶基、嗒基、三基等。 As a 6-membered heteroaryl group, a pyridyl group or a pyridyl group is exemplified. Base, pyrimidinyl, oxime Base, three Base.

作為鹵素基,可列舉:氟基、氯基、溴基、碘基。 Examples of the halogen group include a fluorine group, a chlorine group, a bromine group, and an iodine group.

取代基G1表示羥基、C1~6烷氧基、C1~6烷氧基C1~6烷氧基、C1~6烷氧基羰基、甲醯氧基、C1~6烷基羰氧基、C1~6烷氧基羰氧基、氰基、或鹵素基。再者,於R1、R2、R3、R4或Ra中之兩者以上為 經G1取代之基之情形時,該G1互相可相同,亦可不同。 The substituent G 1 represents a hydroxyl group, a C1-6 alkoxy group, a C1-6 alkoxy C1-6 alkyloxy group, a C1-6 alkoxycarbonyl group, a methyloxy group, a C1-6 alkyloxy group, a C1 group. ~6 alkoxycarbonyloxy, cyano, or halogen. Further, when two or more of R 1 , R 2 , R 3 , R 4 or R a are a group substituted by G 1 , the G 1 may be the same or different from each other.

取代基G1中之C1~6烷氧基、鹵素基係如已說明者。 The C1~6 alkoxy group and the halogen group in the substituent G 1 are as described above.

作為C1~6烷氧基C1~6烷氧基,可列舉:甲氧基甲氧基、甲氧基乙氧基等。 Examples of the C1-6 alkoxy C1-6 alkyloxy group include a methoxymethoxy group and a methoxyethoxy group.

作為C1~6烷氧基羰基,可列舉:甲氧基羰基、乙氧基羰基、正丙氧基羰基、異丙氧基羰基、第三丁氧基羰基等。 Examples of the C1-6 alkoxycarbonyl group include a methoxycarbonyl group, an ethoxycarbonyl group, a n-propoxycarbonyl group, an isopropoxycarbonyl group, and a third butoxycarbonyl group.

作為C1~6烷基羰氧基,可列舉:乙醯氧基、丙醯氧基、丁醯氧基等。 Examples of the C1-6 alkyloxycarbonyl group include an ethoxycarbonyl group, a propenyloxy group, and a butoxy group.

作為C1~6烷氧基羰氧基,可列舉:甲氧基羰氧基、乙氧基羰氧基、正丙氧基羰氧基、異丙氧基羰氧基、正丁氧基羰氧基、第三丁氧基羰氧基等。 Examples of the C1-6 alkoxycarbonyloxy group include a methoxycarbonyloxy group, an ethoxycarbonyloxy group, a n-propoxycarbonyloxy group, an isopropoxycarbonyloxy group, and a n-butoxycarbonyloxy group. A group, a third butoxycarbonyloxy group or the like.

取代基G2表示C1~6烷基、羥基C1~6烷基、C2~6烯基、C2~6炔基、C3~8環烷基、C1~6鹵化烷基、C1~6烷氧基C1~6烷基、C1~6烷氧基C1~6鹵化烷基、C2~6鹵化烯基、C2~6鹵化炔基、羥基、C1~6烷氧基、C3~8環烷基C1~6烷氧基、C1~6烷氧基C1~6烷氧基、C1~6鹵化烷氧基、C1~6鹵化烷氧基C1~6鹵化烷氧基、甲醯基、C1~6烷基羰基、C1~6烷氧基羰基、甲醯氧基、C1~6烷基羰氧基、C1~6烷氧基羰氧基、C1~6烷氧基羰基胺基、未經取代或經G21取代之C6~10芳基、未經取代或經G21取代之C6~10芳基C1~6烷基、未經取代或經G21取代之C6~10芳氧基、未經取代或經G21取代之3~6員雜環基、未經取代或經G21取代之3~6員雜環氧基、C1~6烷硫基、C1~6烷基亞磺醯基、C1~6烷基磺醯基、C1~6鹵化烷硫基、C1~6鹵化烷基亞磺醯基、C1~6鹵化烷基磺醯基、五氟硫基、未經取代或經G21取代之C6~10芳硫基、未經取代或經 G21取代之C6~10芳基亞磺醯基、未經取代或經G21取代之C6~10芳基磺醯基、硝基、氰基、鹵素基、C1~6伸烷基、C1~6伸烷基二氧基、或C1~6鹵化伸烷基二氧基。 The substituent G 2 represents a C1-6 alkyl group, a hydroxy C1-6 alkyl group, a C2-6 alkenyl group, a C2-6 alkynyl group, a C3~8 cycloalkyl group, a C1~6 halogenated alkyl group, a C1~6 alkoxy group. C1~6 alkyl, C1~6 alkoxy C1~6 halogenated alkyl, C2-6 halogenated alkenyl, C2-6 halogenated alkynyl, hydroxyl, C1-6 alkoxy, C3~8 cycloalkyl C1~ 6 alkoxy group, C1~6 alkoxy C1~6 alkoxy group, C1~6 halogenated alkoxy group, C1~6 halogenated alkoxy C1~6 halogenated alkoxy group, formyl group, C1~6 alkyl group Carbonyl, C1-6 alkyloxycarbonyl, methyloxy, C1-6 alkylcarbonyloxy, C1-6 alkyloxycarbonyl, C1-6 alkyloxycarbonyl, unsubstituted or via G the 21-substituted C6 ~ 10 aryl group, unsubstituted or substituted with G 21 C6 ~ 10 aryl group of C1 ~ 6 alkyl, unsubstituted or substituted with the G 21 C6 ~ 10 aryloxy, unsubstituted or G 21 substituted 3-6 member heterocyclic group, unsubstituted or G 21 substituted 3-6 membered heterocyclicoxy group, C1-6 alkylthio group, C1-6 alkyl sulfinylene group, C1~6 Alkyl sulfonyl, C1~6 halogenated alkylthio, C1-6 halogenated alkyl sulfinylene, C1-6 halogenated alkylsulfonyl, pentafluorothio, unsubstituted or substituted by G 21 ~10 arylthio group, unsubstituted or substituted by G 21 C6~10 aryl sulfin Mercapto, unsubstituted or substituted by G 21 C6-10 sulfonyl, nitro, cyano, halo, C1-6 alkyl, C1-6 alkyl dioxy, or C1~ 6 Halogenated alkyldioxy.

取代基G2中之C1~6烷基、C1~6烷氧基、C1~6烷氧基C1~6烷氧基、C1~6烷氧基羰基、C1~6烷基羰氧基、C1~6烷氧基羰氧基、C6~10芳基、3~6員雜環基及鹵素基係如已說明者。 C1~6 alkyl group, C1~6 alkoxy group, C1~6 alkoxy C1~6 alkoxy group, C1~6 alkoxycarbonyl group, C1~6 alkylcarbonyloxy group, C1 in the substituent G 2 The ~6 alkoxycarbonyloxy group, the C6~10 aryl group, the 3-6 membered heterocyclic group and the halogen group are as described.

作為羥基C1~C6烷基,可列舉:羥甲基、羥乙基、羥丙基等。 Examples of the hydroxy C1-C6 alkyl group include a methylol group, a hydroxyethyl group, and a hydroxypropyl group.

作為C2~6烯基,可列舉:乙烯基、1-丙烯基、2-丙烯基(烯丙基)、1-丁烯基、2-丁烯基、3-丁烯基、1-甲基-2-丙烯基、2-甲基-2-丙烯基、1-戊烯基、2-戊烯基、3-戊烯基、4-戊烯基、1-甲基-2-丁烯基、2-甲基-2-丁烯基、1-己烯基、2-己烯基、3-己烯基、4-己烯基、5-己烯基等。 Examples of the C2-6 alkenyl group include a vinyl group, a 1-propenyl group, a 2-propenyl (allyl) group, a 1-butenyl group, a 2-butenyl group, a 3-butenyl group, and a 1-methyl group. 2-propenyl, 2-methyl-2-propenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-methyl-2-butenyl 2-methyl-2-butenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl and the like.

作為C2~6炔基,可列舉:乙炔基、1-丙炔基、2-丙炔基、1-丁炔基、2-丁炔基、3-丁炔基、1-甲基-2-丙炔基、2-甲基-3-丁炔基、1-戊炔基、2-戊炔基、3-戊炔基、4-戊炔基、1-甲基-2-丁炔基、2-甲基-3-戊炔基、1-己炔基、1,1-二甲基-2-丁炔基等。 Examples of the C2-6 alkynyl group include an ethynyl group, a 1-propynyl group, a 2-propynyl group, a 1-butynyl group, a 2-butynyl group, a 3-butynyl group, and a 1-methyl-2- group. Propynyl, 2-methyl-3-butynyl, 1-pentynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, 1-methyl-2-butynyl, 2-methyl-3-pentynyl, 1-hexynyl, 1,1-dimethyl-2-butynyl and the like.

作為C3~8環烷基,可列舉:環丙基、環丁基、環戊基、環己基、環庚基、2-金剛烷基(2-adamantyl group)等。 Examples of the C3-8 cycloalkyl group include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, and a 2-adamantyl group.

C1~6烷氧基C1~6烷基係於已說明之C1~6烷基上取代有上述之C1~6烷氧基者。作為C1~6烷氧基C1~6烷基,可列舉:甲氧基甲基、乙氧基甲基、甲氧基乙基、乙氧基乙基、甲氧基正丙基、乙氧基甲 基、乙氧基乙基、正丙氧基甲基、異丙氧基乙基、第二丁氧基甲基、第三丁氧基乙基等。 The C1~6 alkoxy C1-6 alkyl group is substituted with the above C1~6 alkoxy group on the C1~6 alkyl group described above. Examples of the C1-6 alkoxy C1-6 alkyl group include a methoxymethyl group, an ethoxymethyl group, a methoxyethyl group, an ethoxyethyl group, a methoxy-n-propyl group, and an ethoxy group. A Base, ethoxyethyl, n-propoxymethyl, isopropoxyethyl, second butoxymethyl, tert-butoxyethyl and the like.

C3~8環烷基C1~6烷氧基係於已說明之C1~6烷氧基上取代有上述之C3~8環烷基者。作為C3~8環烷基C1~6烷氧基,可列舉:環丙基甲氧基、環丁基甲氧基、環戊基甲氧基、環己基甲氧基、2-(環丙基)-乙氧基等。 The C3-8 cycloalkyl C1~6 alkoxy group is substituted with the above C3-8 cycloalkyl group on the C1~6 alkoxy group described above. Examples of the C3-8 cycloalkyl C1-6 alkoxy group include a cyclopropylmethoxy group, a cyclobutylmethoxy group, a cyclopentylmethoxy group, a cyclohexylmethoxy group, and a 2-(cyclopropyl group)- Ethoxylate and the like.

C1~6烷基羰基係於羰基上鍵結有上述之C1~6烷基者。作為C1~6烷基羰基,可列舉:乙醯基、丙醯基、丁醯基、異丁醯基、三甲基乙醯基等。 The C1~6 alkylcarbonyl group is bonded to the carbonyl group having the above C1~6 alkyl group. Examples of the C1-6 alkyloxycarbonyl group include an ethyl fluorenyl group, a propyl fluorenyl group, a butyl fluorenyl group, an isobutyl fluorenyl group, and a trimethyl acetyl group.

C1~6烷氧基羰基胺基係於胺基上取代有已說明之C1~6烷氧基羰基者。作為C1~6烷氧基羰基胺基,可列舉:甲氧基羰基胺基、乙氧基羰基胺基、正丙氧基羰基胺基、異丙氧基羰基胺基、正丁氧基羰基胺基、第三丁氧基羰基胺基等。 The C1-6 alkoxycarbonylamino group is substituted on the amine group with the C1-6 alkoxycarbonyl group described. Examples of the C1-6 alkoxycarbonylamino group include a methoxycarbonylamino group, an ethoxycarbonylamino group, a n-propoxycarbonylamino group, an isopropoxycarbonylamino group, and a n-butoxycarbonylamine. A group, a third butoxycarbonylamino group or the like.

C6~10芳基C1~6烷基係於已說明之C1~6烷基上取代有上述之C6~10芳基者。作為C6~10芳基C1~6烷基,可列舉:苄基、苯乙基等。 The C6~10 aryl C1-6 alkyl group is substituted with the above C6~10 aryl group on the C1~6 alkyl group described above. Examples of the C6-10 aryl C1-6 alkyl group include a benzyl group and a phenethyl group.

C6~10芳氧基係於羥基上取代有已說明之C6~10芳基者。作為C6~10芳氧基,可列舉:苯氧基、萘氧基等。 The C6~10 aryloxy group is substituted with a C6~10 aryl group as described above on the hydroxyl group. Examples of the C6-10 aryloxy group include a phenoxy group and a naphthyloxy group.

3~6員雜環氧基係於羥基上取代有3~6員雜環基者。作為3~6員雜環氧基,可列舉:吡唑氧基、吡啶氧基等。3~6員雜環氧基較佳為5~6員雜環氧基。 The 3-6 membered heterocyclic oxy group is substituted with a 3-6 membered heterocyclic group on the hydroxy group. Examples of the 3-6 membered heterocyclic oxy group include a pyrazolyloxy group and a pyridyloxy group. The 3-6 membered heterocyclic oxy group is preferably a 5-6 membered heterocyclic oxy group.

C1~6烷硫基係於SH基上取代有C1~6烷基者。作為C1~6烷硫基,可列舉:甲硫基、乙硫基、正丙硫基、正丁硫基、正戊硫基、正己硫基、 異丙硫基、異丁硫基等。 The C1~6 alkylthio group is substituted with a C1~6 alkyl group on the SH group. Examples of the C1-6 alkylthio group include a methylthio group, an ethylthio group, a n-propylthio group, a n-butylthio group, a n-pentylthio group, a n-hexylthio group, and the like. Isopropylthio, isobutylthio and the like.

C1~6烷基亞磺醯基係於亞磺醯基上取代有C1~6烷基者。作為C1~6烷基亞磺醯基,可列舉:甲基亞磺醯基、乙基亞磺醯基、第三丁基亞磺醯基等。 The C1~6 alkylsulfinyl group is substituted with a C1~6 alkyl group on the sulfinylene group. Examples of the C1-6 alkylsulfinyl group include a methylsulfinyl group, an ethylsulfinyl group, and a tert-butylsulfinyl group.

C1~6烷基磺醯基係於磺醯基上鍵結有C1~6烷基者。作為C1~6烷基磺醯基,可列舉:甲基磺醯基、乙基磺醯基、第三丁基磺醯基等。 The C1~6 alkylsulfonyl group is a C1~6 alkyl group bonded to a sulfonyl group. Examples of the C1-6 alkylsulfonyl group include a methylsulfonyl group, an ethylsulfonyl group, and a tert-butylsulfonyl group.

C6~10芳硫基係於SH基上取代有C6~10芳基者。作為C6~10芳硫基,可列舉:苯硫基、萘硫基等。 The C6~10 arylthio group is substituted with a C6~10 aryl group on the SH group. Examples of the C6-10 arylthio group include a phenylthio group and a naphthylthio group.

C6~10芳硫基係於氫硫基(sulfanyl group)上取代有C6~10芳基者。作為C6~10芳硫基,可列舉:苯硫基、萘硫基等。 The C6~10 arylthio group is substituted with a C6~10 aryl group on a sulfanyl group. Examples of the C6-10 arylthio group include a phenylthio group and a naphthylthio group.

C6~10芳基亞磺醯基係於亞磺醯基上取代有C6~10芳基者。作為C6~10芳基亞磺醯基,可列舉:苯基亞磺醯基、萘基亞磺醯基等。 The C6~10 arylsulfinyl group is substituted with a C6-10 aryl group on the sulfinylene group. Examples of the C6-10 arylsulfinyl group include a phenylsulfinyl group and a naphthylsulfinyl group.

C6~10芳基磺醯基係於磺醯基上取代有C6~10芳基者。作為C6~10芳基磺醯基,可列舉:苯基磺醯基、萘基磺醯基等。 The C6~10 arylsulfonyl group is substituted with a C6-10 aryl group on the sulfonyl group. Examples of the C6-10 arylsulfonyl group include a phenylsulfonyl group and a naphthylsulfonyl group.

作為C1~6伸烷基,係脫去C1~6烷烴中之2個氫原子而成之二價基。作為C1~6伸烷基,可列舉:亞甲基、伸乙基(二亞甲基)、三亞甲基、四亞甲基、丙烷-1,2-二基(即伸丙基)等。 The C1~6 alkylene group is a divalent group obtained by removing two hydrogen atoms of the C1-6 alkane. Examples of the C1-6 alkylene group include a methylene group, an ethylidene group (dimethylene group), a trimethylene group, a tetramethylene group, and a propane-1,2-diyl group (i.e., a propyl group).

C1~6伸烷基二氧基係以氧基取代C1~6烷烴中之2個氫原子而成之二價基。作為C1~6伸烷基二氧基,可列舉:亞甲基二氧基(-OCH2O-)、伸乙基二氧基(-OCH2CH2O-)、三亞甲基二氧基等。作為經作為G2之C1~6伸烷基二氧基取代之C6~10芳基,可列舉:2,3-二氫-苯并[1,4]二氧基、苯并[1,3]二氧呃基等。 The C1~6 alkylenedioxy group is a divalent group obtained by substituting two hydrogen atoms of a C1-6 alkane with an oxy group. Examples of the C1~6 alkylenedioxy group include a methylenedioxy group (-OCH 2 O-), an extended ethylene dioxy group (-OCH 2 CH 2 O-), and a trimethylene dioxy group. Wait. Examples of the C6-10 aryl group substituted by a C1~6 alkylenedioxy group as G 2 include 2,3-dihydro-benzo[1,4]dioxy and benzo[1,3. Dioxinyl and the like.

C1~6鹵化烷基、C2~6鹵化烯基、C2~6鹵化炔基、C1~6鹵化烷氧基、及C1~6鹵化伸烷基二氧基係於已說明之C1~6烷基、C2~6烯基、C2~6炔基、C1~6烷氧基、及C1~6伸烷基二氧基上取代有鹵素基者。 C1~6 halogenated alkyl group, C2-6 halogenated alkenyl group, C2~6 halogenated alkynyl group, C1~6 halogenated alkoxy group, and C1~6 halogenated alkylenedioxy group are described in the C1~6 alkyl group. And a C2-6 alkenyl group, a C2~6 alkynyl group, a C1~6 alkoxy group, and a C1~6 alkylenedioxy group are substituted with a halogen group.

作為C1~6鹵化烷基,可列舉:氟甲基、氯甲基、溴甲基、二氟甲基、二氯甲基、二溴甲基、三氟甲基、三氯甲基、三溴甲基、1-氯乙基、2,2,2-三氟乙基、2,2,2-三氯乙基、五氟乙基、4-氟丁基、4-氯丁基、3,3,3-三氟丙基、2,2,2-三氟-1-三氟甲基乙基、全氟己基、全氯己基、2,4,6-三氯己基等。 Examples of the C1-6 halogenated alkyl group include a fluoromethyl group, a chloromethyl group, a bromomethyl group, a difluoromethyl group, a dichloromethyl group, a dibromomethyl group, a trifluoromethyl group, a trichloromethyl group, and a tribromo group. Methyl, 1-chloroethyl, 2,2,2-trifluoroethyl, 2,2,2-trichloroethyl, pentafluoroethyl, 4-fluorobutyl, 4-chlorobutyl, 3, 3,3-Trifluoropropyl, 2,2,2-trifluoro-1-trifluoromethylethyl, perfluorohexyl, perchlorohexyl, 2,4,6-trichlorohexyl, and the like.

作為C2~6鹵化烯基,可列舉:2-氯-1-丙烯基、2-氟-1-丁烯基等。 Examples of the C2-6 halogenated alkenyl group include a 2-chloro-1-propenyl group and a 2-fluoro-1-butenyl group.

作為C2~6鹵化炔基,可列舉:4,4-二氯-1-丁炔基、4-氟-1-戊炔基、5-溴-2-戊炔基等。 Examples of the C2-6 halogenated alkynyl group include a 4,4-dichloro-1-butynyl group, a 4-fluoro-1-pentynyl group, and a 5-bromo-2-pentynyl group.

作為C1~6鹵化烷氧基,可列舉:氯甲氧基、二氯甲氧基、二氟甲氧基、三氯甲氧基、三氟甲氧基、1-氟乙氧基、1,1-二氟乙氧基、2,2,2-三氟乙氧基、1,1,2,2-四氟乙氧基、五氟乙氧基、2,2,3,4,4,4-六氟丁氧基、1-溴-1,1,2,2-四氟乙氧基等。 Examples of the C1-6 halogenated alkoxy group include a chloromethoxy group, a dichloromethoxy group, a difluoromethoxy group, a trichloromethoxy group, a trifluoromethoxy group, and a 1-fluoroethoxy group. 1-difluoroethoxy, 2,2,2-trifluoroethoxy, 1,1,2,2-tetrafluoroethoxy, pentafluoroethoxy, 2,2,3,4,4, 4-hexafluorobutoxy, 1-bromo-1,1,2,2-tetrafluoroethoxy, and the like.

作為C1~6鹵化伸烷基二氧基,可列舉:二氟亞甲基二氧基(-OCF2O-)、四氟伸乙基二氧基(-OCF2CF2O-)等。作為經作為G2之C1~6鹵化伸烷基二氧基取代之C6~10芳基,可列舉:2,2,3,3-四氟-2,3-二氫-苯并[1,4]二氧基、2,2-二氟-苯并[1,3]二氧呃基等。 Examples of the C1-6 halogenated alkylenedioxy group include difluoromethylenedioxy (-OCF 2 O-) and tetrafluoroethylideneoxy (-OCF 2 CF 2 O-). As warp 2 as the halogenated C1 ~ 6 alkyl substituted with two projecting G group of C6 ~ 10 aryl group, include: 2,2,3,3-tetrafluoro-2,3-dihydro - benzo [1, 4] Dioxy, 2,2-difluoro-benzo[1,3]dioxanyl and the like.

C1~6烷氧基C1~6鹵化烷基、C1~6鹵化烷氧基C1~6鹵 化烷氧基、C1~6鹵化烷硫基、C1~6鹵化烷基亞磺醯基、及C1~6鹵化烷基磺醯基係於已說明之C1~6烷氧基C1~6烷基、C1~6烷氧基C1~6烷氧基、C1~6烷硫基、C1~6烷基亞磺醯基、及C1~6烷基磺醯基上取代有鹵素基者。 C1~6 alkoxy C1~6 halogenated alkyl, C1~6 halogenated alkoxy C1~6 halogen Alkoxy group, C1~6 halogenated alkylthio group, C1~6 halogenated alkyl sulfinylene group, and C1~6 halogenated alkylsulfonyl group are described in the C1~6 alkoxy C1~6 alkyl group. And a C1~6 alkoxy C1~6 alkoxy group, a C1~6 alkylthio group, a C1-6 alkyl sulfinyl group, and a C1~6 alkylsulfonyl group substituted with a halogen group.

作為C1~6烷氧基C1~6鹵化烷基,可列舉:二氟(甲氧基)甲基、1,1,1,3,3,3-六氟-2-甲氧基丙烷-2-基等。 Examples of the C1-6 alkoxy C1~6 halogenated alkyl group include difluoro(methoxy)methyl and 1,1,1,3,3,3-hexafluoro-2-methoxypropane-2. - Base, etc.

作為C1~6鹵化烷氧基C1~6鹵化烷氧基,可列舉:二氟(甲氧基)甲氧基、1,2,2-三氟-2-(三氟甲氧基)乙氧基等。 Examples of the C1-6 halogenated alkoxy C1~6 halogenated alkoxy group include difluoro(methoxy)methoxy and 1,2,2-trifluoro-2-(trifluoromethoxy)ethoxylate. Base.

作為C1~6鹵化烷硫基,可列舉:三氟甲硫基、2,2,2-三氟乙硫基等。 Examples of the C1-6 halogenated alkylthio group include a trifluoromethylthio group and a 2,2,2-trifluoroethylthio group.

作為C1~6鹵化烷基亞磺醯基,可列舉:三氟甲基亞磺醯基、2,2,2-三氟乙基亞磺醯基等。 Examples of the C1-6 halogenated alkylsulfinyl group include a trifluoromethylsulfinyl group and a 2,2,2-trifluoroethylsulfinyl group.

作為C1~6鹵化烷基磺醯基,可列舉:三氟甲基磺醯基、2,2,2-三氟乙基磺醯基等。 Examples of the C1-6 halogenated alkylsulfonyl group include a trifluoromethylsulfonyl group and a 2,2,2-trifluoroethylsulfonyl group.

取代基G21表示C1~6烷基、C1~6鹵化烷基、C1~6烷氧基、C1~6鹵化烷氧基、或鹵素基。該等係如已說明者。 The substituent G 21 represents a C1-6 alkyl group, a C1-6 alkyl halide, a C1-6 alkyloxy group, a C1-6 alkyl alkoxy group, or a halogen group. These are as already stated.

於G2或G4中之兩者以上為經G21取代之上述基之情形時,該G21互相可相同,亦可不同。 In the case where two or more of G 2 or G 4 are the above-mentioned groups substituted by G 21 , the G 21 may be the same or different from each other.

於本發明中,作為R1,較佳為氫原子、未經取代或經G1取代之C1~6烷基(較佳為未經取代)、未經取代或經G1取代之烷氧基(較佳為未經取代)、未經取代或經G2(較佳為C1~6烷氧基、C1~6烷氧基羰氧基)取代之C6~10芳基(較佳為苯基)、未經取代或經G2取代之6員環之雜芳基(較佳為未經取代之吡啶基)、氰基或鹵素基,更佳為未經取代之C1 ~6烷基或鹵素基。 In the present invention, R 1 is preferably a hydrogen atom, an unsubstituted or G 1 -substituted C1-6 alkyl group (preferably unsubstituted), unsubstituted or substituted with G 1 alkoxy group. (preferably unsubstituted), unsubstituted or substituted by G 2 (preferably C1-6 alkoxy, C1-6 alkoxycarbonyloxy) C6~10 aryl (preferably phenyl) a 6-membered heteroaryl group (preferably unsubstituted pyridyl), a cyano group or a halogen group which is unsubstituted or substituted by G 2 , more preferably an unsubstituted C 1-6 alkyl group or a halogen base.

[R2及R3] [R 2 and R 3 ]

R2及R3分別獨立地表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C3~8環烷基、未經取代或經G1取代之C1~6烷氧基、甲醯基、甲醯氧基、未經取代或經G1取代之C1~6烷基羰基、未經取代或經G1取代之C1~6烷基羰氧基、未經取代或經G2取代之C6~10芳基、(未經取代或經G1取代之C1~6烷氧基亞胺基)-C1~6烷基、氰基、或鹵素基。 R 2 and R 3 each independently represent a hydrogen atom, an unsubstituted or G 1 -substituted C 1-6 alkyl group, an unsubstituted or G 1 -substituted C 3 -8 cycloalkyl group, unsubstituted or via G 1 the substituted C1 ~ 6 alkoxy, methyl acyl, carboxylic acyl group, unsubstituted or substituted with G 1 of C1 ~ 6 alkyl carbonyl, unsubstituted or substituted with G 1 of C1 ~ 6 alkyl carbonyloxy a C6-10 aryl group which is unsubstituted or substituted by G 2 , (unsubstituted or substituted by a G 1 C1-6 alkoxyimino group)-C1~6 alkyl group, a cyano group, or a halogen group .

R2及R3中之C1~6烷基、C3~8環烷基、C1~6烷氧基、C1~6烷基羰基、C1~6烷基羰氧基、C6~10芳基、鹵素基、及取代基G1、G2係如已說明者。 C1~6 alkyl group, C3~8 cycloalkyl group, C1~6 alkoxy group, C1-6 alkyloxy group, C1-6 alkyloxy group, C6~10 aryl group, halogen in R 2 and R 3 The groups and the substituents G 1 and G 2 are as described.

作為(C1~6烷氧基亞胺基)-C1~6烷基,可列舉:甲氧基亞胺基-甲基、1-(乙氧基亞胺基)-乙基等。 Examples of the (C1-6 alkoxyimino)-C1-6 alkyl group include a methoxyiminomethyl group and a 1-(ethoxyimino)-ethyl group.

R1與R2亦可一併與R1及R2各自所鍵結之碳原子共同形成5~6員環。作為該5~6員環,可列舉:環戊烯環、環己烯環等。 R 1 and R 2 may together form a 5-6 member ring together with the carbon atoms bonded to each of R 1 and R 2 . Examples of the 5-6 member ring include a cyclopentene ring and a cyclohexene ring.

於本發明中,作為R2,較佳為氫原子、未經取代或經G1(較佳為羥基、鹵素基、C1~6烷氧基、C1~6烷基羰氧基、C1~6烷氧基羰氧基)取代之C1~6烷基、未經取代或經G1取代之C1~6烷氧基(較佳為未經取代)、未經取代或經G2(較佳為C1~6烷氧基)取代之C6~10芳基(較佳為苯基)、未經取代或經G1取代之C1~6烷基羰基(較佳為未經取代)、(未經取代或經G1取代之C1~6烷氧基亞胺基)-C1~6烷基(較佳為未經取代)、鹵素基、氰基、甲醯基,更佳為未經取代之C1~6烷基。 In the present invention, R 2 is preferably a hydrogen atom, unsubstituted or G 1 (preferably a hydroxyl group, a halogen group, a C1-6 alkoxy group, a C1-6 alkyloxy group, a C1~6). alkoxycarbonyl group) substituted with the C1 ~ 6 alkyl, unsubstituted or substituted with G 1 of C1 ~ 6 alkoxy group (preferably unsubstituted), unsubstituted or G 2 (preferably the substituted C1 ~ 6 alkoxy) C6 ~ 10 aryl group (preferably phenyl), unsubstituted or substituted with G 1 of C1 ~ 6 alkyl-carbonyl group (preferably unsubstituted), (unsubstituted Or a C1~6 alkoxyimino)-C1~6 alkyl group (preferably unsubstituted), a halogen group, a cyano group, a formyl group, and more preferably an unsubstituted C1~ substituted by G 1 . 6 alkyl.

於本發明中,作為R3,較佳為未經取代或經G1(較佳為羥基、鹵素基、C1~6烷氧基、C1~6烷基羰氧基、C1~6烷氧基羰氧基)取代之C1~6烷基、未經取代或經G1取代之C1~6烷氧基(較佳為未經取代)、未經取代之C3~8環烷基(較佳為3~4環烷基)、未經取代或經G1取代之C1~6烷基羰氧基(較佳為未經取代)、未經取代或經G2取代之C6~10芳基(較佳為未經取代之苯基)、(未經取代或經G1取代之C1~6烷氧基亞胺基)-C1~6烷基(較佳為未經取代)、鹵素基、氰基或甲醯基,更佳為未經取代或經G1(較佳為羥基、鹵素基、C1~6烷氧基、C1~6烷基羰氧基、C1~6烷氧基羰氧基)取代之C1~6烷基或鹵素基。 In the present invention, as R 3 , it is preferably unsubstituted or G 1 (preferably a hydroxyl group, a halogen group, a C1-6 alkoxy group, a C1-6 alkyloxy group, a C1-6 alkoxy group). carbonyloxy) substituent of C1 ~ 6 alkyl, unsubstituted or substituted with G 1 of C1 ~ 6 alkoxy group (preferably unsubstituted), C3 ~ 8 non-substituted cycloalkyl group (preferably 3~4 cycloalkyl), unsubstituted or substituted by G 1 C1-6 alkylcarbonyloxy (preferably unsubstituted), unsubstituted or substituted by G 2 C6~10 aryl (more Preferred as unsubstituted phenyl), (unsubstituted or substituted by C 1 C1~6 alkoxyimino)-C1~6 alkyl (preferably unsubstituted), halogen, cyano Or a mercapto group, more preferably unsubstituted or substituted by G1 (preferably hydroxy, halo, C1-6 alkoxy, C1-6 alkyloxycarbonyl, C1-6 alkoxycarbonyloxy) C1~6 alkyl or halogen.

[R4] [R 4 ]

R4表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C2~6烯基、未經取代或經G1取代之C2~6炔基、未經取代或經G1取代之C3~8環烷基、未經取代或經G2取代之C6~10芳基C1~6烷基、未經取代或經G2取代之3~6員雜環基、未經取代或經G2取代之3~6員雜環基C1~6烷基、甲醯基、未經取代或經G1取代之C1~6烷基羰基、未經取代或經G1取代之C3~8環烷基羰基、未經取代或經G1取代之C1~6烯基羰基、未經取代或經G2取代之C6~10芳基羰基、未經取代或經G1取代之C1~6烷氧基羰基、未經取代或經G1取代之C2~6烯氧基羰基、未經取代或經G1取代之C1~6烷基磺醯基、未經取代或經G1取代之C1~6烷基胺基羰基、未經取代或經G1取代之(C1~6烷硫基)羰基、未經取代或經G1取代之C1~6烷基胺基(硫羰基)、或者式(IV)所表示之基。 R 4 represents a hydrogen atom, an unsubstituted or G 1 -substituted C 1-6 alkyl group, an unsubstituted or G 1 -substituted C 2 -6 alkenyl group, an unsubstituted or G 1 -substituted C 2 -6 alkynyl group. , unsubstituted or substituted by G 1 C 3-8 cycloalkyl, unsubstituted or G 2 substituted C 6-10 aryl C 1-6 alkyl, unsubstituted or substituted by G 2 3-6 members heterocyclyl, unsubstituted or substituted with G 2 of the 3 to 6-membered heterocyclic group a C1 to 6 alkyl, methyl acyl, unsubstituted or substituted with G 1 of a C1 to 6 alkyl carbonyl, unsubstituted or G 1 via the C3 ~ 8 cycloalkyl substituted alkylcarbonyl, unsubstituted or substituted with G 1 group of C1 ~ 6 alkenyl carbonyl group, unsubstituted or substituted with G 2 of the C6 ~ 10 aryl-carbonyl group, an unsubstituted or G 1 -substituted alkoxycarbonyl group substituted by G 1 , unsubstituted or substituted C 2 6 alkenyloxycarbonyl group by G 1 , unsubstituted or substituted C 1 6 alkylsulfonyl group by G 1 , unsubstituted or one of C1 ~ 6 alkyl substituted aminocarbonyl through G, unsubstituted or substituted with 1 G of (C1 ~ 6 alkylthio) carbonyl, unsubstituted or substituted with 1 G of C1 ~ 6 alkyl group (thiocarbonyl) or a group represented by the formula (IV).

R4中之C1~6烷基、C2~6烯基、C2~6炔基、C3~8環烷 基、C6~10芳基C1~6烷基、3~6員雜環基、C1~6烷基羰基、C1~6烷氧基羰基、C1~6烷基磺醯基、取代基G1及取代基G2係如已說明者。 Of R 4 is a C1 to 6 alkyl, C2 to 6 alkenyl, C2 to 6 alkynyl group, C3 ~ 8 cycloalkyl group, C6 ~ 10 aryl group a C1 to 6 alkyl, 3 to 6-membered heterocyclic group, a C1 ~ 6 alkylcarbonyl group, C1 ~ 6 alkoxycarbonyl, C1 ~ 6 alkylsulfonyl group, a substituted substituent groups G 1 and G 2 as already described were based.

3~6員雜環基C1~6烷基係於C1~6烷基上取代有3~6員雜環基者。作為3~6員雜環基C1~6烷基,較佳可列舉:四氫呋喃基甲基、四氫吡喃基甲基、二氧雜環戊基甲基、二氧雜環己基甲基等5~6員飽和雜環基C1~6烷基;吡唑基甲基、吡啶基甲基等5~6員雜芳基C1~6烷基。 The 3-6 membered heterocyclic C1~6 alkyl group is substituted with a 3-6 membered heterocyclic group on the C1~6 alkyl group. The 3-6 membered heterocyclic group C1-6 alkyl group is preferably a tetrahydrofuranylmethyl group, a tetrahydropyranylmethyl group, a dioxolylmethyl group or a dioxanylmethyl group. ~6 member saturated heterocyclic group C1~6 alkyl; pyrazolylmethyl, pyridylmethyl and the like 5~6 member heteroaryl C1~6 alkyl group.

C3~8環烷基羰基係於羰基上鍵結有上文所述之C3~8環烷基者。作為C3~8環烷基羰基,可列舉:環丙基羰基、環丁基羰基、環戊基羰基、環己基羰基等。 The C3-8 cycloalkylcarbonyl group is bonded to the carbonyl group having the C3-8 cycloalkyl group described above. Examples of the C3-8 cycloalkylcarbonyl group include a cyclopropylcarbonyl group, a cyclobutylcarbonyl group, a cyclopentylcarbonyl group, and a cyclohexylcarbonyl group.

作為C6~10芳基羰基,係於羰基上鍵結有C6~10芳基者。作為C6~10芳基羰基,可列舉苯甲醯基等。 As the C6-10 arylcarbonyl group, a C6-10 aryl group is bonded to a carbonyl group. Examples of the C6-10 arylcarbonyl group include a benzamidine group and the like.

作為C2~6烯基羰基,可列舉:丙烯醯基、甲基丙烯醯基等。 Examples of the C2-6 alkenylcarbonyl group include an acryloyl group and a methacryloyl group.

作為C2~6烯氧基羰基,可列舉:乙烯氧基羰基、1-丙烯氧基羰基、2-丙烯氧基羰基(烯丙氧基羰基)等。 Examples of the C2-6 alkenyloxycarbonyl group include a vinyloxycarbonyl group, a 1-propenyloxycarbonyl group, and a 2-propenyloxycarbonyl group (allyloxycarbonyl group).

作為C1~6烷基胺基羰基,可列舉:甲基胺基羰基、二甲胺基羰基等。 Examples of the C1-6 alkylaminocarbonyl group include a methylaminocarbonyl group and a dimethylaminocarbonyl group.

作為(C1~6烷硫基)羰基,可列舉:(甲硫基)羰基、(乙硫基)羰基等。 Examples of the (C1-6 alkylthio)carbonyl group include a (methylthio)carbonyl group and an (ethylthio)carbonyl group.

作為C1~6烷基胺基(硫羰基),可列舉:甲基胺基(硫羰基)、二甲胺基(硫羰基)等。 Examples of the C1-6 alkylamino group (thiocarbonyl group) include a methylamino group (thiocarbonyl group) and a dimethylamino group (thiocarbonyl group).

[式(IV)中,Ga分別獨立地表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C2~6烯基、未經取代或經G1取代之C2~6炔基、未經取代或經G1取代之C3~8環烷基、或者未經取代或經G2取代之C6~10芳基。 [In the formula (IV), G a each independently represents a hydrogen atom, an unsubstituted or G 1 -substituted C 1-6 alkyl group, an unsubstituted or G 1 -substituted C 2 -6 alkenyl group, unsubstituted or substituted by G 1 group of C2 ~ 6 alkynyl, unsubstituted or substituted with G 1 of C3 ~ 8 cycloalkyl, or unsubstituted or substituted G 2 of the C6 ~ 10 aryl group.

Gb表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C2~6烯基、未經取代或經G1取代之C2~6炔基、未經取代或經G1取代之C3~8環烷基、未經取代或經G2取代之C6~10芳基、或者未經取代或經G2取代之3~6員雜環基。 G b represents a hydrogen atom, an unsubstituted or G 1 -substituted C 1-6 alkyl group, an unsubstituted or G 1 -substituted C 2 -6 alkenyl group, an unsubstituted or G 1 -substituted C 2 -6 alkynyl group. , unsubstituted or substituted with G 1 of C3 ~ 8 cycloalkyl, unsubstituted or substituted with G 2 of the C6 ~ 10 aryl group, or an unsubstituted or substituted G 2 of the 3 to 6-membered heterocyclic group.

T表示氧原子、氧基羰基、羰氧基、氧基羰氧基、硫原子、(硫基)羰基、羰基(硫基)、(硫基)羰氧基、氧基羰基(硫基)、或式:-O-C(=O)-N(Gb)-。 T represents an oxygen atom, an oxycarbonyl group, a carbonyloxy group, an oxycarbonyloxy group, a sulfur atom, a (thio)carbonyl group, a carbonyl group (thio group), a (thio)carbonyloxy group, an oxycarbonyl group (thio group), Or formula: -OC(=O)-N(G b )-.

*表示式(IV)所表示之基之鍵結位置] * indicates the bonding position of the base represented by the formula (IV)]

作為式(IV)所表示之基之例,可列舉如下所示者。 Examples of the group represented by the formula (IV) include the following.

於本發明中,作為R4,較佳為氫原子、未經取代或經G1(較 佳為C1~6烷基羰氧基、C1~6烷氧基羰氧基、鹵素基)取代之C1~6烷基、未經取代或經G1取代之C2~6烯基(較佳為未經取代)、未經取代或經G2(較佳為C1~6烷氧基)取代之C6~10芳基C1~6烷基(較佳為苄基)、未經取代或經G1(較佳為C1~6烷氧基、C1~6烷基羰氧基)取代之C1~6烷基羰基、未經取代或經G1取代之C1~6烷氧基羰基(較佳為未經取代)、未經取代或經G1取代之C2~6烯基羰基(較佳為未經取代)、未經取代或經G1取代之C1~6烷基胺基羰基(較佳為未經取代)、未經取代或經G1取代之(C1~6烷硫基)羰基(較佳為未經取代)、未經取代或經G2(較佳為羥基、羥基C1~6烷基)取代之雜環基(較佳為3~6員飽和雜環基),更佳為氫原子、未經取代或經G1(較佳為C1~6烷基羰氧基、C1~6烷氧基羰氧基)取代之C1~6烷基、未經取代或經G1(較佳為C1~6烷氧基、C1~6烷基羰氧基)取代之C1~6烷基羰基、或者未經取代或經G1取代之C1~6烷氧基羰基。 In the present invention, R 4 is preferably a hydrogen atom, unsubstituted or substituted by G 1 (preferably a C1-6 alkyloxycarbonyl group, a C1-6 alkoxycarbonyloxy group, a halogen group). C1 ~ 6 alkyl, the unsubstituted or substituted by G 1 C2 ~ 6 alkenyl group (preferably unsubstituted), a substituted or unsubstituted by G 2 (preferably C1 ~ 6 alkoxy) of C6 10 ~ C1 ~ 6 alkyl aryl group (preferably a benzyl group), an unsubstituted or G 1 (preferably C1 ~ 6 alkoxy, C1 ~ 6 alkyl-carbonyloxy) of C1 ~ 6 alkoxy substituted with carbonyl group, unsubstituted or substituted with G 1 of C1 ~ 6 alkoxycarbonyl group (preferably unsubstituted), unsubstituted or substituted with G 1 of C2 ~ 6 alkenyl-carbonyl group (preferably unsubstituted ), unsubstituted or substituted with G 1 group of C1 ~ 6 alkyl-carbonyl group (preferably unsubstituted), unsubstituted or substituted with G 1 of (C1 ~ 6 alkylthio) carbonyl group (preferably Unsubstituted), unsubstituted or heterocyclic group substituted by G 2 (preferably hydroxy, hydroxy C 1-6 alkyl) (preferably 3 to 6 membered saturated heterocyclic group), more preferably a hydrogen atom, unsubstituted or G 1 (preferably C1 ~ 6 alkylcarbonyloxy, C1 ~ 6 alkoxycarbonyl group) substituted with the C1 ~ 6 alkyl, unsubstituted or G 1 (preferably C1 ~6 alkoxy C1 ~ 6 alkyl-carbonyloxy) of C1 ~ 6 alkyl substituted with a carbonyl group, or G 1 unsubstituted or substituted with the C1 ~ 6 alkoxycarbonyl group.

[Q] [Q]

Q表示式(II)或式(III)所表示之有機基中之任一者。再者,*表示式(II)或式(III)所表示之有機基之鍵結位置。 Q represents any one of the organic groups represented by the formula (II) or the formula (III). Further, * represents a bonding position of an organic group represented by the formula (II) or the formula (III).

〈Ra<R a

Ra表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C3~8環烷基、胺基、C1~6烷基羰基胺基、或者未經取代或經G2取代之C6~10芳基。 R a represents a hydrogen atom, an unsubstituted or G 1 -substituted C 1-6 alkyl group, an unsubstituted or G 1 -substituted C 3 -8 cycloalkyl group, an amine group, a C 1-6 alkylcarbonylamino group, or C6~10 aryl group which is unsubstituted or substituted by G 2 .

Ra中之C1~6烷基、C3~8環烷基、C6~10芳基、取代基G1及取代基G2係如已說明者。 R a in the C1 ~ 6 alkyl, C3 ~ 8 cycloalkyl group, C6 ~ 10 aryl group, a substituted the substituent group G 1 and G 2 as already described were based.

C1~6烷基羰基胺基係於胺基上取代有已說明之C1~6烷基羰基者。作為C1~6烷基羰基胺基,可列舉:乙醯基胺基、丙醯基胺基等。 The C1~6 alkylcarbonylamino group is substituted on the amine group with the C1~6 alkylcarbonyl group described. Examples of the C1-6 alkyloxycarbonyl group include an ethyl hydrazino group and a propyl hydrazino group.

於本發明中,作為Ra,較佳為氫原子、未經取代之烷基、未經取代之C3~8環烷基(較佳為C3~4環烷基)、胺基、C1~6烷基羰基胺基、未經取代或經G2(較佳為C1~6鹵化烷基)取代之C6~10芳基(較佳為苯基),更佳為未經取代之烷基或氫原子。 In the present invention, as R a , a hydrogen atom, an unsubstituted alkyl group, an unsubstituted C 3-8 cycloalkyl group (preferably a C 3 ~ 4 cycloalkyl group), an amine group, and a C 1 -6 are preferable. An alkylcarbonylamino group, a C6-10 aryl group (preferably a phenyl group) which is unsubstituted or substituted with G 2 (preferably a C1-6 alkyl halide), more preferably an unsubstituted alkyl group or hydrogen atom.

〈Ar1<Ar 1

Ar1表示未經取代或經G2取代之C6~10芳基、或者未經取代或經G2取代之3~10員雜環基。 Ar 1 represents an unsubstituted or substituted G 2 of C6 to 10 aryl group, or an unsubstituted or substituted G 2 of the 3 to 10-membered heterocyclic group.

Ar1中之C6~10芳基、及取代基G2係如已說明者。 The C6-10 aryl group in Ar 1 and the substituent G 2 are as described above.

3~10員雜環基係含有選自由氮原子、氧原子及硫原子所組成之群中之1~4個雜原子作為環之構成原子之環狀之基。雜環基可為單環及多環中之任一種。若多環雜環基中至少一個環為雜環基,則其餘環可為飽和脂環、不飽和脂環或芳香環中之任一種。作為3~10員雜環基,可列舉:3~10員飽和雜環基、5~10員雜芳基、5~6員部分不飽和雜環基等。 The 3 to 10 membered heterocyclic group contains a ring-shaped group of one to four hetero atoms selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom as a constituent atom of the ring. The heterocyclic group may be any of a monocyclic ring and a polycyclic ring. If at least one of the polycyclic heterocyclic groups is a heterocyclic group, the remaining ring may be any of a saturated alicyclic ring, an unsaturated alicyclic ring or an aromatic ring. Examples of the 3 to 10 membered heterocyclic group include a 3 to 10 membered saturated heterocyclic group, a 5 to 10 membered heteroaryl group, and a 5 to 6 membered partially unsaturated heterocyclic group.

作為3~10員飽和雜環基,可列舉: 氮丙啶基、環氧乙烷基等3員飽和雜環基;氮雜環丁基、氧雜環丁基等4員飽和雜環基;吡咯啶基、四氫呋喃基、四氫噻唑基、咪唑啶基、吡唑啶基、二氧雜環戊基等5員飽和雜環基;哌啶基、哌基、啉基、四氫吡喃基、二氧雜環己基等6員飽和雜環基;等。 Examples of the 3 to 10 membered saturated heterocyclic group include a 3-membered saturated heterocyclic group such as an aziridine group or an oxiranyl group; and a 4-membered saturated heterocyclic group such as azetidinyl or oxetanyl; 5-membered saturated heterocyclic group such as pyrrolidinyl, tetrahydrofuranyl, tetrahydrothiazolyl, imidazolidinyl, pyrazolylyl, dioxolyl; piperidinyl, piperidine base, a 6-membered saturated heterocyclic group such as a phenyl group, a tetrahydropyranyl group or a dioxanyl group;

作為5~10員雜芳基,可列舉:吡咯基、呋喃基、噻吩基、咪唑基、吡唑基、唑基、異唑基、噻唑基、異噻唑基、三唑基、二唑基、噻二唑基、四唑基等5員雜芳基;吡啶基、吡基、嘧啶基、嗒基、三基等6員雜芳基;吲哚基、異吲哚基、苯并呋喃基、吲唑基、苯并唑基、苯并異唑基、苯并噻唑基、苯并異噻唑基等9員雜芳基;喹啉基、異喹啉基、啉基、呔基、喹唑啉基、喹啉基等10員雜芳基;等。 Examples of the 5- to 10-membered heteroaryl group include a pyrrolyl group, a furyl group, a thienyl group, an imidazolyl group, and a pyrazolyl group. Azolyl, different Azyl, thiazolyl, isothiazolyl, triazolyl, 5-membered heteroaryl group such as oxazolyl, thiadiazolyl, tetrazolyl; pyridyl, pyridyl Base, pyrimidinyl, oxime Base, three 6-membered heteroaryl; fluorenyl, isodecyl, benzofuranyl, carbazolyl, benzo Azolyl, benzopyrene 9-membered heteroaryl group such as azolyl, benzothiazolyl, benzisothiazolyl; quinolyl, isoquinolinyl, Olinyl group, hydrazine Base, quinazolinyl, quin 10-membered heteroaryl group such as phenyl group;

作為5~6員部分不飽和雜環基,可列舉:吡咯啉基、二氫呋喃基、咪唑啉基、吡唑啉基、唑啉基等5員部分不飽和雜環基;異唑啉基、二氫吡喃基等6員部分不飽和雜環基;等。 Examples of the 5- to 6-membered partially unsaturated heterocyclic group include a pyrrolinyl group, a dihydrofuranyl group, an imidazolinyl group, and a pyrazolinyl group. 5-membered partially unsaturated heterocyclic group such as oxazoline group; a 6-membered partially unsaturated heterocyclic group such as an oxazoline group or a dihydropyranyl group;

作為Ar1中之3~10員雜環基,較佳可列舉:吡唑基、吡啶 基、嘧啶基、喹啉基等5~10員雜芳基。 The 3 to 10 membered heterocyclic group in Ar 1 is preferably a 5- to 10-membered heteroaryl group such as pyrazolyl, pyridyl, pyrimidinyl or quinolyl.

於本發明中,Ar1較佳為未經取代或經G2取代之C6~10芳基(較佳為苯基、萘基)或者未經取代或經G2取代之5~6員雜芳基(較佳為吡啶基),更佳為未經取代或經G2取代之苯基或者未經取代或經G2取代之吡啶基。 In the present invention, Ar 1 is preferably an unsubstituted or G 2 -substituted C 6-10 aryl group (preferably phenyl, naphthyl) or an unsubstituted or G 2 substituted 5-6 member heteroaryl. The group (preferably pyridyl) is more preferably an unsubstituted or G 2 -substituted phenyl group or an unsubstituted or G 2 -substituted pyridyl group.

Ar1中之G2較佳為C1~6烷基、C1~6鹵化烷基、C1~6烷氧基、C1~6烷氧基C1~6鹵化烷基、C1~6鹵化烷氧基、C1~6烷氧基羰基、未經取代或經G21(較佳為C1~6鹵化烷基)取代之C6~10芳基(較佳為苯基)、未經取代或經G21(較佳為C1~6鹵化烷基)取代之C6~10芳基C1~6烷基(較佳為苄基)、未經取代或經G21(較佳為C1~6鹵化烷基)取代之C6~10芳氧基(較佳為苯氧基)、C1~6鹵化烷硫基、C1~6鹵化烷基亞磺醯基、C1~6鹵化烷基磺醯基、五氟硫基、未經取代或經G21(較佳為C1~6鹵化烷基)取代之C6~10芳硫基(較佳為苯硫基)、未經取代或經G21(較佳為C1~6鹵化烷基)取代之C6~10芳基亞磺醯基(較佳為苯基亞磺醯基)、未經取代或經G21(較佳為C1~6鹵化烷基)取代之C6~10芳基磺醯基(較佳為苯基磺醯基)、硝基、C1~6鹵化伸烷基二氧基及/或鹵素基,更佳為C1~6烷基、C1~6鹵化烷基、C1~6鹵化烷氧基、未經取代或經G21(較佳為C1~6鹵化烷基)取代之C6~10芳氧基(較佳為苯氧基)及/或鹵素基。 G 2 in Ar 1 is preferably a C1~6 alkyl group, a C1~6 halogenated alkyl group, a C1~6 alkoxy group, a C1~6 alkoxy C1~6 halogenated alkyl group, a C1~6 halogenated alkoxy group, C1 ~ 6 alkoxycarbonyl, unsubstituted or G 21 (preferably halogenated C1 ~ 6 alkyl) substituted with the C6 ~ 10 aryl group (preferably phenyl), unsubstituted or G 21 (more C6~10 aryl C1~6 alkyl (preferably benzyl) substituted, C6 substituted by G 21 (preferably C1~6 halogenated alkyl) ~10 aryloxy (preferably phenoxy), C1~6 halogenated alkylthio, C1~6 halogenated alkyl sulfinylene, C1~6 halogenated alkylsulfonyl, pentafluorothio, un unsubstituted or G 21 (preferably halogenated C1 ~ 6 alkyl) substituted with the C6 ~ 10 aryl group (preferably phenyl group), an unsubstituted or G 21 (preferably a halogenated alkyl group of C1 ~ 6 ) substituted aryl of C6 ~ 10 acyl alkylsulfinyl (preferably sulfonylurea phenyl group), unsubstituted or G 21 (preferably halogenated C1 ~ 6 alkyl) C6 ~ 10 aryl group of the sulfonyl Sulfhydryl (preferably phenylsulfonyl), nitro, C1~6 halogenated alkyldioxy and/or halogen, more preferably C1~6 alkyl, C1~6 halogenated alkyl, C1~ 6 Halogenated alkoxy, unsubstituted or via G 21 (preferably C1) The ~6 halogenated alkyl group is substituted with a C6-10 aryloxy group (preferably a phenoxy group) and/or a halogen group.

〈Ar2<Ar 2

Ar2表示未經取代或經G2取代之C6~10芳基、未經取代或經G2取代之C6~10芳氧基、未經取代或經G2取代之C6~10芳硫基、未經取代或經G2 取代之C6~10芳基亞磺醯基、未經取代或經G2取代之C6~10芳基磺醯基、未經取代或經G2取代之3~10員雜環基、未經取代或經G2取代之3~10員雜環氧基、未經取代或經G2取代之3~6員雜環硫基或二茂鐵基。 Ar 2 represents an unsubstituted or G 2 -substituted C 6 -10 aryl group, an unsubstituted or G 2 -substituted C 6 -10 aryloxy group, an unsubstituted or G 2 -substituted C 6 -10 arylthio group, Unsubstituted or G 2 substituted C6-10 sulfinyl, unsubstituted or G 2 substituted C6-10 sulfonyl, unsubstituted or substituted by G 2 3~10 members Heterocyclic group, unsubstituted or G 2 substituted 3-10 membered heterocyclic oxy group, unsubstituted or G 2 substituted 3-6 membered heterocyclic thio or ferrocene group.

Ar2中之C6~10芳基係如已說明者,較佳為苯基。 The C6-10 aryl group in Ar 2 is preferably a phenyl group as described above.

C6~10芳氧基係如已說明者,較佳為苯氧基。 The C6-10 aryloxy group is preferably a phenoxy group as described above.

3~10員雜環基係如已說明者,較佳為5~10員環雜芳基,更佳為噻唑基、三唑基、吡唑基、吡啶基、嗒基、喹啉基。 The 3 to 10 membered heterocyclic group is as described, preferably a 5 to 10 membered ring heteroaryl group, more preferably a thiazolyl group, a triazolyl group, a pyrazolyl group, a pyridyl group or a fluorene group. Base, quinolyl.

3~10員雜環氧基係於羥基上取代有3~10員雜環基者。作為3~10員雜環氧基,較佳為5~6員飽和雜環氧基、5~6員雜芳氧基。 The 3 to 10 membered heterocyclic oxy group is substituted with a 3 to 10 membered heterocyclic group on the hydroxy group. The 3- to 10-membered heterocyclic oxy group is preferably a 5- to 6-membered saturated heterocyclic oxy group or a 5- to 6-membered heteroaryloxy group.

作為5~6員雜芳氧基,更佳為吡唑氧基、吡啶氧基、嗒氧基、嘧啶氧基。 As a 5- to 6-membered heteroaryloxy group, more preferably pyrazolyloxy, pyridyloxy or fluorene Oxyl, pyrimidinyloxy.

3~10員雜環硫基係於SH基上取代有3~10員雜環基者。作為3~10員雜環硫基,可列舉:吡唑硫基、吡啶硫基等5~6員雜芳硫基,較佳為吡啶硫基。 The 3 to 10 membered heterocyclic thio group is substituted with a 3 to 10 membered heterocyclic group on the SH group. Examples of the 3 to 10 membered heterocyclic thio group include a 5- to 6-membered heteroarylthio group such as a pyrazolylthio group and a pyridylthio group, and a pyridylthio group is preferred.

C6~10芳硫基係如已說明者,較佳為苯硫基。 The C6-10 arylthio group is as described above, preferably a phenylthio group.

芳基亞磺醯基係如已說明者,較佳為苯基亞磺醯基。 The arylsulfinyl group is preferably a phenylsulfinylene group as described above.

芳基磺醯基係如已說明者,較佳為苯基磺醯基。 The arylsulfonyl group is preferably a phenylsulfonyl group as described above.

取代基G2係如已說明者,較佳為C1~6烷基、C1~6鹵化烷基、C1~6烷氧基、C3~8環烷基C1~6烷氧基(較佳為C3~4環烷基烷氧基)、C1~6鹵化烷氧基、未經取代或經G21取代之C6~10芳基(較佳為苯基)、未經取代或經G21取代之C6~10芳氧基(較佳為苯氧基)、未經取代或經G21取代之5~6員雜環基(較佳為吡啶基)、未經取代或經G21取代 之5~6員雜環氧基(較佳為吡啶氧基)、五氟硫基、氰基、鹵素基、或C1~6鹵化伸烷基二氧基。 The substituent G 2 is as described above, preferably a C1-6 alkyl group, a C1-6 alkyl halide, a C1-6 alkyloxy group, a C3-8 cycloalkyl C1-6 alkyl group (preferably C3). 1-4 cycloalkyl-alkoxy), C1 ~ 6 halogenated alkoxy, unsubstituted or substituted with the G 21 C6 ~ 10 aryl group (preferably phenyl), unsubstituted or substituted with the C6 G 21 ~10 aryloxy (preferably phenoxy), unsubstituted or substituted by G 21 5-6 membered heterocyclic group (preferably pyridyl), unsubstituted or substituted by G 21 5~6 A heterocyclic oxy group (preferably a pyridyloxy group), a pentafluorothio group, a cyano group, a halogen group, or a C1~6 halogenated alkylenedioxy group.

作為G2,更佳為表示C1~6鹵化烷基、C1~6烷氧基、C1~6鹵化烷氧基、未經取代或經G21取代之苯基、未經取代或經G21取代之苯氧基、未經取代或經G21取代之吡啶基、未經取代或經G21取代之吡啶氧基、鹵素基、或C1~2鹵化伸烷基二氧基。 As G 2, more preferably represents a halogenated C1 ~ 6 alkyl, C1 ~ 6 alkoxy group, a halogenated C1 ~ 6 alkoxy, unsubstituted or substituted with G 21 of phenyl, unsubstituted or substituted by G 21 a phenoxy group, an unsubstituted or G 21 -substituted pyridyl group, an unsubstituted or G 21 -substituted pyridyloxy group, a halogen group, or a C1~2 halogenated alkylenedioxy group.

取代基G21係如已說明者,較佳為鹵素基、C1~6鹵化烷基或C1~6鹵化烷氧基。 The substituent G 21 is preferably a halogen group, a C1 to 6 halogenated alkyl group or a C1 to 6 halogenated alkoxy group, as described above.

該等中,作為Ar2,較佳為未經取代或經G2取代之C6~10芳基(較佳為苯基)、未經取代或經G2取代之C6~10芳氧基(較佳為苯氧基)、未經取代或經G2取代之3~10員雜環基(較佳為噻唑基、三唑基、吡唑基、吡啶基、嗒基、喹啉基)、未經取代或經G2取代之3~10員雜環氧基(較佳為吡啶氧基、吡氧基、嘧啶氧基)。 In these, as Ar 2, preferably unsubstituted or substituted with G 2 of the C6 ~ 10 aryl group (preferably phenyl), unsubstituted or substituted by the G 2 C6 ~ 10 aryloxy group (more Preferably, the phenoxy group, the unsubstituted or G 2 substituted 3-10 membered heterocyclic group (preferably thiazolyl, triazolyl, pyrazolyl, pyridyl, fluorene) a 3- to 10-membered heterocyclic oxy group (preferably pyridyloxy, pyridine, unsubstituted or substituted by G 2 ) Oxyl, pyrimidinyloxy).

又,作為G2,更佳為C1~6鹵化烷基、C1~6鹵化烷氧基、鹵素基。 Further, as G 2 , a C1-6 halogenated alkyl group, a C1-6 halogenated alkoxy group, or a halogen group is more preferable.

〈Ba<B a

Ba表示未經取代或經G4取代之C1~C6伸烷基、未經取代或經G4取代之C2~C6伸烯基、未經取代或經G4取代之C2~C6伸炔基、未經取代或經G4取代之C1~C6伸烷氧基C1~6伸烷基、未經取代或經G4取代之C3~C6伸環烷基、未經取代或經G4取代之C1~C6伸烷基C3~6伸環烷基、未經取代或經G4取代之C1~C6伸烷氧基C3~6伸環烷基、未經取代或經G4取代之C4~C6伸環烯基、或者未經取代或經G4取代之3~6員伸雜環基。 B a represents an unsubstituted or G 4 -substituted C 1 -C 6 alkylene group, an unsubstituted or G 4 -substituted C 2 -C 6 alkenyl group, an unsubstituted or G 4 -substituted C 2 -C 6 alkynyl group Unsubstituted or substituted by G 4 C1~C6 alkoxy C1~6 alkyl, unsubstituted or G 4 substituted C3~C6 cycloalkyl, unsubstituted or substituted by G 4 C1~C6 alkylene C3~6 cycloalkyl, unsubstituted or G 4 substituted C1~C6 alkoxy C3~6 cycloalkyl, unsubstituted or substituted by G 4 C4~C6 A cycloalkenyl group, or a 3 to 6 membered heterocyclic group which is unsubstituted or substituted with G 4 .

Ba中之C1~C6伸烷基係如已說明者。 The C1~C6 alkylene group in B a is as described.

C2~C6伸烯基係脫去C2~C6烯烴中之2個氫原子而成之二價基。作為C2~C6伸烯基,可列舉:伸乙烯基、伸丙烯基、伸丁烯基等。 The C2~C6 extended alkenyl group is a divalent group obtained by removing two hydrogen atoms in the C2~C6 olefin. Examples of the C2-C6 alkenyl group include a vinyl group, a propylene group, and a butenyl group.

C2~C6伸炔基係脫去C2~C6炔烴中之2個氫原子而成之二價基。作為C2~C6伸炔基,可列舉:伸乙炔基、伸丙炔基、伸丁炔基等。 The C2~C6 alkynyl group is a divalent group obtained by removing two hydrogen atoms in the C2~C6 alkyne. Examples of the C2 to C6 alkynyl group include an ethynyl group, a propargyl group, and a butynyl group.

C1~C6伸烷氧基C1~6伸烷基係2個C1~6伸烷基經由氧原子鍵結而成之基。作為C1~C6伸烷氧基C1~6伸烷基,可列舉:亞甲氧基亞甲基、亞甲氧基伸乙基、伸乙氧基亞甲基等。 The C1~C6 alkoxy group C1~6 alkyl group is a group in which two C1~6 alkyl groups are bonded via an oxygen atom. Examples of the C1 to C6 alkoxy C1~6 alkylene group include a methyleneoxymethylene group, a methyleneoxyethyl group, and an ethoxymethylene group.

C3~C6伸環烷基係脫去C3~C6環烷烴中之2個氫原子而成之二價基。作為C3~C6伸環烷基,可列舉:伸環丙基(1,2-伸環丙基)、伸環丁基(1,2-伸環丁基、或1,3-伸環戊基)、伸環戊基(1,2-伸環戊基、或1,3-伸環戊基)、伸環己基(1,2-伸環己基、1,3-伸環己基、或1,4-伸環己基)等,較佳為伸環戊基或伸環己基。 The C3~C6 cycloalkyl group is a divalent group obtained by removing two hydrogen atoms of the C3~C6 cycloalkane. Examples of the C3 to C6 cycloalkylene group include a cyclopropyl group (1,2-cyclopropyl group), a cyclobutene butyl group (1,2-cyclopentene butyl group, or a 1,3-cyclopentylene group). ), a cyclopentyl group (1,2-cyclopentyl, or a 1,3-cyclopentyl), a cyclohexyl group (1,2-cyclohexylene, 1,3-cyclohexylene, or 1, 4-cyclohexyl), etc., preferably a cyclopentyl group or a cyclohexyl group.

C1~C6伸烷基C3~6伸環烷基係C1~6伸烷基與C3~6伸環烷基鍵結而成之基。 The C1~C6 alkylene C3~6 extended cycloalkyl group is a group of C1~6 alkylene groups bonded to a C3~6 extended cycloalkyl group.

作為C1~C6伸烷基C3~6伸環烷基,較佳為亞甲基伸環丙基、亞甲氧基伸環己基、伸乙氧基伸環己基等C1~2伸烷基C3~6伸環烷基。 As a C1~C6 alkylene C3~6 cycloalkylene group, preferably a methylene cyclopropyl group, a methyleneoxycyclohexyl group, an exoethoxycyclohexyl group, etc., a C1~2 alkylene group C3~6 Cycloalkyl.

C1~C6伸烷氧基C3~6伸環烷基係C1~6伸烷基與C3~6伸環烷基經由氧原子鍵結而成之基。作為C1~C6伸烷氧基C3~6伸環烷基,較佳為亞甲氧基伸環丙基、亞甲氧基伸環己基、伸乙氧基伸環己基等C1~2伸烷氧基C3~6伸環烷基。 The C1~C6 alkoxy group C3~6 cycloalkylene group C1~6 alkylene group and the C3~6 cycloalkyl group are bonded via an oxygen atom. As the C1~C6 alkoxy C3~6 cycloalkyl group, preferably a methyleneoxycyclopropyl group, a methyleneoxycyclohexyl group, an exoethoxy extended cyclohexyl group, etc. C1~2 alkoxy group C3~ 6 cycloalkyl group.

C4~C6伸環烯基係脫去C3~C6環烯烴中之2個氫原子而成之二價基。作為C4~C6伸環烯基,可列舉:伸環丁烯基(1,2-伸環丁烯 基、1,3-伸環丁烯基、1,3-伸環丁烯基、或3,4-伸環丁烯基)、伸環戊烯基(1,2-伸環戊烯基、1,3-伸環戊烯基、1,4-伸環戊烯基、或1,5-伸環戊烯基)、伸環己烯基(1,2-伸環己烯基、1,3-伸環己烯基、1,4-伸環己烯基)等,較佳為伸環戊烯基或伸環己烯基。 The C4~C6 cycloalkenyl group is a divalent group obtained by removing two hydrogen atoms of the C3~C6 cyclic olefin. Examples of the C4 to C6 cycloalkenyl group include a cyclobutenyl group (1,2-cyclobutene). Base, 1,3-cyclobutenyl, 1,3-cyclobutenyl, or 3,4-cyclobutenyl), cyclopentenyl (1,2-cyclopentenyl, 1,3-cyclopentenyl, 1,4-cyclopentenyl, or 1,5-cyclopentenyl), cyclohexenylene (1,2-cyclohexenyl, 1, 3-cyclohexenylene, 1,4-cyclohexenyl), etc., preferably a cyclopentenyl group or a cyclohexene group.

3~6員伸雜環基係脫去雜脂環式化合物中之2個氫原子而成之二價基。雜脂環式化合物係含有選自由氮原子、氧原子及硫原子所組成之群中之1~4個雜原子作為環之構成原子之非芳香族化合物。 The 3-6 member of the heterocyclic group is a divalent group obtained by removing two hydrogen atoms in the heteroalicyclic compound. The heteroalicyclic compound is a non-aromatic compound containing one to four hetero atoms selected from the group consisting of a nitrogen atom, an oxygen atom and a sulfur atom as a constituent atom of the ring.

作為3~6員伸雜環基,可列舉3~6員飽和伸雜環基或5~6員部分不飽和伸雜環基等。 Examples of the 3- to 6-membered heterocyclic group include a 3 to 6-membered saturated heterocyclic group or a 5- to 6-membered partially unsaturated heterocyclic group.

作為3~6員伸雜環基,可列舉:伸二氫呋喃基、伸四氫呋喃基、伸吡咯啉基、伸吡咯啶基、伸吡唑啉基、伸吡唑啶基、伸咪唑啉基、伸咪唑啶基、伸唑啉基、伸唑啶基、伸噻唑啉基、伸噻唑啶基、異伸唑啶基、異伸噻唑啶基、伸二氫吡喃基、伸四氫吡喃基、伸哌啶基、伸哌基、伸啉基等。 Examples of the heterocyclic group of 3 to 6 members include a dihydrofuranyl group, a tetrahydrofuranyl group, a pyrrolidino group, a pyrrolidinyl group, a pyrazolinyl group, a pyrazolyl group, an imidazolinyl group, and a stretching group. Imidazolidinyl Oxazoline Zyridinyl, thiazolinyl, thiazolidinyl, isoprene Zyridinyl, isothiazolidinyl, dihydropyranyl, tetrahydropyranyl, piperidinyl, piperazine Base Orolinic group and the like.

該等中,作為3~6員伸雜環基,較佳為5~6員飽和伸雜環基,尤佳為伸哌啶基。 In the above, as the 3 to 6 membered heterocyclic group, it is preferably a 5- to 6-membered saturated heterocyclic group, and particularly preferably a piperidinyl group.

再者,於特定之實施態樣中,3~6員伸雜環基亦可經C1~6伸烷基所交聯。 Furthermore, in a specific embodiment, the 3-6 membered heterocyclic group may also be crosslinked by a C1~6 alkylene group.

該等中,Ba較佳為未經取代或經G4取代之C1~C6伸烷基、未經取代或經G4取代之C2~C6伸烯基、未經取代或經G4取代之C2~C6伸炔基、未經取代或經G4取代之C3~C6伸環烷基、或者未經取代或經G4取代之3~6員伸雜環基,更佳為未經取代或經G4取代之C1~C6伸烷基、 未經取代或經G4取代之C3~C6伸環烷基。 In the above, B a is preferably an unsubstituted or G 4 -substituted C 1 -C 6 alkylene group, an unsubstituted or G 4 -substituted C 2 -C 6 alkenyl group, unsubstituted or substituted by G 4 C2 ~ C6 alkynyl group extension, unsubstituted or substituted with G 4 of C3 ~ C6 cycloalkyl stretch, or G 4 unsubstituted or substituted 3 to 6-membered extension of heterocyclyl, more preferably is unsubstituted or G 4 was substituted with the C1 ~ C6 alkylene, unsubstituted or substituted with G 4 of C3 ~ C6 cycloalkyl stretch.

G4表示C1~6烷基、C3~8環烷基、C1~6鹵化烷基、C1~6烷氧基C1~6烷基、C2~6烯氧基C1~6烷基、羥基、C1~6烷氧基、C1~6烷氧基C1~6烷氧基、C2~6烯氧基、C1~6烷氧基羰基、未經取代或經G21取代之C6~10芳基、未經取代或經G21取代之3~6員雜環基、氰基、鹵素基、C1~6伸烷基、C1~6伸烷基二氧基、側氧基、C3~8環烷基C1~6烷基、未經取代或經G21取代之C6~10芳基C1~6烷基、未經取代或經G21取代之3~6員雜環基C1~6烷基、C3~8環烷氧基C1~6烷基、未經取代或經G21取代之C6~10芳氧基C1~6烷基、未經取代或經G21取代之3~6員雜環氧基C1~6烷基、C1~6亞烷基、C1~6烷氧基亞胺基、未經取代或經G21取代之C6~10芳基C1~6烷氧基亞胺基、或C1~6烷基肼基。 G 4 represents a C1~6 alkyl group, a C3~8 cycloalkyl group, a C1~6 halogenated alkyl group, a C1~6 alkoxy C1~6 alkyl group, a C2~6 alkenyloxy C1~6 alkyl group, a hydroxyl group, a C1 group. ~ 6 alkoxy group, a C1 to C6 alkoxy group a C1 ~ 6 alkoxy, C2 ~ 6 alkenyl group, a C1 ~ 6 alkoxycarbonyl, unsubstituted or substituted with the G 21 C6 ~ 10 aryl group, an 3- to 6-membered heterocyclic group substituted by or substituted with G 21 , cyano group, halogen group, C1~6 alkylene group, C1~6 alkylenedioxy group, pendant oxy group, C3-8 cycloalkyl group C1 ~ 6 alkyl, unsubstituted or substituted with G 21 C6 ~ 10 aryl group of a C1 ~ 6 alkyl, unsubstituted or substituted with the G 21-membered heterocyclic group having 3 to 6 a C1 ~ 6 alkyl, C3 ~ 8 cycloalkoxy group having a C1 to 6 alkyl, unsubstituted or substituted with G 21 C6 ~ 10 aryloxy group of a C1 to 6 alkyl, unsubstituted or substituted with the 3 G 21 ~ ~ 6-membered heterocyclic group having a C1 6 alkyl, C1 ~ 6 alkylene group, C1 ~ 6 alkoxyimino group, unsubstituted or substituted with G 21 C6 ~ 10 aryl group of C1 ~ 6 alkoxyimino group, C1 ~ 6 alkoxy, or Base base.

G4中之C1~6烷基、C3~8環烷基、C1~6鹵化烷基、C1~6烷氧基C1~6烷基、C1~6烷氧基、C1~6烷氧基C1~6烷氧基、C1~6烷氧基羰基、C1~6伸烷基二氧基、C6~10芳基、C6~10芳基C1~6烷基、3~6員雜環基、3~6員雜環基C1~6烷基、鹵素基、C1~6伸烷基、取代基G2及取代基G21係如已說明者。 C1~6 alkyl group, C3~8 cycloalkyl group, C1~6 halogenated alkyl group, C1~6 alkoxy C1~6 alkyl group, C1~6 alkoxy group, C1~6 alkoxy group C1 in G 4 ~6 alkoxy, C1-6 alkyloxycarbonyl, C1~6 alkylenedioxy, C6~10 aryl, C6~10 aryl C1-6 alkyl, 3-6 heterocyclyl, 3 a C1 ~ 6-membered heterocyclic group 1-6 alkyl group, a halogen group, a C1 to 6 alkylene, substituted group G 2 and G 21 substituents as already described were based.

C2~6烯氧基係於羥基上取代有C2~6烯基者。作為C2~6烯氧基,可列舉:乙烯氧基、1-丙烯氧基、2-丙烯氧基(烯丙氧基)等。 The C2-6 alkenyloxy group is substituted with a C2-6 alkenyl group on the hydroxyl group. Examples of the C2-6 alkenyloxy group include a vinyloxy group, a 1-propenyloxy group, and a 2-propenyloxy group (allyloxy group).

C2~6烯氧基C1~6烷基係於C1~6烷基上取代有C2~6烯氧基者。作為C2~6烯氧基C1~6烷基,可列舉:乙烯氧基甲基、烯丙氧基甲基等。 The C2-6 alkenyloxy C1-6 alkyl group is substituted with a C2-6 alkenyl group on the C1-6 alkyl group. Examples of the C2-6 alkenyloxy C1-6 alkyl group include a vinyloxymethyl group and an allyloxymethyl group.

作為C3~8環烷基C1~6烷基,可列舉:環丙基甲基、環戊基甲基等。 Examples of the C3-8 cycloalkyl C1-6 alkyl group include a cyclopropylmethyl group and a cyclopentylmethyl group.

作為C3~8環烷氧基C1~6烷基,可列舉:環丙氧基甲基、環己氧基甲基等。 Examples of the C3-8 cycloalkyloxy C1-6 alkyl group include a cyclopropoxymethyl group and a cyclohexyloxymethyl group.

作為C6~10芳氧基C1~6烷基,可列舉:苯氧基甲基、萘氧基甲基等。 Examples of the C6-10 aryloxy C1-6 alkyl group include a phenoxymethyl group and a naphthyloxymethyl group.

作為3~6員雜環氧基C1~6烷基,較佳可列舉:吡唑氧基甲基、吡啶氧基甲基等5~6員雜芳基甲基。 The 3-6 membered heterocyclic oxy C1-6 alkyl group is preferably a 5- to 6-membered heteroarylmethyl group such as a pyrazolylmethyl group or a pyridyloxymethyl group.

作為C1~6亞烷基,可列舉:亞甲基(methylidene)、丙烷-2-亞基等。 Examples of the C1-6 alkylene group include a methylidene group and a propane-2-ylidene group.

作為C1~6烷氧基亞胺基,可列舉:甲氧基亞胺基(MeO-N=)、乙氧基亞胺基(EtO-N=)等。 Examples of the C1-6 alkoxyimine group include a methoxyimino group (MeO-N=) and an ethoxyimino group (EtO-N=).

作為C6~10芳基C1~6烷氧基亞胺基,可列舉苄氧基亞胺基(BnO-N=)等。 Examples of the C6-10 aryl C1-6 alkoxyimine group include a benzyloxyimino group (BnO-N=).

作為C1~6烷基肼基,可列舉:甲基肼基(MeNH-N=)、乙基肼基(EtNH-N=)等。 Examples of the C1-6 alkyl sulfonium group include a methyl fluorenyl group (MeNH-N=) and an ethyl fluorenyl group (EtNH-N=).

該等中,作為G4,較佳為C1~6烷基、C1~6鹵化烷基、C1~6烷氧基C1~6烷基、C2~6烯氧基C1~6烷基、羥基、C1~6烷氧基、C1~6烷氧基羰基、未經取代或經G21取代之C6~10芳基(較佳為苯基)、未經取代或經G21取代之3~6員雜環基(較佳為吡啶基、嘧啶基、二氧雜環戊基)、鹵素基、C1~6伸烷基、C1~6伸烷基二氧基、側氧基、未經取代或經G21取代之C6~10芳基C1~6烷基(較佳為苄基)、未經取代或經G21取代之3~6員雜環基C1~6烷基(較佳為吡啶基甲基、吡唑基甲基、三唑基甲基)、未經取代或經G21取代之C6~10芳氧基C1~6烷基(較佳為苯氧基甲基)、未經取代或經G21取代之3~6員雜環氧基C1~6烷基(較佳為吡唑氧基甲基)、C1~6亞烷基、C1~6烷氧基亞胺基。 In the above, G 4 is preferably a C1-6 alkyl group, a C1-6 halogenated alkyl group, a C1-6 alkoxy C1-6 alkyl group, a C2-6 alkenyl C1-6 alkyl group, a hydroxyl group, or the like. a C1 to 6 alkoxy group, a C1 to 6 alkoxycarbonyl, unsubstituted or substituted with the G 21 C6 ~ 10 aryl group (preferably phenyl), unsubstituted or substituted with the 3 G 21 - 6 Heterocyclic group (preferably pyridyl, pyrimidinyl, dioxolyl), halo, C1-6 alkyl, C1-6 alkyl dioxy, pendant oxy, unsubstituted or via G 21 unsubstituted C6 ~ 10 aryl group of C1 ~ 6 alkyl group (preferably a benzyl group), unsubstituted or substituted by the G21 3 ~ 6-membered heterocyclic group C1 ~ 6 alkyl group (preferably pyridinylmethyl , pyrazolylmethyl, triazolylmethyl), unsubstituted or substituted by G 21 C6-10 aryloxy C1-6 alkyl (preferably phenoxymethyl), unsubstituted or via G- 21 substituted 3-6 membered heterocyclooxy C1-6 alkyl (preferably pyrazolyloxymethyl), C1-6 alkylene, C1-6 alkyl alkoxy.

G4中之取代基G21較佳為C1~6鹵化烷基、C1~6鹵化烷氧基、或鹵素基。 The substituent G 21 in G 4 is preferably a C1-6 halogenated alkyl group, a C1-6 halogenated alkoxy group, or a halogen group.

Ba之碳原子或Ba之取代基G4之一部分亦可與Ar2上之碳原子鍵結而形成5~6員環。作為該5~6員環,可列舉:環戊烯環、環己烯環、二氫呋喃環、二氫二氧雜環己烯(dihydrodioxin)環、二氫吡喃環等,較佳為環戊烯環、環己烯環、二氫二氧雜環己烯環、二氫吡喃環。 The B a B a carbon atom or a part of a substituted group G 4 of carbon atoms may also be bonded to Ar 2 to form the upper 5 to 6-membered ring. Examples of the 5- to 6-membered ring include a cyclopentene ring, a cyclohexene ring, a dihydrofuran ring, a dihydrodioxin ring, a dihydropyran ring, and the like, and preferably a ring. Pentene ring, cyclohexene ring, dihydrodioxane ring, dihydropyran ring.

於本發明之吡啶化合物中亦包含水合物、各種溶劑合物或多晶型等。進而,本發明之吡啶化合物包含基於不對稱碳原子、雙鍵等之立體異構物及該等之混合物、互變異構物。 The pyridine compound of the present invention also contains a hydrate, various solvates or polymorphs. Further, the pyridine compound of the present invention contains a stereoisomer based on an asymmetric carbon atom, a double bond or the like, and a mixture or tautomer thereof.

[互變異構物] [Tautomers]

本發明之吡啶化合物於R4為氫原子之情形時,產生如以下所示之互變異構物吡啶-4-酮化合物。再者,式中之R1、R2、R3、及Q表示與式(I)中之規定同樣之含義。於本發明中,該互變異構物吡啶-4-酮化合物亦包含於本發明中。 In the case where R 4 is a hydrogen atom, the pyridine compound of the present invention produces a tautomeric pyridin-4-one compound as shown below. Further, R 1 , R 2 , R 3 and Q in the formulae have the same meanings as defined in the formula (I). In the present invention, the tautomeric pyridin-4-one compound is also included in the present invention.

[立體異構物] [stereoisomer]

於本發明中,雖然係以同一結構式所表示之化合物,但結構中之原子或取代基之空間配置不同之化合物,例如光學異構物、非鏡像異構物、幾何異構物等全部立體異構物亦包含於本發明中。立體異構物可為單一物 質,亦可為混合物。 In the present invention, although the compounds represented by the same structural formula are used, the compounds having different spatial arrangements of atoms or substituents in the structure, such as optical isomers, non-image isomers, geometric isomers and the like are all three-dimensional. Isomers are also included in the present invention. Stereoisomers can be a single substance It can also be a mixture.

[鹽] [salt]

作為本發明之化合物(I)之鹽,只要為農園藝學上容許之鹽,則無特別限制。例如可列舉:鹽酸、硫酸等無機酸之鹽;乙酸、乳酸等有機酸之鹽;鋰、鈉、鉀等鹼金屬之鹽;鈣、鎂等鹼土金屬之鹽;鐵、銅等過渡金屬之鹽;氨、三乙胺、三丁胺、吡啶、肼等有機鹼之鹽等。化合物(I)之鹽可藉由公知之手法,由化合物(I)而獲得。 The salt of the compound (I) of the present invention is not particularly limited as long as it is an agriculturally acceptable salt. Examples thereof include salts of inorganic acids such as hydrochloric acid and sulfuric acid; salts of organic acids such as acetic acid and lactic acid; salts of alkali metals such as lithium, sodium and potassium; salts of alkaline earth metals such as calcium and magnesium; and salts of transition metals such as iron and copper. A salt of an organic base such as ammonia, triethylamine, tributylamine, pyridine or hydrazine. The salt of the compound (I) can be obtained from the compound (I) by a known method.

[農園藝用殺菌劑、有害生物防除劑、及殺蟲或殺蟎劑] [Agricultural and horticultural fungicides, pest control agents, and insecticides or acaricides]

本發明之農園藝用殺菌劑、有害生物防除劑、及殺蟲或殺蟎劑係含有選自化合物(I)或其鹽(以下有時稱為「本發明化合物」)中之至少一者作為有效成分者。 The agricultural and horticultural fungicide, the pest control agent, and the insecticidal or acaricidal agent of the present invention contain at least one selected from the group consisting of the compound (I) or a salt thereof (hereinafter sometimes referred to as "the compound of the present invention"). Active ingredient.

本發明之農園藝用殺菌劑可用於防除由大範圍種類之絲狀菌、例如屬於藻菌類(Oomycetes)、子囊菌類(Ascomycetes)、不完全菌類(Deuteromycetes)、擔子菌類(Basidiomycetes)、接合菌類(Zygomycetes)之菌引起之植物病害。 The agricultural and horticultural fungicide of the present invention can be used for controlling a wide range of filamentous fungi, for example, belonging to the genus Oomycetes, Ascomycetes, Deuteromycetes, Basidiomycetes, and zygomycetes ( Plant diseases caused by the bacteria of Zygomycetes).

將成為防除對象之植物病害與病原菌之例示於以下。 Examples of plant diseases and pathogenic bacteria to be controlled are shown below.

甜菜:褐斑病(甜菜生尾孢菌(Cercospora beticola))、黑根病(Aphanomyces cochlioides)、根腐病(紋枯病菌(Thanatephorus cucumeris))、葉腐病(Thanatephorus cucumeris)等 Beets: brown spot disease (Cercospora beticola), Aphanomyces cochlioides, root rot (Thanatephorus cucumeris), leaf rot (Thanatephorus cucumeris), etc.

花生:褐斑病(球腔菌(Mycosphaerella arachidis))、污斑病(Ascochyta sp.)、銹病(落花生柄鏽菌(Puccinia arachidis))、立枯病(德巴利腐黴(Pythium debaryanum))、鏽斑病(互生鏈格孢菌(Alternaria alternata))、白絹病(白 絹病菌(Sclerotium rolfsii))、黑澀病(博克萊球腔菌(Mycosphaerella berkeleyi))等 Peanut: brown spot disease (Mycosphaerella arachidis), spot disease (Ascochyta sp.), rust (Puccinia arachidis), blight (Pythium debaryanum) , rust spot (Alternaria alternata), white rickets (white Sclerotium rolfsii, black scorpion (Mycosphaerella berkeleyi), etc.

黃瓜:白粉病(白粉菌(Sphaerotheca fuliginea))、露菌病(露菌病菌(Pseudoperonospora cubensis))、蔓枯病(蔓枯病菌(Mycosphaerella melonis))、莖腐病(尖鐮孢菌(Fusarium oxysporum))、菌核病(菌核病菌(Sclerotinia sclerotiorum))、灰黴病(灰黴病菌(Botrytis cinerea))、炭疽病(炭疽病菌(Colletotrichum orbiculare))、黑星病(Cladosporium cucumerinum)、褐斑病(鐵刀木棒狀桿孢菌(Corynespora cassicola))、苗立枯病(Pythium debaryanum、苗立枯病菌(Rhizoctonia solani Kuhn))、擬莖點黴根腐病(Phomopsis sp.)、斑點細菌病(角斑病假單孢菌(Pseudomonas syringae pv.Lachrymans))等 Cucumber: Powdery mildew (Sphaerotheca fuliginea), Phytophthora (Pseudoperonospora cubensis), Bacterial wilt (Mycosphaerella melonis), Stem rot (Fusarium oxysporum) )), sclerotinia sclerotiorum (Sclerotinia sclerotiorum), gray mold (Botrytis cinerea), anthracnose (Colletotrichum orbiculare), black spot disease (Cladosporium cucumerinum), brown spot Disease (Corynespora cassicola), Bacterial blight (Pythium debaryanum, Rhizoctonia solani Kuhn), Phomopsis sp., spotted bacteria Disease (Pseudomonas syringae pv. Lachrymans), etc.

番茄:灰黴病(灰黴病菌(Botrytis cinerea))、葉黴病(葉黴病菌(Cladosporium fulvum))、疫病(疫菌(Phytophthora infestans))、半身萎凋病(半身萎凋病菌(Verticillium albo-atrum))、白粉病(番茄白粉病菌(Oidium neolycopersici))、輪紋病(番茄輪紋病菌(Alternaria solani))、煤黴病(煤灰假尾孢菌(Pseudocercospora fuligena))等 Tomato: Botrytis cinerea (Botrytis cinerea), leaf mold (Cladosporium fulvum), Phytophthora infestans, and half-body wilt (Verticillium albo-atrum) )), powdery mildew (Oidium neolycopersici), ring disease (Alternaria solani), coal mold (Pseudocercospora fuligena), etc.

茄子:灰黴病(Botrytis cinerea)、黑枯病(茄黑枯病菌(Corynespora melongenae))、白粉病(二孢白粉菌(Erysiphe cichoracearum))、煤黴病(灰毛茄菌絨孢菌(Mycovellosiella nattrassii))、菌核病(Sclerotinia sclerotiorum)等 Eggplant: Botrytis cinerea, black blight (Corynespora melongenae), powdery mildew (Erysiphe cichoracearum), coal mold (Mycovellosiella) Nattrassii)), Sclerotinia sclerotiorum, etc.

草莓:灰黴病(Botrytis cinerea)、白粉病(白粉病菌(Sphaerotheca humuli))、炭疽病(急尖炭疽刺盤孢菌(Colletotrichum acutatum)、Colletotrichum fragariae)、疫病(疫病菌(Phytophthora cactorum))、軟腐病(匍枝根黴(Rhizopus stolonifer))、萎黃病(Fusarium oxysporum)等 Strawberry: Botrytis cinerea, powdery mildew (Sphaerotheca humuli), anthracnose (Colletotrichum acutatum, Colletotrichum) Fragariae), Phytophthora cactorum, soft rot (Rhizopus stolonifer), Fusarium oxysporum, etc.

洋蔥:灰色腐敗病(灰色腐敗病菌(Botrytis allii))、灰黴病(Botrytis cinerea)、白斑葉枯病(Botrytis squamosa)、露菌病(洋蔥露菌病菌(Peronospora destructor))、白色疫病(Phytophthora porri)等 Onions: gray spoilage (Botrytis allii), Botrytis cinerea, Botrytis squamosa, bacterium (Peronospora destructor), white blight (Phytophthora) Porri)

捲心菜:根瘤病(十字花科根瘤病菌(Plasmodiophora brassicae))、軟腐病(軟腐病菌(Erwinia carotovora))、黑腐病(十字花科黑腐病菌(Xanthomonas campestris pv.campestris))、黑斑細菌病(Pseudomonas syringae pv.maculicola、Pseudomonas syringae pv.alisalensis)、露菌病(寄生霜黴(Peronospora parasitica))、菌核病(Sclerotinia sclerotiorum)、黑煤病(嗜甘藍鏈格孢菌(Alternaria brassicicola))、灰黴病(Botrytis cinerea)等 Cabbage: Rhizobium (Plasmodiophora brassicae), soft rot (Erwinia carotovora), black rot (Xanthomonas campestris pv. campestris), black spot bacterial disease (Pseudomonas syringae pv. maculicola, Pseudomonas syringae pv. alisalensis), Phytophthora (Peronospora parasitica), Sclerotinia sclerotiorum, Black coal disease (Alternaria brassicicola) , Botrytis cinerea, etc.

四季豆:菌核病(Sclerotinia sclerotiorum)、灰黴病(Botrytis cinerea)、炭疽病(菜豆炭疽病菌(Colletotrichum lindemuthianum))、角斑病(Phaeoisariopsis griseola)等 Green beans: Sclerotinia sclerotiorum, Botrytis cinerea, anthracnose (Colletotrichum lindemuthianum), horn spot disease (Phaeoisariopsis griseola), etc.

蘋果:白粉病(蘋果白粉病菌(Podosphaera leucotricha))、黑星病(蘋果黑星菌(Venturia inaequalis))、念珠菌病(Monilinia mali)、黑點病(蘋果黑點病菌(Mycosphaerella pomi))、腐爛病(蘋果腐爛病菌(Valsa mali))、斑點落葉病(蘋果褐色斑點病菌(Alternaria mali))、赤星病(蘋果赤星病菌(Gymnosporangium yamadae))、輪紋病(Botryosphaeria berengeriana)、炭疽病(蘋果炭疽病菌(Glomerella cingulata)、Colletotrichum acutatum)、褐斑病(Diplocarpon mali)、煤點病(Zygophiala jamaicensis)、煤污病(Gloeodes pomigena)、紫紋羽病(紫紋羽病菌(Helicobasidium mompa))、 灰黴病(Botrytis cinerea)等 Apple: powdery mildew (Podosphaera leucotricha), black spot disease (Venturia inaequalis), candidiasis (Monilinia mali), black spot disease (Mycosphaerella pomi), Rot disease (Valsa mali), spotted leaf disease (Alternaria mali), brown spot disease (Gymnosporangium yamadae), Botryosphaeria berengeriana, anthracnose (apple) Anthrax (Glomerella cingulata), Colletotrichum acutatum, Diplocarpon mali, Zygophiala jamaicensis, Gloeodes pomigena, Helicoptera (Melocobisidium mompa), Botrytis cinerea, etc.

梅:黑星病(嗜果枝孢菌(Cladosporium carpophilum))、灰黴病(Botrytis cinerea)、褐腐病(Monilinia mumecola)等 Plum: Black spot disease (Cladosporium carpophilum), Botrytis cinerea, brown rot (Monilinia mumecola), etc.

柿:白粉病(柿白粉病菌(Phyllactinia kakicola))、炭疽病(柿炭疽病菌(Gloeosporium kaki))、角斑落葉病(柿角斑落葉病菌(Cercospora kaki))等 Persimmon: powdery mildew (Phyllactinia kakicola), anthracnose (Gloeosporium kaki), keratosis (Cercospora kaki), etc.

桃子:褐腐病(桃褐腐病菌(Monilinia fructicola))、黑星病(Cladosporium carpophilum)、擬莖點黴腐敗病(Phomopsis sp.)、穿孔細菌病(桃穿孔病菌(Xanthomonas campestris pv.pruni))等 Peach: brown rot (Monilinia fructicola), Cladosporium carpophilum, Phomopsis sp., and perforated bacterial disease (Xanthomonas campestris pv. pruni) )Wait

扁桃:褐腐病(Monilinia laxa)、斑點病(Stigmina carpophila)、黑星病(Cladosporium carpophilum)、縮葉病(Polystigma rubrum)、斑點落葉病(Alternaria alternata)、炭疽病(似膠黏孢炭疽刺盤孢菌(Colletotrichum gloeosporioides))等 Almond: brown rot (Monilinia laxa), spot disease (Stigmina carpophila), black spot disease (Cladosporium carpophilum), leaf defect disease (Polystigma rubrum), spotted leaf disease (Alternaria alternata), anthracnose (like gypsum Colletotrichum gloeosporioides, etc.

櫻桃:褐腐病(Monilinia fructicola)、炭疽病(Colletotrichum acutatum)、黑斑病(鏈格孢菌(Alternaria sp.))、幼果菌核病(Monilinia kusanoi)等 Cherry: brown rot (Monilinia fructicola), anthracnose (Colletotrichum acutatum), black spot (Alternaria sp.), Monilinia kusanoi, etc.

葡萄:灰黴病(Botrytis cinerea)、白粉病(葡萄白粉病菌(Uncinula necator))、晚腐病(葡萄晚腐病菌(Glomerella cingulata)、Colletotrichum acutatum)、露菌病(葡萄露菌病菌(Plasmopara viticola))、黑痘病(葡萄黑痘病菌(Elsinoe ampelina))、褐斑病(葡萄假尾孢菌(Pseudocercospora vitis))、黑腐病(葡萄黑腐病菌(Guignardia bidwellii))、白腐病(Coniella castaneicola)等 Grapes: Botrytis cinerea, powdery mildew (Uncinula necator), late rot (Glomerella cingulata, Colletotrichum acutatum), Phytophthora (Plasmopara viticola) )), black pox (Elsinoe ampelina), brown spot (Pseudocercospora vitis), black rot (Guignardia bidwellii), white rot ( Coniella castaneicola)

梨:黑星病(Venturia nashicola)、赤星病(Gymnosporangium asiaticum)、 黑斑病(梨黑斑病菌(Alternaria kikuchiana))、輪紋病(Botryosphaeria berengeriana)、白粉病(Phyllactinia mali)、胴枯病(梨胴枯病菌(Phomopsis fukushii))、褐色斑點病(囊狀匍柄黴(Stemphylium vesicarium))、炭疽病(梨炭疽病菌(Glomerella cingulata))等 Pear: Ventura nashicola, Gymnosporangium asiaticum, Black spot (Alternaria kikuchiana), Botryosphaeria berengeriana, Phyllactinia mali, blight (Phomopsis fukushii), brown spot disease (cystic sputum) Stemphylium vesicarium, anthracnose (Glomerella cingulata), etc.

茶:輪斑病(茶輪斑病菌(Pestalotia theae))、炭疽病(Colletotrichum theae-sinensis)等 Tea: round spot disease (Pestalotia theae), anthracnose (Colletotrichum theae-sinensis), etc.

柑橘:瘡痂病(Elsinoe fawcetti)、青黴病(意大利青黴菌(Penicillium italicum))、綠黴病(柑橘類綠黴病菌(Penicillium digitatum))、灰黴病(Botrytis cinerea)、黑點病(柑橘黑點病菌(Diaporthe citri))、潰瘍病(柑橘潰瘍病菌(Xanthomonas campestris pv.Citri))、白粉病(Oidium sp.)等 Citrus: Elsinoe fawcetti, Penicillium (Penicillium italicum), Green mold (Penicillium digitatum), Botrytis cinerea, Black spot (Citrus black spot) Disease (Diaporthe citri), ulcer disease (Xanthomonas campestris pv. Citri), powdery mildew (Oidium sp.), etc.

小麥:白粉病(Erysiphe graminis f.sp.Tritici)、赤黴病(麥類赤黴病菌(Gibberella zeae))、赤銹病(Puccinia recondita)、褐色雪腐病(麥類褐色雪腐病菌(Pythium iwayamai))、紅色雪腐病(Monographella nivalis)、眼斑病(Pseudocercosporella herpotrichoides)、葉枯病(Septoria tritici)、穎枯病(Leptosphaeria nodorum)、雪腐小粒菌核病(麥類雪腐褐色小粒菌核病菌(Typhula incarnata))、雪腐大粒菌核病(Myriosclerotinia borealis)、立枯病(小麥全蝕病菌(Gaeumannomyces graminis))、麥角病(黑麥角菌(Claviceps purpurea))、腥黑穗病(小麥矮腥黑粉菌(Tilletia caries))、散黑穗病(麥散黑穗菌(Ustilago nuda))等 Wheat: Erysiphe graminis f.sp. Tritici, Scab (Gibberella zeae), Puccinia recondita, brown snow rot (Pythium iwayamai) )), red snow rot (Monographella nivalis), eye spot disease (Pseudocercosporella herpotrichoides), leaf blight (Septoria tritici), blight blight (Leptosphaeria nodorum), snow rot fungus sclerotium (milk rot fungus brown granules) Typhula incarnata, Myriosclerotinia borealis, blight (Gaeumannomyces graminis), ergot (Claviceps purpurea), black stalk Disease (Tilletia caries), smut (Ustilago nuda), etc.

大麥:斑葉病(大麥斑葉病菌(Pyrenophora graminea))、網紋病(大麥網紋病菌(Pyrenophora teres))、雲紋病(大麥雲紋病菌(Rhynchosporium secalis))、散黑穗病(Ustilago tritici、U.nuda)等 Barley: variegated disease (Pyrenophora graminea), reticular disease (Pyrenophora teres), moire (Rhynchosporium secalis), smut (Ustilago) Tritici, U.nuda), etc.

稻:稻瘟病(稻熱病菌(Pyricularia oryzae))、紋枯病(立枯絲核菌(Rhizoctonia solani))、徒長病(稻徒長病菌(Gibberella fujikuroi))、胡麻葉枯病(稻胡麻葉枯病菌(Cochliobolus miyabeanus))、苗立枯病(Pythium graminicolum)、白葉枯病(稻白葉枯病菌(Xanthomonas oryzae))、苗立枯細菌病(Burkholderia plantarii)、褐條病(Acidovorax avenae)、細菌性穀枯病(細菌性穀枯病菌(Burkholderia glumae))、條葉枯病(稻條葉枯病菌(Cercospora oryzae))、稻曲病(稻曲病菌(Ustilaginoidea virens))、褐色米(Alternaria alternata、中間型彎孢菌(Curvularia intermedia))、腹黑米(Alternaria padwickii)、紅變米(Epicoccam purpurascenns)等 Rice: rice blast (Pyricularia oryzae), sheath blight (Rhizoctonia solani), long-term disease (Gibberella fujikuroi), flax leaf blight (rice leaf blight) Pathogen (Cochliobolus miyabeanus), Pythium graminicolum, Bacterial blight (Xanthomonas oryzae), Burkholderia plantarii, Acidovorax avenae, Bacterial Bacterial blight (Burkholderia glumae), strip blight (Cercospora oryzae), rice smut (Ustilaginoidea virens), brown rice (Alternaria alternata, Curvularia intermedia, Alternaria padwickii, Epiccam purpurascenns, etc.

菸草:菌核病(Sclerotinia sclerotiorum)、白粉病(Erysiphe cichoracearum)、疫病(菸草疫病菌(Phytophthora nicotianae))等 Tobacco: Sclerotinia sclerotiorum, Erysiphe cichoracearum, Phytophthora nicotianae, etc.

鬱金香:灰黴病(Botrytis cinerea)等 Tulip: Botrytis cinerea, etc.

向日葵:露菌病(向日葵露菌病菌(Plasmopara halstedii))、菌核病(Sclerotinia sclerotiorum)等 Sunflower: Phytophthora (Plasmopara halstedii), Sclerotinia sclerotiorum, etc.

小糠草:雪腐大粒菌核病(Sclerotinia borealis)、葉腐病(large patch)(Rhizoctonia solani)、幣斑病(Sclerotinia homoeocarpa)、稻瘟病(Pyricularia sp.)、赤燒病(腐黴菌(Pythium aphanidermatum))、炭疽病(禾本科炭疽刺盤孢菌(Colletotrichum graminicola))等 Kobresia: Sclerotinia borealis, large patch (Rhizoctonia solani), Sclerotinia homoeocarpa, Pyricularia sp., Erythrosia (Pythium) Pythium aphanidermatum)), anthracnose (Colletotrichum graminicola), etc.

果園草:白粉病(麥類白粉菌(Erysiphe graminis))等 Orchard grass: powdery mildew (Erysiphe graminis), etc.

大豆:紫斑病(大豆紫斑病菌(Cercospora kikuchii))、露菌病(東北霜黴(Peronospora manshurica))、莖疫病(大豆疫菌(Phytophthora sojae))、銹病(豆薯層鏽菌(Phakopsora pachyrhizi))、菌核病(Sclerotinia sclerotiorum)、 炭疽病(大豆炭疽病菌(Colletotrichum truncatum))、灰黴病(Botrytis cinerea)等 Soybean: Purple spot disease (Cercospora kikuchii), Phytophthora (Peronospora manshurica), Stem blight (Phytophthora sojae), Rust (Phakopsora pachyrhizi) ), Sclerotinia sclerotiorum, Anthracnose (Colletotrichum truncatum), Botrytis cinerea, etc.

馬鈴薯:疫病(Phytophthora infestans)、夏疫病(馬鈴薯夏疫病菌(Alternaria solani))、黑痣病(Thanatephorus cucumeris)等 Potatoes: Phytophthora infestans, summer blight (Alternaria solani), Thanatephorus cucumeris, etc.

香蕉:香蕉萎蔫病(香蕉分化型尖鐮孢菌(Fusarium oxysporum))、香蕉葉斑病(香蕉葉斑病菌(Mycosphaerella fijiensis)、芭蕉生球腔菌(Mycosphaerella musicola))等 Banana: banana wilt disease (Fusarium oxysporum), banana leaf spot (Mycosphaerella fijiensis, Mycosphaerella musicola), etc.

菜籽:菌核病(Sclerotinia sclerotiorum)、根朽病(根朽病菌(Phoma lingam))、黑斑病(黑斑病菌(Alternaria brassicae))等 Rapeseed: Sclerotinia sclerotiorum, root disease (Phoma lingam), black spot (Alternaria brassicae), etc.

咖啡:銹病(咖啡駝孢鏽菌(Hemileia vastatrix))、炭疽病(咖啡刺盤孢菌(Colletotrichum coffeanum))、褐眼病(咖啡生尾孢菌(Cercospora coffeicola))等 Coffee: rust (Hemileia vastatrix), anthracnose (Colletotrichum coffeanum), brown eye (Cercospora coffeicola), etc.

甘蔗:褐銹病(黑頂柄鏽菌(Puccinia melanocephala))等 Sugar cane: brown rust (Puccinia melanocephala), etc.

玉米:豹紋病(Gloecercospora sorghi)、銹病(玉米柄鏽菌(Puccinia sorghi))、南方銹病(多堆柄鏽菌(Puccinia polysora))、黑穗病(玉米黑穗菌(Ustilago maydis))、胡麻葉枯病(玉米胡麻葉枯病菌(Cochliobolus heterostrophus))、煤紋病(Setophaeria turcica)等 Corn: Leopard's disease (Gloecercospora sorghi), rust (Puccinia sorghi), southern rust (Puccinia polysora), smut (Ustilago maydis), Flax leaf blight (Cochliobolus heterostrophus), Setophaeria turcica, etc.

棉:苗立枯病(腐黴菌(Pythium sp))、銹病(棉層鏽菌(Phakopsora gossypii))、白黴病(棉白黴病菌(Mycosphaerella areola))、炭疽病(棉炭疽病菌(Glomerella gossypii))等 Cotton: seedling blight (Pythium sp), rust (Phakopsora gossypii), white mold (Mycosphaerella areola), anthracnose (Glomerella gossypii) ))Wait

本發明之殺蟲或殺蟎劑對於影響到植物生育之各種農業害蟲及蟎類等有害生物之防除效果優異。本發明之殺蟲或殺蟎劑不僅對於敏 感性品系(susceptible strain)之害蟲有效,而且對於對先前之藥劑、例如有機磷劑或胺基甲酸酯(carbamate)劑之抗性發達之品系之害蟲亦有效。作為抗性品系(resistant strain)之害蟲之代表例,可列舉小菜蛾、浮塵子、葉蟬、蚜蟲等。 The insecticidal or acaricidal agent of the present invention is excellent in the control effect against various pests such as agricultural pests and mites which affect plant growth. The insecticidal or acaricidal agent of the invention is not only sensitive Pests of susceptible strains are effective and are also effective against pests of strains that have developed resistance to previous agents, such as organophosphorus or carbamate agents. Representative examples of the pests of the resistant strain include the diamondback moth, the floating dust, the leafhopper, the aphid, and the like.

本發明之有害生物防除劑對農業害蟲、蟎類以外之有害生物之防除表現出效果。作為有害生物,例如,可列舉外部寄生蟲、衛生害蟲等。 The pest control agent of the present invention exhibits an effect on the control of pests other than agricultural pests and mites. Examples of the harmful organism include external parasites, sanitary pests, and the like.

作為可成為本發明之農園藝用殺菌劑、有害生物防除劑、及殺蟲或殺蟎劑之對象之植物,可列舉穀物類、蔬菜類、根菜類、薯類、樹木類、牧草類、草坪類等。 Examples of plants which can be used for the agricultural and horticultural fungicides, pest control agents, and insecticidal or acaricidal agents of the present invention include cereals, vegetables, root vegetables, potatoes, trees, pastures, and lawns. Classes, etc.

本發明之農園藝用殺菌劑、有害生物防除劑、及殺蟲或殺蟎劑可施用於植物類之各部位,例如,葉、莖、柄、花、花蕾、果實、種子、芽、根、塊莖、塊根、幼苗、插條等。又,亦可以該等植物類之改良品種、變種、栽培品種、進而突變體、雜交體、基因改造體(GMO)作為對象。 The agricultural and horticultural fungicides, pest control agents, and insecticidal or acaricides of the present invention can be applied to various parts of plants, for example, leaves, stems, stems, flowers, flower buds, fruits, seeds, buds, roots, Tubers, roots, seedlings, cuttings, etc. Further, it is also possible to use improved varieties, varieties, cultivars, further mutants, hybrids, and genetically modified bodies (GMOs) of such plants.

本發明之農園藝用殺菌劑可用於為了防除包括花卉、草坪、牧草在內之農園藝作物中產生之各種病害而進行之種子處理、莖葉噴灑、土壤施用、水面施用等。 The agricultural and horticultural fungicide of the present invention can be used for seed treatment, stem and leaf spraying, soil application, surface application, and the like for controlling various diseases occurring in agricultural and horticultural crops including flowers, lawns, and pastures.

本發明之農園藝用殺菌劑、有害生物防除劑、及殺蟲或殺蟎劑農園藝用殺菌劑亦可與具有殺菌、殺蟲或殺蟎、殺線蟲、殺土壤害蟲等效果之其他農園藝用藥劑;植物生長調節劑、增效劑、肥料、土壤改良劑、動物用飼料等混用或併用。 The agricultural and horticultural fungicide, the pest control agent, and the insecticide or acaricide agricultural and horticultural fungicide of the invention can also be combined with other agricultural and horticultural plants having the effects of sterilization, insecticide or acaricidal, nematicidal and soil-killing pests. Use of a medicament; a plant growth regulator, a synergist, a fertilizer, a soil conditioner, an animal feed, or the like, or a combination thereof.

將其一例示於以下。 An example of this is shown below.

殺菌劑:(1)核酸生物合成抑制劑:(a)RNA聚合酶I抑制劑:本達樂(benalaxyl)、右本達樂、呋霜靈(furalaxyl)、滅達樂(metalaxyl)、右滅達樂;歐殺斯(oxadixyl);克拉康(clozylacon)、呋醯胺(ofurace);(b)腺苷去胺酶抑制劑:布瑞莫(bupirimate)、二甲嘧酚(dimethirimol)、依瑞莫(ethirimol);(c)DNA/RNA合成抑制劑:殺紋甯(hymexazole)、辛噻酮(octhilinone);(d)DNA拓撲異構酶II抑制劑:歐索林酸(oxolinic acid);(2)有絲核分裂抑制劑及細胞分裂抑制劑:(a)β-微管蛋白聚合抑制劑:苯菌靈(benomyl)、多菌靈(carbendazim)、苯咪唑菌(chlorfenazole)、麥穗寧(fuberidazole)、腐絕(thiabendazole);多保淨(thiophanate)、甲基多保淨(thiophanate-methyl);乙黴威(diethofencarb);座賽胺(zoxamide);噻唑菌胺(ethaboxam);(b)細胞分裂抑制劑:賓克隆(pencycuron);(c)類血影蛋白之非定域化抑制劑:氟比來(fluopicolide);(3)呼吸抑制劑:(a)複合體I NADH氧化還原酶抑制劑:二氟林(diflumetorim);脫芬瑞(tolfenpyrad);(b)複合體II琥珀酸脫氫酶抑制劑:麥鏽靈(benodanil)、福多寧(flutolanil)、滅普寧(mepronil);isofetamid;氟吡菌醯胺(fluopyram);甲呋醯胺(fenfuram)、茂谷樂(furmecyclox);萎鏽靈(carboxin)、嘉保信 (oxycarboxin);賽氟滅(thifluzamide);苯并烯氟菌唑(benzovindiflupyr)、必殺芬(bixafen)、氟唑菌醯胺(fluxapyroxad)、福拉比(furametpyr)、吡唑萘菌胺(isopyrazam)、噴福芬(penflufen)、吡噻菌胺(penthiopyrad)、氟唑環菌胺(sedaxane);白克列(boscalid);(c)複合體III泛醇氧化酶Qo抑制劑:亞托敏(azoxystrobin)、丁香菌酯(coumoxystrobin)、甲香菌酯(coumethoxystrobin)、烯肟菌酯(enoxastrobin)、氟菌蟎酯(flufenoxystrobin)、啶氧菌酯(picoxystrobin)、唑菌酯(pyraoxystrobin);百克敏(pyraclostrobin)、唑胺菌酯(pyrametostrobin)、三環吡菌威(triclopyricarb);克收欣(kresoxim-methyl)、三氟敏(trifloxystrobin);醚菌胺(dimoxystrobin)、烯肟菌胺(fenaminstrobin)、苯氧菌胺(metominostrobin)、肟醚菌胺(orysastrobin);凡殺同(famoxadone);氟嘧菌酯(fluoxastrobin);咪唑菌酮(fenamidone);吡菌苯威(pyribencarb);(d)複合體III泛醇還原酶Qi抑制劑:賽座滅(cyazofamid);安美速(amisulbrom);(e)氧化磷酸化之去偶聯劑:百蟎克(binapacryl)、消蟎多(meptyldinocap)、白粉克(dinocap);扶吉胺(fluazinam);富米綜(ferimzone);(f)氧化磷酸化抑制劑(ATP合成酶之抑制劑):三苯醋錫、三苯氯錫、三苯羥錫;(g)ATP生成抑制劑:矽菌胺(silthiofam);(h)複合體III:細胞色素bcl(泛醌還原酶)之Qx(未知)抑制劑:辛唑嘧菌胺(ametoctradin);(4)胺基酸及蛋白質合成抑制劑 (a)甲硫胺酸生物合成抑制劑:胺撲滅(andoprim)、賽普洛(cyprodinil)、滅派林(mepanipyrim)、派美尼(pyrimethanil);(b)蛋白質合成抑制劑:殺稻瘟菌素(blasticidin)-S;嘉賜黴素(kasugamycin)、鹽酸嘉賜黴素;鏈黴素(streptomycin);土黴素(oxytetracycline);(5)訊號傳遞抑制劑:(a)訊號傳遞抑制劑:快諾芬(quinoxyfen)、丙氧喹啉(proquinazid);(b)滲透壓訊號傳遞中之MAP/組胺酸激酶抑制劑:拌種洛(fenpiclonil)、護汰寧(fludioxonil);克氯得(chlozolinate)、依普同(iprodione)、撲滅寧(procymidone)、免克寧(vinclozolin);(6)脂質及細胞膜合成抑制劑:(a)磷脂質生物合成、甲基轉移酶抑制劑:護粒松(edifenphos)、丙基喜樂松(iprobenfos)、白粉松(pyrazophos);稻瘟靈(isoprothiolane);(b)脂質之過氧化劑:聯苯、地茂散(chloroneb)、氯硝胺(dicloran)、五氯硝基苯(quintozene)、四氯硝基苯(tecnazene)、甲基立枯磷(tolclofos-methyl);依得利(etridiazole);(c)作用於細胞膜之藥劑:克打淨P(iodocarb)、霜黴威(propamocarb)、鹽酸霜黴威、乙膦酸霜黴威(propamocarb-fosetylate)、硫菌威(prothiocarb);(d)擾亂病原菌細胞膜之微生物:枯草桿菌、枯草桿菌QST713株、枯草桿菌FZB24株、枯草桿菌MBI600株、枯草桿菌D747株;(e)擾亂細胞膜之藥劑:茶樹(tea tree)之萃取物;(7)細胞膜之固醇生物合成抑制劑: (a)固醇生物合成中之C14位之去甲基化抑制劑:賽福寧(triforine);比芬諾(pyrifenox)、啶菌唑(pyrisoxazole);芬瑞莫(fenarimol)、呋嘧醇(flurprimidol)、尼瑞莫(nuarimol);依滅列(imazalil)、硫酸依滅列、咪唑(oxpoconazole)、披扶座(pefurazoate)、撲克拉(prochloraz)、賽福座(triflumizole)、烯霜苄唑(viniconazole);阿紮康唑(azaconazole)、比多農(bitertanol)、溴克座(bromuconazole)、環克座(cyproconazole)、苄氯三唑醇(diclobutrazole)、待克利(difenoconazole)、達克利(diniconazole)、右達克利、依普座(epoxiconazole)、乙環唑(etaconazole)、芬克座(fenbuconazole)、氟喹唑(fluquinconazole)、護矽得(flusilazole)、護汰芬(flutriafol)、氟康唑(fluconazole)、順式氟康唑、菲克利(hexaconazole)、易胺座(imibenconazole)、種菌唑(ipconazole)、滅特座(metconazole)、邁克尼(myclobutanil)、平克座(penconazole)、普克利(propiconazole)、快康唑(quinconazole)、矽氟唑(simeconazole)、得克利(tebuconazole)、四克利(tetraconazole)、三泰芬(triadimefon)、三泰隆(triadimenol)、滅菌唑(triticonazole);丙硫菌唑(prothioconazole)、伏立康唑(voriconazole);(b)固醇生物合成中之△14還原酶及△8→△7-異構酶之抑制劑:阿迪啉(aldimorph)、菌靈(dodemorph)、乙酸菌靈、芬普福(fenpropimorph)、三得芬(tridemorph);苯鏽啶(fenpropidin)、粉病靈(piperalin);螺茂胺(spiroxamine);(c)固醇生物合成系之C4位去甲基化中之3-酮還原酶抑制劑:環醯菌胺(fenhexamid);胺苯吡菌酮(fenpyrazamine); (d)固醇生物合成系之角鯊烯環氧酶(squalene epoxidase)抑制劑:稗草畏(pyributicarb);萘替芬(naftifine)、特比萘芬(terbinafine);(8)細胞壁合成抑制(a)海藻糖酶(trehalase)抑制劑:維利黴素(validamycin);(b)甲殼素合成酶抑制劑:保粒黴素(polyoxin)、保粒黴素(丁)(polyoxorim);(c)纖維素合成酶抑制劑:達滅芬(dimethomorph)、氟啉(flumorph)、丁吡啉(pyrimorph);苯噻菌胺(benthiavalicarb)、纈黴威(iprovalicarb)、tolprocarb、valifenalate;曼普胺(mandipropamid);(9)黑色素生物合成抑制劑(a)黑色素生物合成之還原酶抑制劑:四氯苯酞(fthalide);百快隆(pyroquilone);三賽唑(tricyclazole);(b)黑色素生物合成之脫水酶抑制劑:加普胺(carpropamid);二氯西莫(diclocymet);芬諾尼(fenoxanil);(10)宿主植物之抗性誘導劑:(a)作用於水楊酸合成路徑之藥劑:酸化苯并噻二唑-S-甲酯;(b)其他:撲殺熱(probenazole);汰敵寧(tiadinil);亞汰尼(isotianil);昆布糖(laminarin);大虎杖萃取液;(11)作用性不明之藥劑:克絕(cymoxanil)、福賽得(fosetyl-aluminium)、磷酸(磷酸鹽)、克枯爛(tecloftalam)、咪唑(triazoxide)、氟硫滅(flusulfamide)、達滅淨(diclomezine)、滅速克(methasulfocarb)、賽芬胺(cyflufenamid)、滅芬農(metrafenone)、匹力芬諾(pyriofenone)、多果 定(dozine)、多果定自由鹼、氟替尼(flutianil);(12)具有多作用點之藥劑:銅(銅鹽)、波爾多液、氫氧化銅、萘二甲酸銅、氧化銅、氧氯化銅、硫酸銅、硫、硫製品、多硫化鈣;福美鐵(ferbam)、鋅錳乃浦(mancozeb)、錳乃浦(maneb)、代森錳銅(mancopper)、免得爛(metiram)、聚胺基甲酸酯、甲基鋅乃浦(propineb)、得恩地(thiram)、鋅乃浦(zineb)、福美鋅(ziram);克菌丹(captan)、四氯丹(captafol)、滅菌丹(folpet);四氯異苯腈(chlorothalonil);益發靈(dichlofluanid)、對甲抑菌靈(tolylfluanid);雙胍鹽(guazatine)、乙酸克熱淨(iminoctadine acetate)、烷苯磺酸克熱淨;敵菌靈(anilazine);腈硫醌(dithianon);滅蟎猛(chinomethionate);氟醯亞胺(fluoroimide);(13)其他藥劑:DBEDC、氟滅菌丹(fluorfolpet)、雙胍乙酸鹽、雙(8-羥基喹啉)銅(II)、丙烷脒(propamidine)、氯化苦(chloropicrin)、酯菌胺(cyprofuram)、土壤桿菌(agrobacterium)、bethoxazine、二苯胺、異硫氰酸甲酯(MITC)、滅粉黴素(mildiomycin)、辣椒素(capsaicin)、cufraneb、環丙磺醯胺(cyprosulfamide)、邁隆(dazomet)、咪菌威(debacarb)、二氯酚(dichlorophen)、野燕枯(difenzoquat)、野燕枯甲磺酸酯、氟醯菌胺(flumetover)、三乙膦酸鈣、三乙膦酸鈉、人間黴素(irumamycin)、遊黴素(natamycin)、異丙消(nitrothal-isopropyl)、oxamocarb、propanosine sodium、硝吡咯菌素(pyrrolnitrin)、異丁乙氧喹啉(tebufloquin)、甲磺菌胺(tolnifanide)、氰菌胺(zarilamide)、Algophase、拌種靈(Amicarthiazol)、Oxathiapiprolin、代森聯鋅(metiram-zinc)、苯噻硫氰(benthiazol)、水楊菌胺(trichlamide)、烯效唑(uniconazole)、滅粉黴素、氧倍硫素(Oxyfenthiin)、 picarbutrazox;殺蟲/殺蟎劑、殺線蟲劑、殺土壤害蟲劑:(1)乙醯膽鹼酯酶抑制劑:(a)胺基甲酸酯系:棉鈴威(alanycarb)、得滅克(aldicarb)、免敵克(bendiocarb)、免扶克(benfuracarb)、丁酮威(butocarboxim)、丁酮碸威(butoxycarboxim)、加保利(carbaryl)、加保扶(carbofuran)、丁基加保扶(carbosulfan)、愛芬克(ethiofencarb)、丁基滅必虱(fenobucarb)、覆滅蟎(formetanate)、呋線威(furathiocarb)、異丙威(isoprocarb)、滅賜克(methiocarb)、納乃得(methomyl)、歐殺滅(oxamyl)、比加普(pirimicarb)、殘殺威(propoxur)、硫雙威(thiodicarb)、久效威(thiofanox)、唑蚜威(triazamate)、混殺威(trimethacarb)、XMC、滅爾虱(xylylcarb);芬硫克(fenothiocarb)、MIPC、MPMC、MTMC、碸滅威(aldoxycarb)、除害威(allyxycarb)、安美加(aminocarb)、必克虱(bufencarb)、除線威(cloethocarb)、斯美地(metam-sodium)、普滅克(promecarb);(b)有機磷系:歐殺松(acephate)、亞滅松(azamethiphos)、乙基穀速松(azinphos)、甲基穀速松、硫線磷(cadusafos)、氯氧磷(chlorethoxyfos)、克芬松(chlorfenvinphos)、氯甲磷(chlormephos)、陶斯松(chlorpyrifos)、甲基陶斯松、牛壁逃(coumaphos)、氰乃松(cyanophos)、滅賜松(demeton-S-methyl)、大利松(diazinon)、二氯松(dichlorvos)/DDVP、雙特松(dicrotophos)、大滅松(dimethoate)、甲基毒蟲畏(dimethylvinphos)、二硫松(disulfoton)、EPN、愛殺松(ethion)、普伏松(ethoprophos)、胺磺磷(famphur)、芬滅松(fenamiphos)、撲滅松 (fenitrothion)、芬殺松(fenthion)、福賽絕(fosthiazate)、飛達松(heptenophos)、菸鹼硫磷(imicyafos)、亞芬松(isofenphos)、水胺硫磷(isocarbophos)、加福松(isoxathio)、馬拉松(malathion)、滅加松(mecarbam)、達馬松(methamidophos)、滅大松(methidathion)、美文松(mevinphos)、亞素靈(monocrotophos)、乃力松(naled)、歐滅松(omethoate)、滅多松(oxydemeton-methyl)、巴拉松(parathion)、甲基巴拉松、賽達松(phenthoate)、福瑞松(phorate)、裕必松(phosalone)、益滅松(phosmet)、福賜米松(phosphamidon)、辛硫磷(phoxim)、亞特松(pirimiphos-methyl)、布飛松(profenofos)、撲達松(propetamphos)、普硫松(prothiofos)、白克松(pyraclofos)、必芬松(pyridaphenthion)、拜裕松(quinalphos)、硫特普(sulfotep)、嘧丙磷(tebupirimfos)、亞培松(temephos)、託福松(terbufos)、樂本松(tetrachlorvinphos)、硫滅松(thiometon)、三落松(triazophos)、三氯松(trichlorfon)、繁米松(vamidothion);乙基溴磷松(bromophos-ethyl)、BRP、加芬松(carbophenothion)、施力松(cyanofenphos)、CYAP、滅賜松碸(demeton-S-methylsulfone)、得拉松(dialifos)、氯線磷(dichlofenthion)、殺力松(dioxabenzofos)、益多松(etrimfos)、繁福松(fensulfothion)、吡氟硫磷(flupyrazofos)、大福松(fonofos)、安果(formothion)、甲基亞芬松(phosmethylan)、依殺松(isazofos)、阿發松(iodofenphos)、滅克松(methacrifos)、乙基亞特松(pirimiphos-ethyl)、乙丙磷威(phosphocarb)、丙蟲磷(propaphos)、飛克松(prothoate)、乙丙硫磷(sulprofos);(2)GABA-功能性氯離子通道拮抗劑:可氯丹(chlordane)、安殺番(endosulfan)、益斯普(ethiprole)、芬普尼(fipronil)、 氟蟲腈(pyrafluprole)、派瑞樂(pyriprole);毒殺芬(camphechlor)、飛布達(heptachlor);(3)鈉離子通道調節劑:阿納寧(acrinathrin)、右旋順反亞列寧(allethrin)、右旋反式亞列寧、畢芬寧(bifenthrin)、百亞列寧(bioallethrin)、百亞列寧S-環戊基異構物、百列滅寧(bioresmethrin)、乙氰菊酯(cycloprothrin)、賽扶寧(cyfluthrin)、β-賽扶寧(beta-cyfluthrin)、賽洛寧(cyhalothrin)、λ-賽洛寧、γ-賽洛寧、賽滅寧(cypermethrin)、亞滅寧(alphacypermethrin)、β-賽滅寧、θ-賽滅寧、ζ-賽滅寧、賽酚寧(cyphenothrin)[(1R)-反式異構物]、第滅寧(deltamethrin)、益避寧(empenthrin)[(EZ)-(1R)-異構物]、益化利(esfenvalerate)、依芬寧(ethofenprox)、芬普寧(fenpropathrin)、芬化利(fenvalerate)、護賽寧(flucythrinate)、氟氯苯菊酯(flumethrin)、τ-福化利(taufluvalinate)、合芬寧(halfenprox)、依普寧(imiprothrin)、克特寧(kadethrin)、百滅寧(permethrin)、酚丁滅寧(phenothrin)[(1R)-反式異構物]、普亞列寧(prallethrin)、除蟲菊精(pyrethrum)、列滅寧(resmethrin)、矽護芬(silafluofen)、七氟菊酯(tefluthrin)、治滅寧(tetramethrin)、治滅寧[(1R)-異構物]、泰滅寧(tralomethrin)、拜富寧(transfluthrin);亞列寧(allethrin)、畢列寧(pyrethrin)、畢列寧I、畢列寧II、丙氟菊酯(profluthrin)、四氟甲醚菊酯(dimefluthrin)、苄呋烯菊酯(bioethanomethrin)、生物氯菊酯(biopermethrin)、反式百滅寧(trans-permethrin)、五氟苯菊酯(fenfluthrin)、吡氯氰菊酯(fenpirithrin)、溴氟菊酯(flubrocythrinate)、三氟醚菊酯(flufenprox)、美特寧(metofluthrin)、丙三苯醚菊酯(protrifenbute)、芘呋 菊酯(pyresmethrin)、環戊烯丙菊酯(terallethrin);(4)菸鹼性乙醯膽鹼受體促效劑:亞滅培(acetamiprid)、可尼丁(clothianidin)、達特南(dinotefuran)、益達胺(imidacloprid)、烯啶蟲胺(nitenpyram)、硝蟲噻(nithiazine)、賽果培(thiacloprid)、賽滅速殺(thiamethoxam)、氟啶蟲胺腈(sulfoxaflor)、菸鹼;flupyradifurone;(5)菸鹼性乙醯膽鹼受體異位調節劑(allosteric modulator):賜諾特(spinetoram)、賜諾殺(spinosad);(6)氯離子通道活化劑:阿巴汀(abamectin)、因滅汀(emamectin benzoate)、林皮沒丁(lepimectin)、密滅汀(milbemectin);害獲滅(ivermectin)、色拉菌素(selamectin)、多滅蟲(doramectin)、依普菌素(eprinomectin)、莫西菌素(moxidectin)、倍脈心(milbemycin)、倍脈心肟(milbemycin oxime);(7)保幼激素類似物:烯蟲乙酯(hydroprene)、烯蟲炔酯(kinoprene)、美賜平(methoprene)、芬諾克(fenoxycarb)、百利普芬(pyriproxyfen);苯蟲醚(diofenolan)、保幼醚(epofenonane)、烯蟲硫酯(triprene);(8)其他非特異性抑制劑:溴甲烷、氯化苦(chloropicrin)、磺醯氟(sulfuryl fluoride)、硼砂、吐酒石;(9)選擇性同翅目拒食劑:氟尼胺(flonicamid)、派滅淨(pymetrozine)、新喹唑啉(pyrifluquinazon);(10)蟎類生育抑制劑:克芬蟎(clofentezine)、氟蟎(diflovidazin)、合賽多(hexythiazox)、依殺蟎(etoxazole);(11)微生物源昆蟲中腸內膜破壞劑:蘇力菌以色列亞種(Bacillus thuringiensis subsp.Israelensis)、球形桿菌(Bacillus sphaericus)、蘇力菌鯰澤亞 種(Bacillus thuringiensis subsp.Aizawai)、蘇力菌庫斯克亞種(Bacillus thuringiensis subsp.Kurstaki)、蘇力菌擬步行亞種(Bacillus thuringiensis subsp.Tenebrionis)、Bt作物蛋白質:Cry1Ab、Cry1Ac、Cry1Fa、Cry1A.105、Cry2Ab、Vip3A、mCry3A、Cry3Ab、Cry3Bb、Cry34Ab1/Cry35Ab1;(12)線粒體ATP生物合成酶抑制劑:汰芬諾克(diafenthiuron)、亞環錫(azocyclotin)、錫蟎丹(cyhexatin)、芬布錫(fenbutatin oxide)、歐蟎多(propargite)、得脫蟎(tetradifon);(13)氧化磷酸化去偶聯劑:克凡派(chlorfenapyr)、氟蟲胺(sulfluramid)、DNOC;百蟎克、大脫蟎(dinobuton)、白粉克;(14)菸鹼性乙醯膽鹼受體通道阻斷劑:免速達(bensultap)、培丹鹽酸鹽(cartap hydrochloride);沙蠶毒素(nereistoxin);殺蟲單(thiosultap-monosodium)、硫賜安(thiocyclam);(15)甲殼素合成抑制劑:雙三氟蟲脲(bistrifluron)、克福隆(chlorfluazuron)、二福隆(diflubenzuron)、氟環脲(flucycloxuron)、氟芬隆(flufenoxuron)、六福隆(hexaflumuron)、祿芬隆(lufenuron)、諾伐隆(novaluron)、諾福隆(noviflumuron)、得福隆(teflubenzuron)、三福隆(triflumuron)、布芬淨(buprofezin)、氟佐隆(fluazuron);(16)雙翅目蛻皮擾亂劑:賽滅淨(cyromazine);(17)蛻皮激素受體促效劑:可芬諾(chromafenozide)、合芬隆(halofenozide)、滅芬諾(methoxyfenozide)、得芬諾(tebufenozide);(18)章魚胺受體促效劑:三亞蟎(amitraz)、得米地曲(demiditraz)、殺蟲脒(chlordimeform); (19)線粒體電子傳遞系統複合體III抑制劑:亞醌蟎(acequinocyl)、嘧蟎酯(fluacrypyrim)、愛美松hydramethylnon);(20)線粒體電子傳遞系統複合體I抑制劑:芬殺蟎(fenazaquin)、芬普蟎(fenpyroximate)、畢汰芬(pyrimidifen)、比達本(pyridaben)、得芬瑞(tebufenpyrad)、脫芬瑞、魚藤酮(rotenone);(21)電位依賴性鈉離子通道阻斷劑:因得克(indoxacarb)、美氟綜(metaflumizone);(22)乙醯輔酶A羧化酶抑制劑:賜派芬(spirodiclofen)、螺甲蟎酯(spiromesifen)、賜派滅(spirotetramat);(23)線粒體電子傳遞系統複合體IV抑制劑:好達勝(Aluminium phosphide)、磷化鈣、磷化氫(phosphine)、磷化鋅、氰化物;(24)線粒體電子傳遞系統複合體II抑制劑:唑蟎氰(cyenopyrafen)、丁氟蟎酯(cyflumetofen)、pyflubumide;(25)阿諾鹼受體調節劑:克安勃(chlorantraniliprole)、氰蟲醯胺(cyantraniliprole)、氟苯蟲醯胺(flubendiamide)、cyclaniliprole、tetraniliprole;(26)混合功能氧化酶抑制劑化合物:協力精(piperonyl butoxide);(27)蛛毒素(latrophilin)受體作用藥:酯肽(depsipeptide)、環狀酯肽、24員環狀酯肽、艾莫德斯(emodepside);(28)其他藥劑(作用機制未知):印楝素(azadirachtin)、西脫蟎(benzoximate)、必芬蟎(bifenazate)、新殺蟎(bromopropylate)、滅蟎猛、冰晶石(cryolite)、大克蟎(dicofol)、啶蟲丙醚(pyridalyl);苯氯噻(benclothiaz)、硫、磺胺蟎酯(amidoflumet)、1,3-二氯丙烯、DCIP、溴蟎 酯(phenisobromolate)、苯蟎特(benzomate)、聚乙醛(metaldehyde)、克氯苯(chlorobenzilate)、氯噻唑(clothiazoben)、環蟲腈(dicyclanil)、fenoxacrim、氟硝二苯胺(fentrifanil)、flubenzimin、氟芬那辛(fluphenazine)、紅鈴蟲性誘素(gossyplure)、金龜子性誘劑(japonilure)、噁蟲酮(metoxadiazone)、石油、油酸鉀、殺蟎好(tetrasul)、苯蟎噻(triarathene);afidopyropen、flometoquin、丁烯氟蟲腈(flufiprole)、氟碸靈(fluensulfone)、氯氟醚菊酯(meperfluthrin)、四氟醚菊酯(tetramethylfluthrin)、溴代吡咯腈(tralopyril)、四氟甲醚菊酯(dimefluthrin)、甲基新癸醯胺(methylneodecanamide);fluralaner、afoxolaner、fluxametamide、5-[5-(3,5-二氯苯基)-5-三氟甲基-4,5-二氫異唑-3-基]-2-(1H-1,2,4-三唑-1-基)苯甲腈(CAS:943137-49-3)、broflanilide、其他meta-diamide類。 Fungicides: (1) Nucleic acid biosynthesis inhibitors: (a) RNA polymerase I inhibitors: benalaxyl, dextrodamine, furalaxyl, metalaxyl, right Dales; oxadixyl; clozylacon, ofurace; (b) adenosine deaminase inhibitors: bupirimate, dimethirimol, dimethoate Ethirimol; (c) DNA/RNA synthesis inhibitors: hymexazole, octhiminone; (d) DNA topoisomerase II inhibitor: oxolinic acid (2) mitotic mitotic inhibitors and cell division inhibitors: (a) β-tubulin polymerization inhibitors: benomyl (benomyl), carbendazim, chlorfenazole, wheat ears Fuberidazole, thiabendazole; thiophanate, thiophanate-methyl; diethofencarb; zoxamide; ethaboxam; (b) cell division inhibitor: pencycuron; (c) delocalization inhibitor of spectrin: fluopicolide; (3) respiratory inhibitor: (a) complex I NA DH oxidoreductase inhibitor: diflumetorim; tolfenpyrad; (b) complex II succinate dehydrogenase inhibitor: benodanil, flutolanil, extinction Mepronil; isofetamid; floopyram; fenfuram, furmecyclox; carboxin, oxycarboxin; thifluzamide; Benzovindiflupyr, bixafen, fluxapyroxad, furametpyr, isopyrazam, penflufen, pyrithione Penthiopyrad, sedaxane; boscalid; (c) complex III panthenol oxidase Qo inhibitor: azoxystrobin, coumoxystrobin, Coamethoxystrobin, enoxastrobin, flufenoxystrobin, picoxystrobin, pyraoxystrobin; pyraclostrobin, pyraclostrobin Pyrametostrobin), triclopyricarb; kresoxim-methyl, triflo Xystrobin); dimoxystrobin, fenaminstrobin, metominostrobin, oressastrobin; famoxadone; fluoxastrobin; imidazole Fenamidone; pyridencarb; (d) complex III panthenol reductase Qi inhibitor: cyazofamid; amisulbrom; (e) oxidative phosphorylation decoupling Binding agents: binapacryl, meptyldinocap, dinocap; fluazinam; ferimzone; (f) oxidative phosphorylation inhibitor (ATP synthase) Inhibitors): triphenylacetate, triphenylchlorotin, triphenylhydroxytin; (g) ATP production inhibitor: silthiofam; (h) complex III: cytochrome bcl (ubiquinone reductase) Qx (unknown) inhibitor: acetoctradin; (4) amino acid and protein synthesis inhibitors (a) methionine biosynthesis inhibitors: amine extinguish (andoprim), cypro ( Cyprodinil), mepanipyrim, pyrimethanil; (b) protein synthesis inhibitor: blasticidin-S; carbachol (kasuga) (mycin), cathamycin hydrochloride; streptomycin; oxytetracycline; (5) signal delivery inhibitors: (a) signal delivery inhibitors: quinoxyfen, propoxyquinol ( Proquinazid); (b) MAP/histidine kinase inhibitors in osmotic pressure signaling: fenpiclonil, fludioxonil; chlozolinate, iprodione, extinguish Procymidone, vinclozolin; (6) lipid and cell membrane synthesis inhibitors: (a) phospholipid biosynthesis, methyltransferase inhibitors: edifenphos, propyl sheisson (iprobenfos) ), white pine (pyrazophos); rice scorpion (isoprothiolane); (b) lipid peroxidizer: biphenyl, chloroneb, chloramine (dicloran), pentachloronitrobenzene (quintozene), four Etnazene, tolclofos-methyl; etridiazole; (c) agents acting on the cell membrane: iodocarb, propamocarb, Propamocarb hydrochloride, propamocarb-fosetylate, prothiocarb; (d) disturbing the cell membrane of the pathogen Microorganisms: Bacillus subtilis, Bacillus subtilis QST713 strain, Bacillus subtilis FZB24 strain, Bacillus subtilis MBI600 strain, Bacillus subtilis D747 strain; (e) Agent for disturbing cell membrane: extract of tea tree; (7) Steroidal organism of cell membrane Synthetic inhibitors: (a) Demethylation inhibitors at position C14 in sterol biosynthesis: triforine; pyrifenox, pyridine Pyrosoxazole; fenarimol, flurprimidol, nuarimol; imazalil, sulphuric acid, Ixazole (oxoconazole), pefurazoate, prochloraz, triflumizole, viniconazole, azaconazole, bitertanol, bromide Bromuconazole, cyproconazole, diclobutrazole, difenoconazole, diniconazole, dextran, epoxiconazole, etaconazole , fenbuconazole, fluquinconazole, flusilazole, flutriafol, fluconazole, cis-fluconazole, hexaconazole, easy amine Block (imibenconazole), ipconazole, metconazole, myclobutanil, penconazole, propiconazole, quinconazole, simeconazole , tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole; prothioconazole, voriconazole; (b) sterol △14 reduction in biosynthesis And △ 8 → △ 7- isomerase inhibitors: Adi Aldimorph, Dodemorph, acetic acid Fungi, fenpropimorph, tridemorph; fenpropidin, piperalin; snail Spiroxamine; (c) 3-ketoreductase inhibitor in the C4 demethylation of sterol biosynthesis: fenhexamid; fenpyrazamine; (d Squalene epoxidase inhibitors: pyributicarb; naftifine, terbinafine; (8) inhibition of cell wall synthesis (a) Trehalase inhibitor: validamycin; (b) chitin synthase inhibitor: polyoxin (polyoxin), polyoxorim (polyoxorim); (c) Cellulase synthase inhibitor: dimethomorph, fluoride Flumorph, butyro Pyrimorph; benthiavalicarb, iprovalicarb, tolprocarb, valifenalate; mandipropamid; (9) melanin biosynthesis inhibitor (a) melanin biosynthesis reductase inhibitor : fthalide; pyroquilone; tricyclazole; (b) dehydratase inhibitor of melanin biosynthesis: carpropamid; diclocymet; Fenoxanil; (10) resistance inducing agent for host plants: (a) an agent acting on the salicylic acid synthesis pathway: acidified benzothiadiazole-S-methyl ester; (b) other: culling heat (probenazole); tiadinil; isotianil; laminarin; extract of giant knotweed; (11) unidentified agents: cymoxanil, fosetyl- Aluminium), phosphoric acid (phosphate), tecloftalam, imidazole (triazoxide), flusulfamide, diclomezine, methasulfocarb, cyflufenamid, metrafenone, pyrofenone, polydatin (dozine), doxorubicin, flutianil; (12) agents with multiple sites: copper (copper salt), Bordeaux mixture, copper hydroxide, copper naphthalate, copper oxide, oxygen chloride Copper, copper sulfate, sulfur, sulfur products, calcium polysulfide; ferbate, mancozeb, maneb, mancopper, metiram, Polyurethane, propineb, thiram, zineb, ziram; captan, captafol, sterilization Dan (folpet); chlorothalonil; dichlofluanid, tolylfluanid; guazatine, iminoctadine acetate, alkane sulfonate Net; anilazine; dithianon; chinomethionate; fluoroimide; (13) other agents: DBEDC, fluoride Fluorolpet, biguanide acetate, bis(8-hydroxyquinoline) copper (II), propamidine, chloropicrin, cyprofuram, agrobacterium, bethoxazine , diphenylamine, methyl isothiocyanate (MITC), mildiomycin, capsaicin, cufraneb, cyprosulfamide, dazome, debacarb ), dichlorophen, difenzoquat, wild swallow methanesulfonate, flumetover, calcium triethylphosphonate, sodium triethionate, irumamycin , natamycin, nitrothal-isopropyl, oxamocarb, propanosine sodium, pyrrolnitrin, tebufloquin, tolnifanide, cyanogen Azar (amide), Algophase, Amicarthiazol, Oxathiapiprolin, metiram-zinc, benthiazol, trichlamide, uniconazole, extinction Powderymycin, Oxyfenthiin, picarbutrazox; insecticidal/killing agents, nematicides, killing Pesticide: (1) Acetylcholinesterase inhibitor: (a) Amino acid ester system: alanycarb, aldicarb, bendiocarb, free gram ( Benfuracarb), butocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan, ethiofencarb, butyl Fenobucarb, formetanate, furathiocarb, isoprocarb, metiocarb, methodyl, oxamyl, bicap (pirimicarb), propoxur, thiodicarb, thiofanox, triazamate, trimethacarb, XMC, xylylcarb; fensulfur (fenothiocarb), MIPC, MPMC, MTMC, aldoxycarb, allyxycarb, aminocarb, bufencarb, cloethocarb, metam- Sodium), (promecarb); (b) organophosphorus: acephate, azamethiphos, azinphos, methyl tamarind, Cadusafos, chlorethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifos, methyl tausson, coumaphos, cyanophos, Demeton-S-methyl, diazinon, dichlorvos/DDVP, dicrotophos, dimethoate, dimethylvinphos, two Disulfoton, EPN, ethion, ethoprophos, famphur, fenamiphos, fenitrothion, fenthion, blessing Fosthiazate, heptenophos, imicyafos, isofenphos, isocarbophos, isoxathio, malathion, degassos (mecarbam), methamidophos, methidathion, mevinphos, monocrotophos, naled, omethoate, oxydemeton-methyl ), parathion, methyl balason, phenthoate, phorate, phosa Lone), phosmet, phosphamidon, phoxim, pirimiphos-methyl, profenofos, propetamphos, prosulfadosone Prothiofos), pyraclofos, pyridaphenthion, quinalphos, sulfotep, tebupirimfos, temephos, terfufos, le Tetrachlorvinphos, thiometon, triazophos, trichlorfon, vamidothion; bromophos-ethyl, BRP, and fifeson ( Carbophenothion), cyanofenphos, CYAP, demeton-S-methylsulfone, dialifos, dichlofenthion, dioxabenzofos, etrimfos, Fensulfothion, flupyrazofos, fonofos, formothion, phosmethylan, isazofos, iodofenphos, extinction Methacrifos, pirimiphos-ethyl, phosphocarb, propylidene (pr Opaphos), prothoate, sulprofos; (2) GABA-functional chloride channel antagonists: chlordane, endosulfan, ethiprole ), fipronil, pyrafluprole, pyriprole; camphechlor, heptachlor; (3) sodium channel modulator: acrinathrin , ethnosine, allethrin, dextrorotatory, bifenthrin, bioallethrin, sulphate, S-cyclopentyl isomer, bioresmethrin, Cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, λ-saironin, γ-cylonine, cypermethrin ), alphacypermethrin, β-赛宁宁, θ-赛灭宁, ζ-赛灭宁, cyphenothrin ((1R)-trans isomer], dying (deltamethrin) ), empenhamin [(EZ)-(1R)-isomer], esfenvalerate, ethofenprox, fenpropathrin, fenvalerate, care Match (flucythrinate), flumethrin, taufluvalinate, halfenprox, imiprothrin, kadethrin, permethrin, phenol Phenothrin [(1R)-trans isomer], prallethrin, pyrethrum, resmethrin, silafluofen, sulphur Ester (tefluthrin), tetramethrin, chlorpyrifos [(1R)-isomer], tramomethrin, transfluthrin, allethrin, pyrethrin , Bielenin I, Bierin II, profluthrin, dimefluthrin, bioethanomethrin, biopermethrin, trans-hundengin Trans-permethrin), fenfluthrin, fenpirithrin, flubrocythrinate, flufenprox, metofluthrin, fenfluthrin (protrifenbute), pyrethyrrin (pyresmethrin), cyclopentethrin (terallethrin); (4) nicotinic acetylcholine receptor agonist: Off Pei (acetamiprid), clothianidin (clothianidin), Date Nan (dinotefuran), benefits of the amine (imidacloprid), nitenpyram (nitenpyram), nitro thiazol insect (nithiazine), thiacloprid, thiamethoxam, sulfoxaflor, nicotine; flupyradifurone; (5) nicotinic acetylcholine receptor ectopic modulator ( Allosteric modulator): spinetoram, spinosad; (6) chloride channel activator: abamectin, emamectin benzoate, lepimectin, Milbemectin; ivermectin, selamectin, doramectin, eprinomectin, moxidectin, milbemycin , milbemycin oxime; (7) juvenile hormone analogues: hydroprene, kinoprene, metoprene, fenoxycarb, hundred Pyriproxyfen; diofenolan, epofenonane, triprene; (8) other non-specific inhibitors: methyl bromide, chloropicrin, sulfonate Sulfuryl fluoride, borax, tartar; (9) Selective homoptera antifeedant: flonicamid, pymetrozine ), new quinazoline (pyrifluquinazon); (10) terpene growth inhibitor: clofentezine (clofentezine), fluoroquinone (diflovidazin), hexythiazox, etoxazole; (11) microbial source insect midgut destruction agent: Bacillus thuringiensis subsp. Israelensis, Bacillus sphaericus ), Bacillus thuringiensis subsp. Aizawai, Bacillus thuringiensis subsp. Kurstaki, Bacillus thuringiensis subsp. Tenebrionis, Bt crop protein : Cry1Ab, Cry1Ac, Cry1Fa, Cry1A.105, Cry2Ab, Vip3A, mCry3A, Cry3Ab, Cry3Bb, Cry34Ab1/Cry35Ab1; (12) Mitochondrial ATP biosynthetic enzyme inhibitors: diafenthiuron, azocyclotin , cyhexatin, fenbutatin oxide, propargite, tetradifon; (13) oxidative phosphorylation decoupling agent: chlorfenapyr, flubendiles Sulfaramid, DNOC; Baikeke, Dinobuton, Baijike; (14) Nicotinic acetylcholine receptor channel blocker: Bensultap, Pedan hydrochloride ( Cartap hydrochloride); Ereistoxin); thiosultap-monosodium, thiocyclam; (15) chitin synthesis inhibitors: bistrifluron, chlorfluazuron, diflubenzuron , flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noififlumuron, teflubenzuron, three Triflumuron, buprofezin, fluzuron; (16) diptera molting agent: cyromazine; (17) ecdysone receptor agonist: cofen Chromafenozide, halofenozide, methoxyfenozide, tebufenozide; (18) octopamine receptor agonist: amitraz, demiditraz , chlordimeform; (19) mitochondrial electron transport system complex III inhibitor: acequinocyl, fluacrypyrim, hydramethylnon); (20) mitochondrial electron transport system complex I Inhibitors: fenazaquin, fenpyroximate, pyrimid Ifen), pyripaben, tebufenpyrad, defenfen, rotenone; (21) potential-dependent sodium channel blockers: indoxacarb, fluorinated Metaflumizone); (22) acetaminophen coenzyme A carboxylase inhibitor: spirodiclofen, spiromesifen, spirotetramat; (23) mitochondrial electron transport system complex IV inhibitor : Aluminium phosphide, calcium phosphide, phosphine, zinc phosphide, cyanide; (24) mitochondrial electron transport system complex II inhibitor: cyenopyrafen (cyenopyrafen) (cyflumetofen), pyflubumide; (25) alkaloid receptor modulator: chlorantraniliprole, cyantraniliprole, flubendiamide, cyclaniliprole, tetraniliprole; (26) mixed Functional oxidase inhibitor compound: piperonyl butoxide; (27) latrophilin receptor drug: ester peptide (depsipeptide), cyclic ester peptide, 24 member cyclic ester peptide, Emodus ( Emodepside); (28) Other agents (unknown mechanism of action): azadirachtin (az Adirachtin), benzoximate, bifenazate, bromopropylate, chlorpyrifos, cryolite, dicofol, pyridalyl; benzene Chlorothiophene (benclothiaz), sulfur, amidoflumet, 1,3-dichloropropene, DCIP, phenisobromolate, benzomate, metaldehyde, chlorobenzilate , clothiazoben, dicyclanil, fenoxacrim, fentrifanil, flubenzimin, fluphenazine, gossyplure, chafer sex attractant (japonilure ), metoxadiazone, petroleum, potassium oleate, tetrasul, triarathene; afidopyropen, flometoquin, flufiprole, fluensulfone, chlorine Meperfluthrin, tetramethylfluthrin, tralopyril, dimefluthrin, methylneodecanamide; flulalaner, afoxolaner, fluxametamide 5-[5-(3,5-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroiso Zin-3-yl]-2-(1H-1,2,4-triazol-1-yl)benzonitrile (CAS: 943137-49-3), broflanilide, and other meta-diamides.

[製劑配方] [formulation formula]

本發明之農園藝用殺菌劑、有害生物防除劑、及殺蟲或殺蟎劑並不特別限定於劑型。例如,可列舉水合劑、乳劑、水溶劑、顆粒水合劑、粉劑、錠劑等劑型。製備成製劑之方法並無特別限制,可根據劑形採用公知之製備方法。 The agricultural and horticultural fungicide, the pest control agent, and the insecticidal or acaricidal agent of the present invention are not particularly limited to the dosage form. For example, a dosage form such as a hydrating agent, an emulsion, an aqueous solvent, a particulate hydrating agent, a powder, or a tablet can be mentioned. The method of preparing the preparation is not particularly limited, and a known preparation method can be employed depending on the dosage form.

以下,示出若干製劑配方,但添加物及添加比例並不應限定於該等實施例,可在大範圍內變化。製劑配方中之份表示質量份。 In the following, several formulation formulations are shown, but the additions and addition ratios are not limited to these examples and can vary widely. Parts in the formulation of the formulation represent parts by mass.

示出若干製劑實施例。再者,以下所示之製劑配方僅為例示,可於不違反本發明之主旨之範圍內進行修正。 Several formulation examples are shown. Further, the formulation of the formulation shown below is merely illustrative, and modifications may be made without departing from the spirit of the invention.

(製劑1:水合劑) (Formulation 1: Hydrating Agent)

本發明化合物 40份 40 parts of the compound of the invention

將以上物質混合均勻並粉碎成微細狀,而獲得有效成分40%之水合劑。 The above materials were uniformly mixed and pulverized into a fine form to obtain a hydrating agent having an active ingredient of 40%.

(製劑2:乳劑) (Formulation 2: Emulsion)

將以上物質混合溶解,而獲得有效成分30%之乳劑。 The above materials were mixed and dissolved to obtain an emulsion having an active ingredient of 30%.

(製劑3:粒劑) (Formulation 3: granules)

將以上物質混合均勻並粉碎成微細狀後,造粒成直徑0.5~1.0mm之粒狀而獲得有效成分5%之粒劑。 The above materials were uniformly mixed and pulverized into fine particles, and then granulated into granules having a diameter of 0.5 to 1.0 mm to obtain granules having an active ingredient of 5%.

(製劑4:粒劑) (Formulation 4: granules)

將以上物質充分粉碎並混合,添加水並充分混練後,進行造粒乾燥而獲得有效成分5%之粒劑。 The above materials were sufficiently pulverized and mixed, and water was added thereto and thoroughly kneaded, followed by granulation and drying to obtain granules having an active ingredient of 5%.

(製劑5:懸浮劑) (Formulation 5: suspending agent)

將以上物質混合,進行濕式粉碎直至粒度成為3微米以下為止,而獲得有效成分10%之懸浮劑。 The above materials were mixed and wet-pulverized until the particle size became 3 μm or less to obtain a suspending agent having 10% of the active ingredient.

[實施例] [Examples]

繼而,示出實施例,對本發明進一步進行具體說明。但本發明並不受以下實施例任何限制。 Next, the embodiments are shown, and the present invention will be further described in detail. However, the present invention is not limited by the following examples.

(實施例1) (Example 1)

1-(4-乙醯氧基-2,5,6-三甲基吡啶-3-基)乙酮O-(4-三氟甲基苄基)肟之製造 Manufacture of 1-(4-acetoxy-2,5,6-trimethylpyridin-3-yl)ethanone O-(4-trifluoromethylbenzyl)indole

(步驟1) (step 1)

1-(4-羥基-2,5,6-三甲基吡啶-3-基)乙酮之合成 Synthesis of 1-(4-hydroxy-2,5,6-trimethylpyridin-3-yl)ethanone

將4-胺基-3-戊烯-2-酮3.2g與2,2,5,6-四甲基-4H-1,3-二氧雜環己烯-4-酮10.0g加以混合,於120~130℃攪拌2.5小時。其後,將反應液冷卻至室溫,並添加二乙醚,而析出結晶。將該結晶過濾分離,從而獲得目標化合物。產率為38%。 Mixing 3.2 g of 4-amino-3-penten-2-one with 10.0 g of 2,2,5,6-tetramethyl-4H-1,3-dioxen-4-one, Stir at 120~130 ° C for 2.5 hours. Thereafter, the reaction liquid was cooled to room temperature, and diethyl ether was added to precipitate crystals. The crystal was separated by filtration to obtain a target compound. The yield was 38%.

目標化合物之物性如以下所述。 The physical properties of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)1.99(3H,s),2.29(3H,s),2.34(3H,s),2.58(3H,s),10.42(1H,br.s) 1 H-NMR (CDCl 3 , δ ppm) 1.99 (3H, s), 2.29 (3H, s), 2.34 (3H, s), 2.58 (3H, s), 10.42 (1H, br.s)

(步驟2) (Step 2)

N-{(4-三氟甲基苄基)氧基}胺基甲酸第三丁酯之合成 Synthesis of T-butyl N-{(4-trifluoromethylbenzyl)oxy}carbamic acid

將4-三氟甲基苄基溴化物1.5g溶解於乙腈20ml中。於該溶液中添加N-羥基胺基甲酸第三丁酯1.2g與1,8-二氮雜雙環[5.4.0]-7-十一烯1.7g,於室溫下攪拌1小時。其後,將反應液注入至1N鹽酸中,藉由乙酸乙酯進行萃取。藉由飽和氯化銨水溶液洗淨有機層,繼而以10%氫氧化鈉水溶液洗淨,最後藉由無水硫酸鎂加以乾燥。將溶劑減壓蒸餾去除,而獲得目標化合物2.28g。產率為100%。 1.5 g of 4-trifluoromethylbenzyl bromide was dissolved in 20 ml of acetonitrile. 1.2 g of N-hydroxyaminocarbamic acid tert-butyl ester and 1.7 g of 1,8-diazabicyclo[5.4.0]-7-undecene were added to the solution, and the mixture was stirred at room temperature for 1 hour. Thereafter, the reaction solution was poured into 1N hydrochloric acid, and extracted with ethyl acetate. The organic layer was washed with a saturated aqueous solution of ammonium chloride, then washed with a 10% aqueous sodium hydroxide solution and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to give the title compound 2.28 g. The yield was 100%.

目標化合物之物性如以下所述。 The physical properties of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)1.48(9H,s),4.91(2H,s),7.15(1H,br.s),7.51(2H,d),7.63(2H,d) 1 H-NMR (CDCl 3 , δ ppm) 1.48 (9H, s), 4.91 (2H, s), 7.15 (1H, br. s), 7.51 (2H, d), 7.63 (2H, d)

(步驟3) (Step 3)

1-(4-羥基-2,5,6-三甲基吡啶-3-基)乙酮O-(4-三氟甲基苄基)肟之合成 Synthesis of 1-(4-hydroxy-2,5,6-trimethylpyridin-3-yl)ethanone O-(4-trifluoromethylbenzyl)indole

將N-{(4-三氟甲基苄基)氧基}胺基甲酸第三丁酯0.65g溶解於1,2-二氯乙烷15ml中。於該溶液中添加1-(4-羥基-2,5,6-三甲基吡啶-3-基)-乙酮0.30g與三氟乙酸1ml,並於50~60℃攪拌1小時。其後,將反應液注入至飽和氯化銨水溶液中,藉由乙酸乙酯進行萃取。藉由飽和碳酸氫鈉水溶液將有機層洗淨,繼而藉由無水硫酸鎂加以乾燥。將溶劑減壓蒸餾去除,藉由乙酸乙酯將所得之殘渣洗淨,而獲得目標化合物0.20g。產率為34%。 0.65 g of N-{(4-trifluoromethylbenzyl)oxy}aminocarboxylic acid tert-butyl ester was dissolved in 15 ml of 1,2-dichloroethane. To the solution, 0.30 g of 1-(4-hydroxy-2,5,6-trimethylpyridin-3-yl)-ethanone and 1 ml of trifluoroacetic acid were added, and the mixture was stirred at 50 to 60 ° C for 1 hour. Thereafter, the reaction solution was poured into a saturated aqueous solution of ammonium chloride, and extracted with ethyl acetate. The organic layer was washed with a saturated aqueous solution of sodium hydrogen carbonate and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was washed with ethyl acetate to afford 0.20 g of the object compound. The yield was 34%.

目標化合物之物性如以下所述。 The physical properties of the target compound are as follows.

1H-NMR(DMSO-d6,δ ppm)1.78(3H,s),1.96(3H,s),2.00(3H,s),2.17(3H,s),5.16(2H,s),7.56(2H,d),7.71(2H,d),10.92(1H,br.s) 1 H-NMR (DMSO-d 6 , δ ppm) 1.78 (3H, s), 1.96 (3H, s), 2.00 (3H, s), 2.17 (3H, s), 5.16 (2H, s), 7.56 ( 2H, d), 7.71 (2H, d), 10.92 (1H, br.s)

(步驟4) (Step 4)

1-(4-乙醯氧基-2,5,6-三甲基吡啶-3-基)乙酮O-(4-三氟甲基苄基)肟之合成 Synthesis of 1-(4-acetoxy-2,5,6-trimethylpyridin-3-yl)ethanone O-(4-trifluoromethylbenzyl)indole

將1-(4-羥基-2,5,6-三甲基吡啶-3-基)乙酮O-(4-三氟甲基苄基)肟0.16g溶解於氯仿10ml中。於該溶液中添加吡啶45mg與乙醯氯43mg,於室溫下攪拌一晚。其後,藉由氯仿將反應液稀釋,以1N鹽酸將其洗淨,繼而以飽和碳酸氫鈉水溶液洗淨,最後藉由無水硫酸鎂加以乾燥。將溶劑減壓蒸餾去除,而獲得目標化合物0.19g。產率為100%。 0.16 g of 1-(4-hydroxy-2,5,6-trimethylpyridin-3-yl)ethanone O-(4-trifluoromethylbenzyl)indole was dissolved in 10 ml of chloroform. To the solution were added 45 mg of pyridine and 43 mg of acetonitrile, and the mixture was stirred at room temperature overnight. Thereafter, the reaction liquid was diluted with chloroform, washed with 1N hydrochloric acid, and then washed with a saturated aqueous sodium hydrogen carbonate solution and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to give the title compound (0.19 g). The yield was 100%.

目標化合物之物性如以下所述。 The physical properties of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)2.03(3H,s),2.07(3H,s),2.11(3H,s),2.37(3H,s),2.50(3H,s),5.22(2H,s),7.49(2H,d),7.62(2H,d) 1 H-NMR (CDCl 3 , δ ppm) 2.03 (3H, s), 2.07 (3H, s), 2.11 (3H, s), 2.37 (3H, s), 2.50 (3H, s), 5.22 (2H, s), 7.49 (2H, d), 7.62 (2H, d)

(實施例2) (Example 2)

1-(4-乙醯氧基-2,5,6-三甲基吡啶-3-基)乙酮O-{2-(4-三氟甲基苯基)乙基}肟之製造 Manufacture of 1-(4-acetoxy-2,5,6-trimethylpyridin-3-yl)ethanone O-{2-(4-trifluoromethylphenyl)ethyl}anthracene

(步驟1) (step 1)

N-{2-(4-三氟甲基苯基)乙氧基}鄰苯二甲醯亞胺之合成 Synthesis of N-{2-(4-Trifluoromethylphenyl)ethoxy}phthalimidoimine

將4-三氟甲基苯乙醇1.0g與N-羥基鄰苯二甲醯亞胺1.28 g溶解於四氫呋喃12ml中。於該溶液中添加三苯膦2.07g。於冰浴冷卻下向該溶液中滴加偶氮二羧酸二乙酯之40%甲苯溶液3.43g。將反應液升溫至室溫,並攪拌一晚。其後,將溶劑減壓蒸餾去除。藉由矽膠管柱層析法(展開溶劑:正己烷/乙酸乙酯=4/1(體積比))對所得之殘渣進行精製,而獲得目標化合物1.94g。產率為100%。 4-trifluoromethylphenylethanol 1.0g and N-hydroxyphthalimide 1.28 g was dissolved in 12 ml of tetrahydrofuran. To the solution was added 2.07 g of triphenylphosphine. To the solution was added dropwise 3.43 g of a 40% toluene solution of diethyl azodicarboxylate under ice cooling. The reaction solution was warmed to room temperature and stirred overnight. Thereafter, the solvent was distilled off under reduced pressure. The residue obtained was purified by a silica gel column chromatography (developing solvent: n-hexane / ethyl acetate = 4 / 1 (volume ratio)) to obtain 1.94 g of the object compound. The yield was 100%.

目標化合物之物性如以下所述。 The physical properties of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)3.21(2H,t),4.47(2H,t),7.45(2H,d),7.56(2H,d),7.72-7.78(2H,m),7.80-7.86(2H,m) 1 H-NMR (CDCl 3 , δ ppm) 3.21 (2H, t), 4.47 (2H, t), 7.45 (2H, d), 7.56 (2H, d), 7.72-7.78 (2H, m), 7.80- 7.86 (2H, m)

(步驟2) (Step 2)

O-{2-(4-三氟甲基苯基)乙基}羥胺之合成 Synthesis of O-{2-(4-trifluoromethylphenyl)ethyl}hydroxylamine

將N-{2-(4-三氟甲基苯基)乙氧基}鄰苯二甲醯亞胺1.44g溶解於二氯甲烷20ml中。將該溶液冷卻為0℃,並滴加甲基肼0.22g。於0℃將反應液攪拌1.5小時。其後,加入二乙醚,將不溶物過濾分離。將溶劑減壓蒸餾去除,而獲得目標化合物0.83g。產率為94%。 1.44 g of N-{2-(4-trifluoromethylphenyl)ethoxy}phthalimide was dissolved in 20 ml of dichloromethane. The solution was cooled to 0 ° C, and 0.22 g of methylhydrazine was added dropwise. The reaction solution was stirred at 0 ° C for 1.5 hours. Thereafter, diethyl ether was added, and the insoluble matter was separated by filtration. The solvent was distilled off under reduced pressure to give 0.83 g of desired compound. The yield was 94%.

目標化合物之物性如以下所述。 The physical properties of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)2.96(2H,t),3.90(2H,t),5.43(2H,br.s),7.33(2H,d),7.55(2H,d) 1 H-NMR (CDCl 3 , δ ppm) 2.96 (2H, t), 3.90 (2H, t), 5.43 (2H, br.s), 7.33 (2H, d), 7.55 (2H, d)

(步驟3) (Step 3)

1-(4-羥基-2,5,6-三甲基吡啶-3-基)乙酮O-{2-(4-三氟甲基苯基)乙基}肟之合成 Synthesis of 1-(4-hydroxy-2,5,6-trimethylpyridin-3-yl)ethanone O-{2-(4-trifluoromethylphenyl)ethyl}indole

將O-{2-(4-三氟甲基苯基)乙基}羥胺0.83g溶解於1,2-二氯乙烷10ml中。於該溶液中添加1-(4-羥基-2,5,6-三甲基吡啶-3-基)乙酮0.50g與三氟乙酸1ml,於室溫下攪拌一晚。其後,將反應液注入飽和碳酸氫鈉水溶液中,並藉由氯仿進行萃取。藉由無水硫酸鎂對有機層加以乾燥。將溶劑減壓蒸餾去除,藉由二乙醚將所得之殘渣洗淨,而獲得目標化合物0.68g。產率為67%。 0.83 g of O-{2-(4-trifluoromethylphenyl)ethyl}hydroxylamine was dissolved in 10 ml of 1,2-dichloroethane. To the solution were added 0.50 g of 1-(4-hydroxy-2,5,6-trimethylpyridin-3-yl)ethanone and 1 ml of trifluoroacetic acid, and stirred at room temperature overnight. Thereafter, the reaction solution was poured into a saturated aqueous solution of sodium hydrogencarbonate, and extracted with chloroform. The organic layer was dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was washed with diethyl ether to give the title compound (0.68 g). The yield was 67%.

目標化合物之物性如以下所述。 The physical properties of the target compound are as follows.

1H-NMR(DMSO-d6,δ ppm)1.79(3H,s),1.88(3H,s),2.11(3H,s),2.19(3H,s),3.00(2H,t),4.23(2H,t),7.49(2H,d),7.64(2H,d),10.96(1H,br.s) 1 H-NMR (DMSO-d 6 , δ ppm) 1.79 (3H, s), 1.88 (3H, s), 2.11 (3H, s), 2.19 (3H, s), 3.00 (2H, t), 4.23 ( 2H, t), 7.49 (2H, d), 7.64 (2H, d), 10.96 (1H, br.s)

(步驟4) (Step 4)

1-(4-乙醯氧基-2,5,6-三甲基吡啶-3-基)乙酮O-{2-(4-三氟甲基苯基)乙基}肟之合成 Synthesis of 1-(4-acetoxy-2,5,6-trimethylpyridin-3-yl)ethanone O-{2-(4-trifluoromethylphenyl)ethyl}anthracene

將1-(4-羥基-2,5,6-三甲基吡啶-3-基)乙酮O-{2-(4-三氟甲基苯基)乙基}肟0.48g溶解於二氯甲烷10ml中。於該溶液中添加三乙胺0.19g與乙醯氯0.13g,並於室溫下攪拌一晚。其後,將反應液減壓濃縮,藉由矽膠管柱層析法(展開溶劑:正己烷/乙酸乙酯)對所得之殘渣進行精製,而獲得目標化合物0.38g。產率為72%。 Dissolving 1-(4-hydroxy-2,5,6-trimethylpyridin-3-yl)ethanone O-{2-(4-trifluoromethylphenyl)ethyl}anthracene 0.48g in dichloro Methane in 10ml. 0.19 g of triethylamine and 0.13 g of ethyl hydrazine chloride were added to the solution, and the mixture was stirred at room temperature overnight. Then, the reaction liquid was concentrated under reduced pressure, and the residue obtained was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate) to afford the title compound 0.38 g. The yield was 72%.

目標化合物之物性如以下所述。 The physical properties of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)2.04(3H,s),2.06(3H,s),2.21(3H,s),2.44(3H,s),2.51(3H,s),3.06(2H,t),4.36(2H,t),7.35(2H,d),7.56(2H,d) 1 H-NMR (CDCl 3 , δ ppm) 2.04 (3H, s), 2.06 (3H, s), 2.21 (3H, s), 2.44 (3H, s), 2.51 (3H, s), 3.06 (2H, t), 4.36 (2H, t), 7.35 (2H, d), 7.56 (2H, d)

(實施例3) (Example 3)

1-(4-乙醯氧基-2,5,6-三甲基吡啶-3-基)乙酮O-(4-三氟甲基苯基)肟之製造 Manufacture of 1-(4-acetoxy-2,5,6-trimethylpyridin-3-yl)ethanone O-(4-trifluoromethylphenyl)anthracene

(步驟1) (step 1)

N-(4-三氟甲基苯氧基)胺基甲酸第三丁酯之合成 Synthesis of T-butyl N-(4-trifluoromethylphenoxy)carbamate

將4-氟三氟甲苯2.0g溶解於二甲基亞碸24ml中。於該溶液中添加N-羥基胺基甲酸第三丁酯1.95g與氫氧化鉀1.05g,並於室溫下攪拌一晚。其後,將反應液注入水中,藉由乙酸乙酯進行萃取。藉由飽和食鹽水將有機層洗淨,最後藉由無水硫酸鎂加以乾燥。將溶劑減壓蒸餾去除,藉由矽膠管柱層析法(展開溶劑:正己烷/乙酸乙酯=4/1(體積比))對所得之殘渣進行精製,而獲得目標化合物1.5g。產率為44%。 2.0 g of 4-fluorobenzotrifluoride was dissolved in 24 ml of dimethyl hydrazine. To the solution was added 1.95 g of N-hydroxyaminocarbamic acid tert-butyl ester and 1.05 g of potassium hydroxide, and the mixture was stirred at room temperature overnight. Thereafter, the reaction liquid was poured into water and extracted with ethyl acetate. The organic layer was washed with saturated brine and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue obtained was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate = 4 / 1 (volume ratio)) to obtain 1.5 g of the target compound. The yield was 44%.

目標化合物之物性如以下所述。 The physical properties of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)1.50(9H,s),7.19(2H,d),7.50(1H,s),7.56(2H,d) 1 H-NMR (CDCl 3 , δ ppm) 1.50 (9H, s), 7.19 (2H, d), 7.50 (1H, s), 7.56 (2H, d)

(步驟2) (Step 2)

1-(4-羥基-2,5,6-三甲基吡啶-3-基)乙酮O-(4-三氟甲基苯基)肟之合成 Synthesis of 1-(4-hydroxy-2,5,6-trimethylpyridin-3-yl)ethanone O-(4-trifluoromethylphenyl)indole

將N-(4-三氟甲基苯氧基)胺基甲酸第三丁酯0.85g溶解於1,2-二氯乙烷10ml中。於該溶液中添加1-(4-羥基-2,5,6-三甲基吡啶-3-基)-乙酮0.50g與三氟乙酸1ml,於50℃攪拌1小時。其後,將反應液注入飽和碳酸氫鈉水溶液中,並藉由氯仿進行萃取。藉由飽和食鹽水將有機層洗淨,最後藉由無水硫酸鎂加以乾燥。將溶劑減壓蒸餾去除,藉由二乙醚將所得之殘渣洗淨,而獲得目標化合物0.39g。產率為41%。 0.85 g of N-(4-trifluoromethylphenoxy)carbamic acid tert-butyl ester was dissolved in 10 ml of 1,2-dichloroethane. To the solution, 0.50 g of 1-(4-hydroxy-2,5,6-trimethylpyridin-3-yl)-ethanone and 1 ml of trifluoroacetic acid were added, and the mixture was stirred at 50 ° C for 1 hour. Thereafter, the reaction solution was poured into a saturated aqueous solution of sodium hydrogencarbonate, and extracted with chloroform. The organic layer was washed with saturated brine and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was washed with diethyl ether to give the title compound (0.39 g). The yield was 41%.

目標化合物之物性如以下所述。 The physical properties of the target compound are as follows.

1H-NMR(DMSO-d6,δ ppm)1.83(3H,s),2.21(3H,s),2.22(3H,s),2.24(3H,s),7.32(2H,d),7.68(2H,d),11.14(1H,br.s) 1 H-NMR (DMSO-d 6 , δ ppm) 1.83 (3H, s), 2.21 (3H, s), 2.22 (3H, s), 2.24 (3H, s), 7.32 (2H, d), 7.68 ( 2H, d), 11.14 (1H, br.s)

(步驟3) (Step 3)

1-(4-乙醯氧基-2,5,6-三甲基吡啶-3-基)乙酮O-(4-三氟甲基苯基)肟之合成 Synthesis of 1-(4-acetoxy-2,5,6-trimethylpyridin-3-yl)ethanone O-(4-trifluoromethylphenyl)anthracene

將1-(4-羥基-2,5,6-三甲基吡啶-3-基)乙酮O-(4-三氟甲基苯基)肟0.25g溶解於二氯甲烷8ml中。於該溶液中添加三乙胺0.10g與乙醯氯70mg,並於室溫下攪拌一晚。其後,將反應液減壓濃縮,藉由矽膠管柱層析法(展開溶劑:正己烷/乙酸乙酯)對所得之殘渣進行精製,而獲得目標化合物0.14g。產率為49%。 1-(4-Hydroxy-2,5,6-trimethylpyridin-3-yl)ethanone O-(4-trifluoromethylphenyl)phosphonium 0.25 g was dissolved in 8 ml of dichloromethane. 0.10 g of triethylamine and 70 mg of ethyl hydrazine chloride were added to the solution, and the mixture was stirred at room temperature overnight. Then, the reaction liquid was concentrated under reduced pressure, and the residue obtained was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate) to obtain the target compound (0.14 g). The yield was 49%.

目標化合物之物性如以下所述。 The physical properties of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)2.10(3H,s),2.23(3H,s),2.32(3H,s),2.50(3H,s),2.55(3H,s),7.27(2H,d),7.57(2H,d) 1 H-NMR (CDCl 3 , δ ppm) 2.10 (3H, s), 2.23 (3H, s), 2.32 (3H, s), 2.50 (3H, s), 2.55 (3H, s), 7.27 (2H, d), 7.57 (2H, d)

(實施例4) (Example 4)

1-(4-乙醯氧基-2,5,6-三甲基吡啶-3-基)甲醛O-{2-(4-三氟甲基苯基)乙基}肟之製造 Manufacture of 1-(4-acetoxy-2,5,6-trimethylpyridin-3-yl)carboxaldehyde O-{2-(4-trifluoromethylphenyl)ethyl}anthracene

(步驟1) (step 1)

4-羥基-2,5,6-三甲基菸鹼酸乙酯之合成 Synthesis of ethyl 4-hydroxy-2,5,6-trimethylnicotinate

將3-胺基丁烯酸乙酯45g、及2-甲基乙醯乙酸乙酯50g 溶解於二甲苯100ml中。將該溶液加熱回流一晚。其後,冷卻至室溫。過濾析出之結晶,藉由二乙醚洗淨,最後加以乾燥,而獲得目標化合物24.2g。產率為33%。 45 g of ethyl 3-aminobutenoate and ethyl 2-methylacetate 50 g Dissolved in 100 ml of xylene. The solution was heated to reflux for one night. Thereafter, it was cooled to room temperature. The precipitated crystals were filtered, washed with diethyl ether, and finally dried to give the title compound. The yield was 33%.

目標化合物之物性如以下所述。 The physical properties of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)1.21(3H,t),2.14(3H,s),2.46(3H,s),2.71(3H,s),4.45(2H,q),12.14(3H,s) 1 H-NMR (CDCl 3 , δ ppm) 1.21 (3H, t), 2.14 (3H, s), 2.46 (3H, s), 2.71 (3H, s), 4.45 (2H, q), 12.14 (3H, s)

(步驟2) (Step 2)

4-甲氧基-2,5,6-三甲基菸鹼酸乙酯之合成 Synthesis of ethyl 4-methoxy-2,5,6-trimethylnicotinate

將4-羥基-2,5,6-三甲基菸鹼酸乙酯12.2g溶解於丙酮120ml中。於該溶液中添加碳酸銫21.0g,繼而添加碘甲烷10.0g,並加熱回流8小時。其後,將反應液冷卻至室溫,並注入水中,藉由乙酸乙酯進行萃取。藉由飽和食鹽水將有機層洗淨,最後藉由無水硫酸鎂加以乾燥。將溶劑減壓蒸餾去除,而獲得目標化合物10.0g。產率為77%。 12.2 g of ethyl 4-hydroxy-2,5,6-trimethylnicotinate was dissolved in 120 ml of acetone. 21.0 g of cesium carbonate was added to the solution, followed by the addition of 10.0 g of methyl iodide, and the mixture was heated under reflux for 8 hours. Thereafter, the reaction liquid was cooled to room temperature, poured into water, and extracted with ethyl acetate. The organic layer was washed with saturated brine and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to give the title compound 10.0 g. The yield was 77%.

目標化合物之物性如以下所述。 The physical properties of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)1.40(3H,t),2.17(3H,s),2.48(6H,s),3.86(3H,s)4.41(2H,q) 1 H-NMR (CDCl 3 , δ ppm) 1.40 (3H, t), 2.17 (3H, s), 2.48 (6H, s), 3.86 (3H, s) 4.41 (2H, q)

(步驟3) (Step 3)

(4-甲氧基-2,5,6-三甲基吡啶-3-基)-甲醇之合成 Synthesis of (4-methoxy-2,5,6-trimethylpyridin-3-yl)-methanol

將氫化鋁鋰2.8g加入至四氫呋喃300ml中。於冰浴冷卻下向該液中滴加4-甲氧基-2,5,6-三甲基菸鹼酸乙酯10.0g。滴加結束後,於室溫下攪拌2小時。其後,將反應液冰浴冷卻,加水直至未反應之氫化鋁鋰分解為止,最後藉由無水硫酸鎂加以乾燥。將溶劑減壓蒸餾去除,而獲得目標化合物7.9g。產率為97%。 2.8 g of lithium aluminum hydride was added to 300 ml of tetrahydrofuran. To the liquid, 10.0 g of ethyl 4-methoxy-2,5,6-trimethylnicotinate was added dropwise under ice cooling. After the completion of the dropwise addition, the mixture was stirred at room temperature for 2 hours. Thereafter, the reaction liquid was cooled in an ice bath, water was added until the unreacted lithium aluminum hydride was decomposed, and finally dried by anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to give the title compound 7.9 g. The yield was 97%.

目標化合物之物性如以下所述。 The physical properties of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)2.18(3H,s),2.48(3H,s),2.56(3H,s),3.81(3H,s),4.72(2H,s) 1 H-NMR (CDCl 3 , δ ppm) 2.18 (3H, s), 2.48 (3H, s), 2.56 (3H, s), 3.81 (3H, s), 4.72 (2H, s)

(步驟4) (Step 4)

4-甲氧基-2,5,6-三甲基吡啶-3-甲醛之合成 Synthesis of 4-methoxy-2,5,6-trimethylpyridine-3-carbaldehyde

將(4-甲氧基-2,5,6-三甲基吡啶-3-基)-甲醇7.9g溶解於苯90ml中。於該溶液中添加二氧化錳15.2g,並加熱回流一晚。其後,將反應液冷卻至室溫,藉由矽藻土進行過濾。將該濾液減壓濃縮,而獲得目標化合物5.98g。產率為77%。 7.9 g of (4-methoxy-2,5,6-trimethylpyridin-3-yl)-methanol was dissolved in 90 ml of benzene. To the solution, 15.2 g of manganese dioxide was added and heated to reflux for one night. Thereafter, the reaction liquid was cooled to room temperature, and filtered through celite. The filtrate was concentrated under reduced pressure to give the title compound 5. The yield was 77%.

目標化合物之物性如以下所述。 The physical properties of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)2.22(3H,s),2.53(3H,s),2.73(3H,s),3.87(3H,s),10.50(1H,s) 1 H-NMR (CDCl 3 , δ ppm) 2.22 (3H, s), 2.53 (3H, s), 2.73 (3H, s), 3.87 (3H, s), 10.50 (1H, s)

(步驟5) (Step 5)

4-羥基-2,5,6-三甲基吡啶-3-甲醛之合成 Synthesis of 4-hydroxy-2,5,6-trimethylpyridine-3-carbaldehyde

將4-甲氧基-2,5,6-三甲基吡啶-3-甲醛3.0g溶解於二氯甲烷50ml中。於冰浴冷卻下向該溶液中滴加1N三溴化硼/二氯甲烷溶液33ml。滴加結束後,於室溫下攪拌一晚。其後,將反應液冰浴冷卻,添加10%碳酸氫鈉水溶液進行中和。過濾析出之結晶,最後加以乾燥,而獲得目標化合物0.9g。產率為33%。 3.0 g of 4-methoxy-2,5,6-trimethylpyridine-3-carbaldehyde was dissolved in 50 ml of dichloromethane. To the solution, 33 ml of a 1 N boron tribromide/dichloromethane solution was added dropwise under ice cooling. After the completion of the dropwise addition, the mixture was stirred at room temperature for one night. Thereafter, the reaction solution was cooled in an ice bath, and neutralized by adding a 10% aqueous sodium hydrogencarbonate solution. The precipitated crystals were filtered, and finally dried to obtain 0.9 g of the objective compound. The yield was 33%.

目標化合物之物性如以下所述。 The physical properties of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)2.18(3H,s),2.43(3H,s),2.53(3H,s),10.46(1H,s) 1 H-NMR (CDCl 3 , δ ppm) 2.18 (3H, s), 2.43 (3H, s), 2.53 (3H, s), 10.46 (1H, s)

(步驟6) (Step 6)

4-羥基-2,5,6-三甲基吡啶-3-甲醛O-{2-(4-三氟甲基苯基)乙基}肟之合成 Synthesis of 4-hydroxy-2,5,6-trimethylpyridine-3-carbaldehyde O-{2-(4-trifluoromethylphenyl)ethyl}anthracene

將O-{2-(4-三氟甲基苯基)乙基}羥胺0.32g溶解於1,2-二氯乙烷10ml中。於該溶液中添加4-羥基-2,5,6-三甲基吡啶-3-甲醛0.26g與數滴三氟乙酸,並於室溫下攪拌一晚。其後,將反應液注入飽和碳酸氫鈉水溶液中,並藉由氯仿進行萃取。繼而藉由無水硫酸鎂對有機層加以乾燥。將溶劑減壓蒸餾去除,藉由二乙醚將所得之殘渣洗淨,而獲得目標化合物0.42g。產率為76%。 0.32 g of O-{2-(4-trifluoromethylphenyl)ethyl}hydroxylamine was dissolved in 10 ml of 1,2-dichloroethane. To the solution was added 0.26 g of 4-hydroxy-2,5,6-trimethylpyridine-3-carbaldehyde and a few drops of trifluoroacetic acid, and stirred at room temperature overnight. Thereafter, the reaction solution was poured into a saturated aqueous solution of sodium hydrogencarbonate, and extracted with chloroform. The organic layer was then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was washed with diethyl ether to give the title compound 0.42 g. The yield was 76%.

目標化合物之物性如以下所述。 The physical properties of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)2.15(3H,s),2.45(3H,s),2.51(3H,s),3.11(2H,d),4.42(2H,d),7.36(2H,d),7.57(2H,d),8.47(1H,s) 1 H-NMR (CDCl 3 , δ ppm) 2.15 (3H, s), 2.45 (3H, s), 2.51 (3H, s), 3.11 (2H, d), 4.42 (2H, d), 7.36 (2H, d), 7.57 (2H, d), 8.47 (1H, s)

(步驟7) (Step 7)

1-(4-乙醯氧基-2,5,6-三甲基吡啶-3-基)甲醛O-{2-(4-三氟甲基苯基)乙基}肟之合成 Synthesis of 1-(4-acetoxy-2,5,6-trimethylpyridin-3-yl)carboxaldehyde O-{2-(4-trifluoromethylphenyl)ethyl}indole

將4-羥基-2,5,6-三甲基吡啶-3-甲醛O-{2-(4-三氟甲基苯基)乙基}肟0.42g溶解於二氯甲烷20ml中。於該溶液中添加三乙胺0.22g。繼而,於冰浴冷卻下添加乙醯氯0.14g,並於室溫下攪拌一晚。其後,將反應液注入飽和碳酸氫鈉水溶液中,並藉由氯仿進行萃取。繼而藉由無水硫酸鎂對有機層加以乾燥。將溶劑減壓蒸餾去除,藉由矽膠管柱層 析法(展開溶劑:正己烷/乙酸乙酯)對所得之殘渣進行精製,而獲得目標化合物0.37g。產率為79%。 0.42 g of 4-hydroxy-2,5,6-trimethylpyridine-3-carbaldehyde O-{2-(4-trifluoromethylphenyl)ethyl}anthracene was dissolved in 20 ml of dichloromethane. 0.22 g of triethylamine was added to the solution. Then, 0.14 g of ethyl hydrazine chloride was added under ice cooling, and the mixture was stirred at room temperature overnight. Thereafter, the reaction solution was poured into a saturated aqueous solution of sodium hydrogencarbonate, and extracted with chloroform. The organic layer was then dried over anhydrous magnesium sulfate. The solvent is distilled off under reduced pressure, and the column is laminated with a rubber tube. The residue obtained by the purification method (developing solvent: n-hexane / ethyl acetate) was purified to give the title compound 0.37 g. The yield was 79%.

目標化合物之物性如以下所述。 The physical properties of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)2.09(3H,s),2.33(3H,s),2.54(3H,s),2.61(3H,s),3.09(2H,d),4.39(2H,d),7.35(2H,d),7.57(2H,d),8.17(1H,s) 1 H-NMR (CDCl 3 , δ ppm) 2.09 (3H, s), 2.33 (3H, s), 2.54 (3H, s), 2.61 (3H, s), 3.09 (2H, d), 4.39 (2H, d), 7.35 (2H, d), 7.57 (2H, d), 8.17 (1H, s)

(實施例5) (Example 5)

甲基[2,3,6-三甲基-5-[[4-(4-三氟甲氧基)苯基]環己氧基]-4-吡啶基]碳酸酯之製造 Manufacture of methyl [2,3,6-trimethyl-5-[[4-(4-trifluoromethoxy)phenyl]cyclohexyloxy]-4-pyridyl]carbonate

(步驟1) (step 1)

4-羥基-2-乙基-5,6-二甲基菸鹼酸甲酯之合成 Synthesis of methyl 4-hydroxy-2-ethyl-5,6-dimethylnicotinate

將3-胺基-2-戊烯酸甲酯13.6g、及2,2,5,6-四甲基-4H-1,3-二氧雜環己烯-4-酮20.0g加以混合,於150℃攪拌5小時。冷卻至室溫後,過濾析出之結晶,藉由二乙醚洗淨後加以乾燥,而獲得目標化合物13.7g。產率為31%。 13.6 g of methyl 3-amino-2-pentenoate and 20.0 g of 2,2,5,6-tetramethyl-4H-1,3-dioxan-4-one were mixed. Stir at 150 ° C for 5 hours. After cooling to room temperature, the precipitated crystals were filtered, washed with diethyl ether and dried to give the title compound (13.7 g). The yield was 31%.

目標化合物之物性如以下所述。 The physical properties of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)1.21(3H,t),2.14(3H,s),2.46(3H,s),2.71(2H,q),3.89(3H,s) 1 H-NMR (CDCl 3 , δ ppm) 1.21 (3H, t), 2.14 (3H, s), 2.46 (3H, s), 2.71 (2H, q), 3.89 (3H, s)

(步驟2) (Step 2)

4-烯丙氧基-2-乙基-5,6-二甲基菸鹼酸甲酯之合成 Synthesis of methyl 4-allyloxy-2-ethyl-5,6-dimethylnicotinate

將4-羥基-2-乙基-5,6-二甲基菸鹼酸甲酯13.7g溶解於乙腈150ml中。於該反應液中添加碳酸鉀18.2g,繼而添加烯丙基溴15.8g,並加熱回流8小時。將反應液冷卻至室溫,並注入水中,藉由乙酸乙酯進行萃取。藉由飽和食鹽水將有機層洗淨後,藉由無水硫酸鎂加以乾燥。將溶劑減壓蒸餾去除,而獲得目標化合物16.6g。產率為100%。 13.7 g of methyl 4-hydroxy-2-ethyl-5,6-dimethylnicotinate was dissolved in 150 ml of acetonitrile. 18.2 g of potassium carbonate was added to the reaction liquid, followed by the addition of 15.8 g of allyl bromide, followed by heating under reflux for 8 hours. The reaction solution was cooled to room temperature, poured into water and extracted with ethyl acetate. The organic layer was washed with saturated brine and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to give the title compound 16.6 g. The yield was 100%.

目標化合物之物性如以下所述。 The physical properties of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)1.25(3H,t),2.16(3H,s),2.48(3H,s),2.69(2H,q),3.88(3H,s),4.39(2H,d),5.23-5.39(2H,m),5.93-6.05(1H,m) 1 H-NMR (CDCl 3 , δ ppm) 1.25 (3H, t), 2.16 (3H, s), 2.48 (3H, s), 2.69 (2H, q), 3.88 (3H, s), 4.39 (2H, d), 5.23-5.39 (2H, m), 5.93-6.05 (1H, m)

(步驟3) (Step 3)

(4-烯丙氧基-2-乙基-5,6-二甲基吡啶-3-基)-甲醇之合成 Synthesis of (4-allyloxy-2-ethyl-5,6-dimethylpyridin-3-yl)-methanol

將氫化鋰鋁2.8g加入至四氫呋喃300ml中。於冰浴冷卻下向該反應液中滴加4-烯丙氧基-2-乙基-5,6-二甲基菸鹼酸甲酯16.6g,滴加結束後,於室溫下攪拌2小時。其後,將反應液冰浴冷卻,加水直 至未反應之氫化鋰鈉分解為止,藉由無水硫酸鎂加以乾燥。將溶劑減壓蒸餾去除,而獲得目標化合物11.3g。產率為77%。 2.8 g of lithium aluminum hydride was added to 300 ml of tetrahydrofuran. To the reaction mixture, 16.6 g of methyl 4-allyloxy-2-ethyl-5,6-dimethylnicotinate was added dropwise under ice cooling, and after stirring, stirring at room temperature 2 hour. Thereafter, the reaction solution was cooled in an ice bath, and water was added straight. The unreacted lithium hydride was decomposed and dried by anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure to give the title compound 11.3 g. The yield was 77%.

目標化合物之物性如以下所述。 The physical properties of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)1.26(3H,t),2.16(3H,s),2.46(3H,s),2.84(2H,q),4.39(2H,d),4.70(2H,d),5.29-5.45(2H,m),6.03-6.14(1H,m) 1 H-NMR (CDCl 3 , δ ppm) 1.26 (3H, t), 2.16 (3H, s), 2.46 (3H, s), 2.84 (2H, q), 4.39 (2H, d), 4.70 (2H, d), 5.29-5.45 (2H, m), 6.03-6.14 (1H, m)

(步驟4) (Step 4)

4-烯丙氧基-2-乙基-5,6-二甲基吡啶-3-甲醛之合成 Synthesis of 4-allyloxy-2-ethyl-5,6-dimethylpyridine-3-carbaldehyde

將(4-烯丙氧基-2-乙基-5,6-二甲基吡啶-3-基)-甲醇11.3g溶解於二氯甲烷120ml中,於冰浴冷卻下添加飽和碳酸氫鈉水溶液120ml、溴化鉀0.6g及4-側氧基-TEMPO 0.4g。於冰浴冷卻下,歷經30分鐘以上向該反應液中滴加5%次氯酸鈉溶液91g。滴加結束後,於0℃攪拌30分鐘,將反應液注入冰水中。藉由二氯甲烷進行萃取,並藉由硫代硫酸鈉水溶液、飽和食鹽水洗淨,藉由無水硫酸鎂對有機層加以乾燥。將溶劑減壓蒸餾去除,藉由矽膠管柱層析法(展開溶劑:正己烷/乙酸乙酯)對所得之殘渣進行精製,而獲得目標化合物11.1g。產率為99%。 11.3 g of (4-allyloxy-2-ethyl-5,6-dimethylpyridin-3-yl)-methanol was dissolved in 120 ml of dichloromethane, and a saturated aqueous solution of sodium hydrogencarbonate was added under ice cooling. 120 ml, 0.6 g of potassium bromide and 4-sided oxy-TEMPO 0.4 g. Under cooling with an ice bath, 91 g of a 5% sodium hypochlorite solution was added dropwise to the reaction solution over 30 minutes. After completion of the dropwise addition, the mixture was stirred at 0 ° C for 30 minutes, and the reaction liquid was poured into ice water. The organic layer was dried over anhydrous magnesium sulfate by extraction with methylene chloride aqueous solution and saturated brine. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate) to afford 11.1 g of the desired compound. The yield was 99%.

目標化合物之物性如以下所述。 The physical properties of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)1.25(3H,t),2.21(3H,s),2.52(3H,s),3.06(2H,q),4.42(2H,d),5.32-5.43(2H,m),6.01-6.11(1H,m),10.47(1H,s) 1 H-NMR (CDCl 3 , δ ppm) 1.25 (3H, t), 2.21 (3H, s), 2.52 (3H, s), 3.06 (2H, q), 4.42 (2H, d), 5.32-5.43 ( 2H, m), 6.01-6.11 (1H, m), 10.47 (1H, s)

(步驟5) (Step 5)

1-(4-烯丙氧基-2-乙基-5,6-二甲基-3-吡啶基)-N-[2-[[3-氯-5-(三氟甲基)-2-吡啶基]氧基]-1-甲基-丙氧基]甲亞胺之合成 1-(4-allyloxy-2-ethyl-5,6-dimethyl-3-pyridyl)-N-[2-[[3-chloro-5-(trifluoromethyl)-2 Synthesis of pyridyl]oxy]-1-methyl-propoxy]methylimine

將4-烯丙氧基-2-乙基-5,6-二甲基吡啶-3-甲醛0.5g溶解於二氯甲烷10ml中。於冰浴冷卻下向該反應液中添加O-[2-[[3-氯-5-(三氟甲基)-2-吡啶基]氧基]-1-甲基-丙基]羥胺0.8g、數滴三氟乙酸,並於室溫下攪拌一晚。將反應液注入飽和碳酸氫鈉水溶液中,藉由氯仿加以萃取後,藉由無水硫酸鎂對有機層加以乾燥。將溶劑減壓蒸餾去除,藉由矽膠管柱層析法(展開溶劑:正己烷/乙酸乙酯)對所得之殘渣進行精製,而獲得目標化合物0.75g。產率為68%。 0.5 g of 4-allyloxy-2-ethyl-5,6-dimethylpyridine-3-carbaldehyde was dissolved in 10 ml of dichloromethane. O-[2-[[3-chloro-5-(trifluoromethyl)-2-pyridyl]oxy]-1-methyl-propyl]hydroxylamine 0.8 was added to the reaction mixture under ice cooling. g, a few drops of trifluoroacetic acid, and stirred at room temperature for one night. The reaction solution was poured into a saturated aqueous solution of sodium hydrogencarbonate and extracted with chloroform, and the organic layer was dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue obtained was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate) to yield 0.75 g of the desired compound. The yield was 68%.

目標化合物之物性如以下所述。 The physical properties of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)1.19-1.43(9H,m),2.21(3H,s),2.52(3H,s),3.06(2H,q),4.33-4.42(3H,m),5.32-5.43(2H,m),5.57-5.61(1H,m),6.01-6.11(1H,m),7.79-8.25(3H,m) 1 H-NMR (CDCl 3 , δ ppm) 1.19-1.43 (9H, m), 2.21 (3H, s), 2.52 (3H, s), 3.06 (2H, q), 4.33-4.42 (3H, m), 5.32-5.43(2H,m), 5.57-5.61(1H,m), 6.01-6.11(1H,m),7.79-8.25(3H,m)

(步驟6) (Step 6)

3-[2-[[3-氯-5-(三氟甲基)-2-吡啶氧基]-1-甲基-丙氧基]亞胺基甲基]-2-乙基-5,6-二甲基-吡啶-4-醇之合成 3-[2-[[3-chloro-5-(trifluoromethyl)-2-pyridyloxy]-1-methyl-propoxy]iminomethyl]-2-ethyl-5, Synthesis of 6-dimethyl-pyridin-4-ol

將1-(4-烯丙氧基-2-乙基-5,6-二甲基-3-吡啶基)-N-[2-[[3-氯-5-(三氟甲基)-2-吡啶基]氧基]-1-甲基-丙氧基]甲亞胺0.5g溶解於甲醇10ml中。於該溶液中添加四(三苯膦)鈀0.012g、碳酸鉀0.28g,並於室溫下攪拌2小時。將反應液注入冰水中,藉由氯仿進行萃取,並藉由飽和食鹽水將其洗淨,藉由無水硫酸鎂對有機層加以乾燥。將溶劑減壓蒸餾去除,藉由二乙醚將所得之殘渣洗淨,而獲得目標化合物0.4g。產率為87%。 1-(4-Allyloxy-2-ethyl-5,6-dimethyl-3-pyridyl)-N-[2-[[3-chloro-5-(trifluoromethyl)- 0.5 g of 2-pyridyl]oxy]-1-methyl-propoxy]methylimine was dissolved in 10 ml of methanol. To the solution, 0.012 g of tetrakis(triphenylphosphine)palladium and 0.28 g of potassium carbonate were added, and the mixture was stirred at room temperature for 2 hours. The reaction solution was poured into ice water, extracted with chloroform, and washed with saturated brine, and the organic layer was dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was washed with diethyl ether to give the object compound (0.4 g). The yield was 87%.

目標化合物之物性如以下所述。 The physical properties of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)1.17-1.41(9H,m),1.99(3H,s),2.22(3H,s),2.85(2H,q),4.33-4.42(1H,m),5.57-5.61(1H,m),7.78-8.22(3H,m) 1 H-NMR (CDCl 3 , δ ppm) 1.17-1.41 (9H, m), 1.99 (3H, s), 2.22 (3H, s), 2.85 (2H, q), 4.33-4.42 (1H, m), 5.57-5.61 (1H, m), 7.78-8.22 (3H, m)

(步驟7) (Step 7)

[3-[2-[[3-氯-5-(三氟甲基)-2-吡啶基]氧基-1-甲基-丙氧基]亞胺基甲基]-2-乙基-5,6-二甲基-4-吡啶基]乙酸酯之合成 [3-[2-[[3-chloro-5-(trifluoromethyl)-2-pyridyl]oxy-1-methyl-propoxy]iminomethyl]-2-ethyl- Synthesis of 5,6-Dimethyl-4-pyridyl]acetate

將3-[2-[[3-氯-5-(三氟甲基)-2-吡啶氧基]-1-甲基-丙氧基]亞胺基甲基]-2-乙基-5,6-二甲基-吡啶-4-醇0.4g溶解於氯仿10ml中。於該溶液中添加三乙胺0.2g後,於冰浴冷卻下添加乙醯氯0.16g,並於室溫下攪拌一晚。將反應液注入飽和碳酸氫鈉水溶液中,藉由氯仿加以萃取後,藉由無水硫酸鎂對有機層加以乾燥。將溶劑減壓蒸餾去除,藉由矽膠管柱層析法(展開溶劑:正己烷/乙酸乙酯)對所得之殘渣進行精製,而獲得目標化合物0.37g。產率為84%。 3-[2-[[3-chloro-5-(trifluoromethyl)-2-pyridyloxy]-1-methyl-propoxy]iminomethyl]-2-ethyl-5 0.4 g of 6-dimethyl-pyridin-4-ol was dissolved in 10 ml of chloroform. After 0.2 g of triethylamine was added to the solution, 0.16 g of ethyl hydrazine chloride was added thereto under ice cooling, and the mixture was stirred at room temperature overnight. The reaction solution was poured into a saturated aqueous solution of sodium hydrogencarbonate and extracted with chloroform, and the organic layer was dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate) to afford the title compound 0.37 g. The yield was 84%.

目標化合物之物性如以下所述。 The physical properties of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)1.19-1.43(9H,m),2.06(3H,s),2.30(3H,s),2.51(3H,s),2.86(2H,q),4.43-4.45(1H,m),5.59-5.62(1H,m),7.82-8.26(3H,m) 1 H-NMR (CDCl 3 , δ ppm) 1.19-1.43 (9H, m), 2.06 (3H, s), 2.30 (3H, s), 2.51 (3H, s), 2.86 (2H, q), 4.43 4.45(1H,m), 5.59-5.62(1H,m),7.82-8.26(3H,m)

將藉由與上述之實施例同樣之方法所製造之化合物示於第1表~第10表中。 The compounds produced by the same methods as the above examples are shown in Tables 1 to 10.

並且將化合物之物性資料記載於「物性」一欄。作為物性資料,係記載熔點(℃)、折射率(nD)或其性狀。 And the physical property data of the compound is recorded in the column of "physical properties". The physical property data describes the melting point (° C.), the refractive index (n D ), or the properties thereof.

如「立體組態」一欄所示之「E」表示化合物中之亞胺之雙鍵為E組態,「Z」表示為Z組態,「EZ」表示化合物為兩種組態之化合物之混合物。 The "E" shown in the column of "Three-dimensional Configuration" indicates that the double bond of the imine in the compound is the E configuration, "Z" is the Z configuration, and "EZ" indicates that the compound is the compound of the two configurations. mixture.

表中之Ph表示苯基,Me表示甲基,Et表示乙基,nPr表示正丙基,iPr表示異丙基,cPr表示環丙基,nBu表示正丁基,tBu基表示第三丁基,Py表示吡啶基,Ac表示乙醯基,Bn表示苄基,PMB表示對甲氧基苄基。 The table Ph means phenyl, Me means methyl, Et represents an ethyl group, n Pr represents n-propyl group, i Pr denotes an isopropyl group, c Pr a cyclopropyl group, n Bu represents a n-butyl group, t Bu represents a group The third butyl group, Py represents a pyridyl group, Ac represents an ethyl fluorenyl group, Bn represents a benzyl group, and PMB represents a p-methoxybenzyl group.

第1表揭示式(I)所表示之化合物中Q為式(I)所表示之有機基之化合物(以下所示之式(I-1)所表示之化合物)。 The first table discloses a compound in which the compound represented by the formula (I) is an organic group represented by the formula (I) (a compound represented by the formula (I-1) shown below).

第2表~第6表揭示式(I)所表示之化合物中Q為式(II)所表示之有機基之化合物(以下所示之式(I-2)所表示之化合物)。此處,第2表~第6表中所記載之化合物係R1、R2及R3為甲基之化合物。 In the compound represented by the formula (I), a compound represented by the formula (I) wherein Q is an organic group represented by the formula (II) (a compound represented by the formula (I-2) shown below) is disclosed. Here, the compounds described in the second to sixth tables are compounds in which R 1 , R 2 and R 3 are a methyl group.

「Ba」中之結構式中之附有*之碳原子表示與肟之氧鍵結之碳原子(於後文之表中亦表示同樣之含義)。進而,「Ba」中之結構式中之附有**之碳原子或氮原子表示與「Ar2」鍵結之碳原子或氮原子(於後文之表中亦表示同樣之含義)。 The carbon atom to which * is attached to the structural formula in "B a " represents a carbon atom bonded to the oxygen of hydrazine (the same meaning is also expressed in the following table). Further, the carbon atom or nitrogen atom attached to ** in the structural formula in "B a " represents a carbon atom or a nitrogen atom bonded to "Ar 2 " (the same meaning is also expressed in the following table).

再者,第3表中之化合物c-187為N-氧化物。 Further, the compound c-187 in the third table is an N-oxide.

第7表~第8表表示式(I-3)所表示之化合物中之取代基。 The seventh to eighth tables represent the substituents in the compound represented by the formula (I-3).

第9表表示式(I-4)所表示之化合物中之取代基。 The ninth table represents a substituent in the compound represented by the formula (I-4).

將上述之第1表~第10表中所記載之若干化合物之1H-NMR資料示於第11表中。 The 1 H-NMR data of some of the compounds described in the above Tables 1 to 10 are shown in Table 11.

[生物試驗] [biological test]

藉由以下之試驗例表現出本發明化合物作為農園藝用殺菌劑之有效成分而有用。 The compound of the present invention is useful as an active ingredient of agricultural and horticultural fungicides by the following test examples.

(試驗例1)小麥白粉病防除試驗-1 (Test Example 1) Wheat Powdery Mildew Control Test-1

將本發明化合物5質量份溶解於含有聚氧乙烯山梨醇酐單月桂酸酯1.5%之二甲基甲醯胺溶液95質量份中,製備有效成分5%之乳劑。 5 parts by mass of the compound of the present invention was dissolved in 95 parts by mass of a dimethylformamide solution containing 1.5% of polyoxyethylene sorbitan monolaurate to prepare an emulsion having an active ingredient of 5%.

藉由含有聚氧乙烯山梨醇酐單月桂酸酯0.02%之水溶液稀釋上述乳劑,而獲得化合物濃度100ppm之藥液。繼而,對在素燒盆中栽培之小麥幼苗(品種「Chihoku」、1.0~1.2葉期)噴灑該藥液。使葉風乾。其後,抖粉接種小麥白粉病菌(Erysiphe graminis f.sp.tritici)之分生孢子,於22~25℃之溫室中保持7天(處理)。另一方面,不噴灑藥液而對小麥幼苗抖粉接種小麥白粉病之分生孢子,於22~25℃之溫室中保持7天(無處理)。與無處理區域比較葉上之病斑出現狀態並進行調查,計算出防除值。 The emulsion was diluted with an aqueous solution containing 0.02% polyoxyethylene sorbitan monolaurate to obtain a chemical solution having a compound concentration of 100 ppm. Then, the chemical solution was sprayed on the wheat seedlings (variety "Chihoku", 1.0 to 1.2 leaf stage) cultivated in the vegetarian pot. Let the leaves dry. Thereafter, the conidia of wheat powdery mildew (Erysiphe graminis f.sp. tritici) were inoculated and shaken in a greenhouse at 22 to 25 ° C for 7 days (treatment). On the other hand, the wheat seedlings were inoculated with the conidia of wheat powdery mildew without spraying the liquid, and kept in a greenhouse at 22 to 25 ° C for 7 days (no treatment). The state of the lesion on the leaf was compared with the untreated area and investigated, and the control value was calculated.

防除值(%)=100-{出現病斑之面積(處理)/出現病斑之面積(無處理)}×100 Control value (%) = 100 - {area of lesions (treatment) / area of lesions (no treatment)} × 100

對第12表所示之化合物進行小麥白粉病防除試驗。任一化合物之防除值均為75%以上。 The wheat powdery mildew control test was carried out on the compound shown in Table 12. The control value of any compound is 75% or more.

(試驗例2)小麥赤銹病防除試驗-1 (Test Example 2) Wheat Red Rust Control Test-1

藉由與試驗例1相同之方法製備乳劑。藉由含有聚氧乙烯山梨醇酐單月桂酸酯0.02%之水溶液稀釋該乳劑,而獲得化合物濃度100ppm之藥液。對在素燒盆中栽培之小麥幼苗(品種「農林61號」、1.0~1.2葉期)噴灑該藥液。使葉風乾。其後,抖粉接種小麥赤銹病菌(Puccinia recondita)之夏孢子,於22~25℃之溫室中保持10天。以與試驗例1同樣之方式與未處理之情況比較葉上之病斑出現狀態並進行調查,計算出防除值。 An emulsion was prepared by the same method as Test Example 1. The emulsion was diluted with an aqueous solution containing 0.02% polyoxyethylene sorbitan monolaurate to obtain a chemical solution having a compound concentration of 100 ppm. Spray the liquid on the wheat seedlings cultivated in the simmered pots (variety "Nonglin No. 61", 1.0~1.2 leaf stage). Let the leaves dry. Thereafter, the summer spores of Puccinia recondita were inoculated with powder and kept in a greenhouse at 22 to 25 ° C for 10 days. The state of the lesion on the leaf was compared with the untreated condition in the same manner as in Test Example 1 and investigated, and the control value was calculated.

對第13表所示之化合物進行小麥赤銹病防除試驗。任一化合物之防除值均為75%以上。 The wheat red rust prevention test was carried out on the compound shown in Table 13. The control value of any compound is 75% or more.

(試驗例3)小麥白粉病防除試驗-2 (Test Example 3) Wheat powdery mildew control test-2

將本發明化合物5.62質量份、界面活性劑4.49質量份、二甲基甲醯胺89.89質量份加以混合並溶解,而獲得有效成分5.62%之乳劑。 5.62 parts by mass of the compound of the present invention, 4.49 parts by mass of a surfactant, and 89.89 parts by mass of dimethylformamide were mixed and dissolved to obtain an emulsion having an active ingredient of 5.62%.

以有效成分成為125ppm之方式藉由水稀釋上述乳劑而獲得藥液。對在素燒盆中栽培之小麥幼苗(品種「Chihoku」、1.0~1.2葉期)噴灑上述藥液。使葉風乾後,抖粉接種小麥白粉病菌(Erysiphe graminis f.sp.tritici)之分生孢子,於20~25℃之溫室中保持7天。以與試驗例1同樣之方式與未處理之情況比較葉上之病斑出現狀態並進行調查,計算出防除值。 The above solution was diluted with water so that the active ingredient became 125 ppm to obtain a chemical solution. The above-mentioned liquid medicine was sprayed on the wheat seedlings (variety "Chihoku", 1.0 to 1.2 leaf stage) cultivated in the vegetarian pot. After the leaves were dried, the conidia of wheat powdery mildew (Erysiphe graminis f.sp. tritici) were inoculated and kept in a greenhouse at 20-25 ° C for 7 days. The state of the lesion on the leaf was compared with the untreated condition in the same manner as in Test Example 1 and investigated, and the control value was calculated.

對第14表所示之化合物進行病防除試驗。任一化合物均顯示出75%以上之防除值。 The disease control test was performed on the compound shown in Table 14. Any compound showed a control value of 75% or more.

(試驗例4)小麥赤銹病防除試驗-2 (Test Example 4) Wheat Red Rust Control Test-2

藉由與試驗例3相同之方法製備乳劑。以有效成分成為125ppm之方式藉由水稀釋該乳劑而獲得藥液。對在素燒盆中栽培之小麥幼苗(品種「農林61號」、1.0~1.2葉期)噴灑上述藥液。使葉風乾後,抖粉接種小麥赤銹病菌(Puccinia recondita)之夏孢子,於20~25℃之溫室中保持10天。以與試驗例1同樣之方式與未處理之情況比較葉上之病斑出現狀態並進行調查,計算出防除值。 An emulsion was prepared by the same method as Test Example 3. The emulsion was obtained by diluting the emulsion with water so that the active ingredient became 125 ppm. The above-mentioned liquid medicine is sprayed on the wheat seedlings cultivated in the simmered pots (variety "Nonglin No. 61", 1.0-1.2 leaf stage). After the leaves were air-dried, the summer spores of Puccinia recondita were inoculated and kept in a greenhouse at 20-25 ° C for 10 days. The state of the lesion on the leaf was compared with the untreated condition in the same manner as in Test Example 1 and investigated, and the control value was calculated.

對第15表所示者進行上述小麥赤銹病防除試驗。任一化合物均顯示出75%以上之防除值。 The wheat red rust prevention test described above was carried out for the person shown in Table 15. Any compound showed a control value of 75% or more.

繼而,藉由以下之試驗例表現出本發明化合物作為殺蟲劑或殺蟎劑之有效成分是有用的。 Then, it is useful to exhibit the compound of the present invention as an active ingredient of an insecticide or an acaricide by the following test examples.

(試驗例5)針對斜紋夜盜蛾之效力確認試驗 (Test Example 5) Validation test for the effectiveness of the tantrum

將本發明化合物5質量份、二甲基甲醯胺93.6質量份、及聚氧乙烯烷基芳基醚1.4質量份加以混合並溶解,而製備有效成分5%之乳劑。 5 parts by mass of the compound of the present invention, 93.6 parts by mass of dimethylformamide, and 1.4 parts by mass of polyoxyethylene alkyl aryl ether were mixed and dissolved to prepare an emulsion having an active ingredient of 5%.

藉由水稀釋上述乳劑而獲得化合物濃度125ppm之藥劑。將捲心菜葉於該藥液中浸漬30秒,繼而進行風乾。其後,將捲心菜葉放入至鋪有濾紙之 培養皿中,接種5隻斜紋夜盜蛾之2齡幼蟲。蓋上玻璃蓋,置於溫度25℃、濕度65%之恆溫恆濕室內,於5天後觀察斜紋夜盜蛾之生死,計算出殺蟲率。將試驗反覆進行2次。 An agent having a compound concentration of 125 ppm was obtained by diluting the above emulsion with water. Cabbage leaves were immersed in the drug solution for 30 seconds and then air dried. Thereafter, the cabbage leaves are placed in a filter paper. In the culture dish, 2 second instar larvae of the genus Spodoptera were inoculated. The glass cover was placed and placed in a constant temperature and humidity chamber at a temperature of 25 ° C and a humidity of 65%. After 5 days, the life and death of the tick moth was observed, and the insecticidal rate was calculated. The test was repeated twice.

對第16表所示之化合物進行針對斜紋夜盜蛾之效力確認試驗。任一化合物之殺蟲率均為100%。 The compound shown in Table 16 was subjected to an efficacy confirmation test for Spodoptera litura. The insecticidal rate of either compound was 100%.

(試驗例6)針對棉蚜之效力確認試驗 (Test Example 6) Validation test for the effectiveness of cotton aphid

以水稀釋藉由與試驗例5相同之方法製備之乳劑而獲得化合物濃度125ppm之藥液。 The emulsion prepared in the same manner as in Test Example 5 was diluted with water to obtain a drug solution having a compound concentration of 125 ppm.

於播種於3寸缽中、經過10天發芽之黃瓜之第一片葉上接種棉蚜成蟲。1天後除去成蟲,對產下之若蟲所寄生之黃瓜噴灑上述藥液。置於溫度25℃、濕度65%之恆溫恆濕室內,於5天後觀察棉蚜之生死,計算出殺蟲率。將試驗反覆進行2次。 The cotton aphid was inoculated on the first leaf of a cucumber that was sown in a 3-inch pot and germinated for 10 days. After one day, the adult was removed, and the above-mentioned liquid medicine was sprayed on the cucumber parasitized by the laid nymph. The mixture was placed in a constant temperature and humidity chamber at a temperature of 25 ° C and a humidity of 65%. After 5 days, the life and death of the cotton aphid were observed, and the insecticidal rate was calculated. The test was repeated twice.

對第17表所示之化合物進行針對棉蚜之效力確認試驗。任一化合物之殺蟲率均為100%。 The compound shown in Table 17 was tested for efficacy against cotton aphid. The insecticidal rate of either compound was 100%.

(試驗例7)針對二點葉蟎之效力確認試驗 (Test Example 7) Validation test for the efficacy of the two-point leafhopper

以水稀釋藉由與試驗例5相同之方法製備之乳劑而獲得化合物濃度125ppm之藥液。於播種於3寸缽中、經過10天發芽之四季豆之第一片葉上接種10隻二點葉蟎雌成蟲。1天後噴灑上述藥液。置於溫度25℃、濕度65%之恆溫恆濕室內,於3天後觀察二點葉蟎之生死,計算出殺蟲率。將試驗反覆進行2次。 The emulsion prepared in the same manner as in Test Example 5 was diluted with water to obtain a drug solution having a compound concentration of 125 ppm. Ten adult mites were inoculated on the first leaves of the green beans germinated in a 3-inch sputum and germinated for 10 days. The above liquid was sprayed after 1 day. The temperature was set at 25 ° C and the humidity was 65% in a constant temperature and humidity chamber. After 3 days, the life and death of the two leaf mites were observed, and the insecticidal rate was calculated. The test was repeated twice.

對第18表所示之化合物進行針對二點葉蟎之效力確認試驗。任一化合物之殺蟲率均為100%。 The compound shown in Table 18 was tested for potency against the two-spotted spider mites. The insecticidal rate of either compound was 100%.

(試驗例8)針對豆蚜之效力確認試驗 (Test Example 8) Validation test for the effectiveness of soybean meal

以水稀釋藉由與試驗例5相同之方法製備之乳劑而獲得化合物濃度125ppm之藥液。於3寸缽中培育豇豆,在初生葉上接種豆蚜若蟲。對豆蚜若蟲所寄生之豇豆噴灑上述藥液。將該豇豆置於溫度25℃、濕度60%之恆溫室內,於4天後觀察豆蚜之生死。將試驗反覆進行2次。 The emulsion prepared in the same manner as in Test Example 5 was diluted with water to obtain a drug solution having a compound concentration of 125 ppm. The cowpea is cultivated in a 3-inch sputum, and the soybean nymph is inoculated on the primary leaf. The above liquid is sprayed on the cowpea parasitized by the soybean meal nymph. The cowpea was placed in a constant temperature room at a temperature of 25 ° C and a humidity of 60%, and the life and death of the soybean meal was observed after 4 days. The test was repeated twice.

對第19表所示之化合物進行針對豆蚜之效力確認試驗。任一化合物之殺蟲率均為80%以上。 The compound shown in Table 19 was tested for potency against soybean meal. The insecticidal rate of any compound is 80% or more.

(試驗例9)針對神澤葉蟎之效力確認試驗 (Test Example 9) Confirmation test for the efficacy of Aesop's leafhopper

以水稀釋藉由與試驗例5相同之方法製備之乳劑而獲得化合物濃度125 ppm之藥液。於3寸缽中培育四季豆,在初生葉上接種10隻神澤葉蟎雌性成蟲。對四季豆幼苗噴灑上述藥液。將該四季豆置於溫度25℃、濕度65%之恆溫室內,於自噴灑起10天後觀察成蟲之生死。 The emulsion prepared by the same method as Test Example 5 was diluted with water to obtain a compound concentration of 125. Ppm solution. The green beans were cultivated in a 3-inch sputum, and 10 female larvae were inoculated on the primary leaves. The above liquid medicine is sprayed on the green bean seedlings. The green beans were placed in a constant temperature room at a temperature of 25 ° C and a humidity of 65%, and the adult life was observed 10 days after the spraying.

對第20表所示之化合物進行針對神澤葉蟎之效力確認試驗。任一化合物之殺蟲率均為90%以上。 The compound shown in Table 20 was tested for efficacy against the genus Astragalus. The insecticidal rate of any compound is above 90%.

[產業上之可利用性] [Industrial availability]

本發明之吡啶化合物係具有有害生物防除、殺菌、殺蟎、殺蟲等效果,不會對植物體產生藥害,對人畜魚類之毒性或對環境之影響較少之新穎化合物。尤其是對麥類病害表現出優異之防除效果。本發明之吡啶化合物作為農園藝用殺菌劑、有害生物防除劑、及殺蟲或殺蟎劑之有效成分是有用的。因此,本發明之吡啶化合物於產業上有用。 The pyridine compound of the present invention is a novel compound which has the effects of pest control, sterilization, acaricidal killing, insecticidal action, and the like, does not cause phytotoxicity to plants, and has little toxicity to human or animal fish or has little influence on the environment. In particular, it exhibits excellent control effects against wheat diseases. The pyridine compound of the present invention is useful as an active ingredient for agricultural and horticultural fungicides, pest control agents, and insecticidal or acaricidal agents. Therefore, the pyridine compound of the present invention is industrially useful.

Claims (4)

一種化合物或其鹽,該化合物係以式(I)表示, [式(I)中,R1表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C1~6烷氧基、未經取代或經G2取代之C6~10芳基、未經取代或經G2取代之3~6員雜環基、氰基或鹵素基;R2及R3分別獨立地表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C3~8環烷基、未經取代或經G1取代之C1~6烷氧基、甲醯基、甲醯氧基、未經取代或經G1取代之C1~6烷基羰基、未經取代或經G1取代之C1~6烷基羰氧基、未經取代或經G2取代之C6~10芳基、(未經取代或經G1取代之C1~6烷氧基亞胺基)-C1~6烷基、氰基、或鹵素基;此處,R1與R2亦可一併與R1及R2各自所鍵結之碳原子共同形成5~6員環;R4表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C2~6烯基、未經取代或經G1取代之C2~6炔基、未經取代或經G1取代之C3~8環烷基、未經取代或經G2取代之C6~10芳基C1~6烷基、未經取代或經G2取代之3~6員雜環基、未經取代或經G2 取代之3~6員雜環基C1~6烷基、甲醯基、未經取代或經G1取代之C1~6烷基羰基、未經取代或經G1取代之C3~8環烷基羰基、未經取代或經G1取代之C1~6烯基羰基、未經取代或經G2取代之C6~10芳基羰基、未經取代或經G1取代之C1~6烷氧基羰基、未經取代或經G1取代之C2~6烯氧基羰基、未經取代或經G1取代之C1~6烷基磺醯基、未經取代或經G1取代之C1~6烷基胺基羰基、未經取代或經G1取代之(C1~6烷硫基)羰基、未經取代或經G1取代之C1~6烷基胺基(硫羰基)、或者式(IV)所表示之基; 式(IV)中,Ga分別獨立地表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C2~6烯基、未經取代或經G1取代之C2~6炔基、未經取代或經G1取代之C3~8環烷基、或者未經取代或經G2取代之C6~10芳基;式(IV)中,Gb表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C2~6烯基、未經取代或經G1取代之C2~6炔基、未經取代或經G1取代之C3~8環烷基、未經取代或經G2取代之C6~10芳基、或者未經取代或經G2取代之3~6員雜環基;式(IV)中,T表示氧原子、氧基羰基、羰氧基、氧基羰氧基、硫原子、(硫基)羰基、羰基(硫基)、(硫基)羰氧基、氧基羰基(硫基)、或-O-C(=O)-N(Gb)-所表示之二價基; *表示式(IV)所表示之基之鍵結位置;Q表示式(II)或式(III)所表示之有機基中之任一者; [式(II)及式(III)中,Ar1表示未經取代或經G2取代之C6~10芳基、或者未經取代或經G2取代之3~10員雜環基;Ar2表示未經取代或經G2取代之C6~10芳基、未經取代或經G2取代之C6~10芳氧基、未經取代或經G2取代之C6~10芳硫基、未經取代或經G2取代之C6~10芳基亞磺醯基、未經取代或經G2取代之C6~10芳基磺醯基、未經取代或經G2取代之3~10員雜環基、未經取代或經G2取代之3~10員雜環氧基、未經取代或經G2取代之3~10員雜環硫基或二茂鐵基;Ra表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C3~8環烷基、胺基、C1~6烷基羰基胺基、或者未經取代或經G2取代之C6~10芳基;Ba表示未經取代或經G4取代之C1~C6伸烷基(alkylene group)、未經取代或經G4取代之C2~C6伸烯基(alkenylene group)、未經取代或經 G4取代之C2~C6伸炔基(alkynylene group)、未經取代或經G4取代之C1~C6伸烷氧基C1~6伸烷基、未經取代或經G4取代之C3~C6伸環烷基(cycloalkylene group)、未經取代或經G4取代之C1~C6伸烷基C3~6伸環烷基、未經取代或經G4取代之C1~C6伸烷氧基C3~6伸環烷基、未經取代或經G4取代之C4~C6伸環烯基(cycloalkenylene group)、或者未經取代或經G4取代之3~6員伸雜環基(heterocyclylene group);又,Ba之碳原子或Ba上之取代基G4之一部分亦可與Ar2上之碳原子鍵結而形成5~6員環;*表示式(II)或式(III)所表示之有機基之鍵結位置]G1表示羥基、C1~6烷氧基、C1~6烷氧基C1~6烷氧基、C1~6烷氧基羰基、甲醯氧基、C1~6烷基羰氧基、C1~6烷氧基羰氧基、氰基、或鹵素基;於R1、R2、R3、R4或Ra中之兩者以上為經G1取代之上述基之情形時,該G1互相可相同,亦可不同;G2表示C1~6烷基、羥基C1~6烷基、C2~6烯基、C2~6炔基、C3~8環烷基、C1~6鹵化烷基、C1~6烷氧基C1~6烷基、C1~6烷氧基C1~6鹵化烷基、C2~6鹵化烯基、C2~6鹵化炔基、羥基、C1~6烷氧基、C3~8環烷基C1~6烷氧基、C1~6烷氧基C1~6烷氧基、C1~6鹵化烷氧基、C1~6鹵化烷氧基C1~6鹵化烷氧基、甲醯基、C1~6烷基羰基、C1~6烷氧基羰基、甲醯氧基、C1~6烷基羰氧基、C1~6烷氧基羰氧基、C1~6烷氧基羰基胺基、未經取代或經G21取代之C6~10芳基、未經取代或經G21取代之C6~10芳基C1~6烷基、未經取代或經G21取代之C6~10芳氧基、未經取代或經G21取代之3~6員雜 環基、未經取代或經G21取代之3~6員雜環氧基、C1~6烷硫基、C1~6烷基亞磺醯基、C1~6烷基磺醯基、C1~6鹵化烷硫基、C1~6鹵化烷基亞磺醯基、C1~6鹵化烷基磺醯基、五氟硫基(pentafluorosulfanyl group)、未經取代或經G21取代之C6~10芳硫基、未經取代或經G21取代之C6~10芳基亞磺醯基、未經取代或經G21取代之C6~10芳基磺醯基、硝基、氰基、鹵素基、C1~6伸烷基、C1~6伸烷基二氧基、或C1~6鹵化伸烷基二氧基;於R1、R2、R3、R4、Ra、G4、Ar1或Ar2中之兩者以上為經G2取代之上述基之情形時,該G2互相可相同,亦可不同;G21表示C1~6烷基、C1~6鹵化烷基、C1~6烷氧基、C1~6鹵化烷氧基、或鹵素基;於G2或G4中之兩者以上為經G21取代之上述基之情形時,該G21互相可相同,亦可不同;G4表示C1~6烷基、C3~8環烷基、C1~6鹵化烷基、C1~6烷氧基C1~6烷基、C2~6烯氧基C1~6烷基、羥基、C1~6烷氧基、C1~6烷氧基C1~6烷氧基、C2~6烯氧基、C1~6烷氧基羰基、未經取代或經G21取代之C6~10芳基、未經取代或經G21取代之3~6員雜環基、氰基、鹵素基、C1~6伸烷基、C1~6伸烷基二氧基、側氧基、C3~8環烷基C1~6烷基、未經取代或經G21取代之C6~10芳基C1~6烷基、未經取代或經G21取代之3~6員雜環基C1~6烷基、C3~8環烷氧基C1~6烷基、未經取代或經G21取代之C6~10芳氧基C1~6烷基、未經取代或經G21取代之3~6員雜環氧基C1~6烷基、C1~6亞烷基(alkylidene group)、C1~6烷氧基亞胺基、未經取代或經G21取代之C6~10芳基C1~6烷氧基亞胺基、或C1~6烷基肼基]。 a compound or a salt thereof, which is represented by formula (I), [In the formula (I), R 1 represents a hydrogen atom, unsubstituted or substituted. 1 G of C1 ~ 6 alkyl, unsubstituted or substituted. 1 G of C1 ~ 6 alkoxy, unsubstituted or G 2 substituted C6~10 aryl, unsubstituted or G 2 substituted 3-6 membered heterocyclic group, cyano group or halogen group; R 2 and R 3 each independently represent a hydrogen atom, unsubstituted or via G a substituted C1~6 alkyl group, an unsubstituted or G 1 substituted C 3-8 cycloalkyl group, an unsubstituted or G 1 substituted C 1-6 alkoxy group, a decyl group, a methyl methoxy group, Unsubstituted or G 1 -substituted C 1-6 alkylcarbonyl, unsubstituted or G 1 substituted C 1-6 alkylcarbonyloxy, unsubstituted or G 2 substituted C 6 ~ 10 aryl, a C1~6 alkoxyimino)-C1~6 alkyl group, a cyano group or a halogen group which is unsubstituted or substituted with G 1 ; here, R 1 and R 2 may also be combined with R 1 and R 2 The carbon atoms bonded to each of them form a 5-6 membered ring; R 4 represents a hydrogen atom, an unsubstituted or G 1 substituted C 1 ~ 6 alkyl group, an unsubstituted or G 1 substituted C 2 6 olefin group, unsubstituted or substituted with G 1 group of C2 ~ 6 alkynyl, unsubstituted or substituted with G 1 of C3 ~ 8 cycloalkyl, unsubstituted or substituted with the C6 ~ 1 G 2 0 aryl C1~6 alkyl, unsubstituted or G 2 substituted 3-6 membered heterocyclic group, unsubstituted or G 2 substituted 3-6 membered heterocyclic C1-6 alkyl group, formazan group, unsubstituted or substituted with G 1 of C1 ~ 6 alkyl carbonyl, unsubstituted or substituted with G 1 of C3 ~ 8 cycloalkylcarbonyl, unsubstituted or substituted with G 1 group of C1 ~ 6 alkenyl carbonyl group Unsubstituted or G 2 substituted C 6-10 arylcarbonyl, unsubstituted or G 1 substituted C 1-6 alkoxycarbonyl, unsubstituted or G 1 substituted C 2 -6 oxycarbonyl , unsubstituted or substituted with G 1 of C1 ~ 6 alkylsulfonyl group, unsubstituted or G 1 of C1 ~ 6 alkyl substituted aminocarbonyl, unsubstituted or substituted with G 1 of (C1 ~ 6 alkylthio) carbonyl, unsubstituted or substituted with G 1 group of C1 ~ 6 alkyl (thiocarbonyl), or formula (IV) represented by the group; In the formula (IV), G a each independently represents a hydrogen atom, an unsubstituted or G 1 -substituted C 1 - 6 alkyl group, an unsubstituted or G 1 -substituted C 2 - 6 alkenyl group, unsubstituted or via G 1 substituents of C2 ~ 6 alkynyl, unsubstituted or substituted with G 1 of C3 ~ 8 cycloalkyl, or unsubstituted or substituted G 2 of the C6 ~ 10 aryl group; in the formula (IV), G b It represents a hydrogen atom, unsubstituted or substituted with G 1 of C1 ~ 6 alkyl, unsubstituted or substituted with G 1 of C2 ~ 6 alkenyl, unsubstituted or substituted with G 1 of C2 ~ 6 alkynyl group, an substituted or substituted by G 1 of C3 ~ 8 cycloalkyl, unsubstituted or substituted with G 2 of the C6 ~ 10 aryl group, or an unsubstituted or substituted G 2 of the 3 to 6-membered heterocyclic group; the formula ( In IV), T represents an oxygen atom, an oxycarbonyl group, a carbonyloxy group, an oxycarbonyloxy group, a sulfur atom, a (thio)carbonyl group, a carbonyl group (thio group), a (thio)carbonyloxy group, or an oxycarbonyl group ( a divalent group represented by thio) or -OC(=O)-N(G b )-; * represents a bonding position of a group represented by the formula (IV); and Q represents a formula (II) or a formula (III) Any of the organic bases indicated; [In the formulae (II) and (III), Ar 1 represents an unsubstituted or G 2 -substituted C 6-10 aryl group, or an unsubstituted or G 2 -substituted 3-10 membered heterocyclic group; Ar 2 ; An unsubstituted or G 2 -substituted C6-10 aryl group, an unsubstituted or G 2 -substituted C6-10 aryloxy group, an unsubstituted or G 2 -substituted C6-10 arylthio group, Substituted or G 2 substituted C6-10 sulfinyl, unsubstituted or G 2 substituted C6-10 sulfonyl, unsubstituted or G 2 substituted 3-10 heterocycle group, unsubstituted or substituted by G 2 of the 3 to 10-membered heterocyclic group, unsubstituted or substituted with G 2 of the 3 to 10-membered heterocyclic group or a ferrocenyl group; R a represents a hydrogen atom, an Substituted or substituted by C 1 C1~6 alkyl, unsubstituted or substituted by G 1 C3-8 cycloalkyl, amine, C1-6 alkylcarbonylamino, or unsubstituted or via G 2 Substituted C6~10 aryl; B a represents unsubstituted or G 4 substituted C1~C6 alkylene group, unsubstituted or substituted by G 4 C2~C6 alkenylene group , unsubstituted or substituted with G 4 of C2 ~ C6 alkynyl group extension (alkynylene group), unsubstituted or substituted with G 4 of C1 ~ C6 alkoxy extending C1 ~ 6 alkylene, unsubstituted or substituted with G 4 of C3 ~ C6 cycloalkyl extension (cycloalkylene group), G 4 unsubstituted or substituted alkylene group of C1 ~ C6 cycloalkyl, C3 ~ 6 extends Unsubstituted or substituted by C 4 C1~C6 alkoxy C3~6 cycloalkyl, unsubstituted or G 4 substituted C4~C6 cycloalkenylene group, or unsubstituted Or a 3 to 6 member heterocyclicylene group substituted by G 4 ; further, a carbon atom of B a or a part of the substituent G 4 on B a may also be bonded to a carbon atom on Ar 2 to form 5~6 member ring; * indicates the bonding position of the organic group represented by formula (II) or formula (III)] G 1 represents a hydroxyl group, a C1-6 alkoxy group, a C1~6 alkoxy C1~6 alkoxy group a C1-6 alkoxycarbonyl group, a methyloxy group, a C1-6 alkyloxycarbonyl group, a C1-6 alkoxycarbonyloxy group, a cyano group, or a halogen group; and R 1 , R 2 , R 3 When two or more of R 4 or R a are the above-mentioned groups substituted by G 1 , the G 1 may be the same or different from each other; G 2 represents a C1-6 alkyl group, a hydroxy C1-6 alkyl group, C2~6 alkenyl group, C2~6 alkynyl group, C3~8 cycloalkyl group, C1~6 halogenated alkyl group, C1~6 alkoxy C1~6 alkyl group, C1~6 alkoxy C1~6 halogen Alkyl, C2-6 halogenated alkenyl, C2-6 halogenated alkynyl, hydroxy, C1-6 alkoxy, C3~8 cycloalkyl C1~6 alkoxy, C1~6 alkoxy C1~6 alkoxy Base, C1~6 halogenated alkoxy group, C1~6 halogenated alkoxy C1~6 halogenated alkoxy group, formyl group, C1~6 alkylcarbonyl group, C1~6 alkoxycarbonyl group, formyloxy group, C1 1-6 alkylcarbonyloxy group, a C1 - 6 alkoxycarbonyl group, a C1 - 6 alkoxycarbonyl group, unsubstituted or substituted with the G 21 C6 ~ 10 aryl group, unsubstituted or G 21 the C6 ~ 10 aryl substituted with a C1 to 6 alkyl group, unsubstituted or substituted with the G 21 C6 ~ 10 aryloxy, unsubstituted or substituted with the G 21 3 to 6-membered heterocyclic group, unsubstituted or 3-6 membered heterocyclic oxy group substituted by G 21 , C1~6 alkylthio group, C1-6 alkyl sulfinyl group, C1~6 alkylsulfonyl group, C1~6 halogenated alkylthio group, C1~ 6 alkylsulfinyl acyl halides, C1 ~ 6 halogenated alkylsulfonyl group, a pentafluoroethyl group (pentafluorosulfanyl group), unsubstituted or substituted with the G 21 C6 ~ 10 aryl group, unsubstituted or G 21 substituted aryl of C6 ~ 10 alkylsulfinyl acyl, unsubstituted or substituted with the G 21 C6 ~ 10 aryl sulfonic acyl group, a nitro group, a cyano group, a halogen group, C1 ~ 6 alkylene, C1 ~ 6 Alkyl dioxy Or a halogenated C1 ~ 6 alkylene dioxy; to R 1, R 2, R 3 , R 4, R a, G 4, two or more Ar 1 or Ar 2 in the G 2 is substituted by the above group of In this case, the G 2 may be the same or different from each other; G 21 represents a C1-6 alkyl group, a C1-6 halogenated alkyl group, a C1-6 alkoxy group, a C1-6 alkoxylated alkoxy group, or a halogen group; When two or more of G 2 or G 4 is a group substituted with G 21 , the G 21 may be the same or different from each other; G 4 represents a C1-6 alkyl group, a C3-8 cycloalkyl group, and C1. ~6 halogenated alkyl, C1~6 alkoxy C1~6 alkyl, C2~6 alkenyl C1~6 alkyl, hydroxy, C1-6 alkoxy, C1~6 alkoxy C1~6 alkoxy group, C2 to 6 alkenyl group, a C1 to 6 alkoxycarbonyl, unsubstituted or substituted with the G 21 C6 ~ 10 aryl group, unsubstituted or substituted with of 213 G to 6-membered heterocyclic group, a cyano a group, a halogen group, a C1~6 alkylene group, a C1~6 alkylenedioxy group, a pendant oxy group, a C3-8 cycloalkyl C1-6 alkyl group, an unsubstituted or C21 substituted C21 ~10 Aryl C1~6 alkyl, unsubstituted or G 21 substituted 3-6 membered heterocyclic C1-6 alkyl, C3-8 cycloalkoxy C1-6 alkyl, unsubstituted or via G 21 Substituted C6~10 aryloxy C1~6 alkyl, not Unsubstituted or substituted by G of 21 3 to 6-membered heterocyclic group having a C1 to 6 alkyl group, a C1 1-6 alkylene (alkylidene group), C1 ~ 6 alkoxyimino group, an unsubstituted or substituted by G 21 The C6~10 aryl C1~6 alkoxyimino group or the C1~6 alkyl fluorenyl group]. 一種農園藝用殺菌劑,其含有選自由申請專利範圍第1項之化合物及其鹽所組成之群中之至少一者作為有效成分。 An agricultural and horticultural fungicide comprising at least one selected from the group consisting of a compound of the first aspect of the patent application and a salt thereof as an active ingredient. 一種有害生物防除劑,其含有選自由申請專利範圍第1項之化合物及其鹽所組成之群中之至少一者作為有效成分。 A pest control agent containing at least one selected from the group consisting of a compound of the first aspect of the patent application and a salt thereof as an active ingredient. 一種殺蟲或殺蟎劑,其含有選自由申請專利範圍第1項之化合物及其鹽所組成之群中之至少一者作為有效成分。 An insecticidal or acaricidal agent containing at least one selected from the group consisting of the compound of the first aspect of the patent application and a salt thereof as an active ingredient.
TW104120127A 2014-06-24 2015-06-23 Pyridine compound and use thereof TW201605800A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014129726 2014-06-24

Publications (1)

Publication Number Publication Date
TW201605800A true TW201605800A (en) 2016-02-16

Family

ID=54938147

Family Applications (1)

Application Number Title Priority Date Filing Date
TW104120127A TW201605800A (en) 2014-06-24 2015-06-23 Pyridine compound and use thereof

Country Status (3)

Country Link
JP (1) JP6508540B2 (en)
TW (1) TW201605800A (en)
WO (1) WO2015199065A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2019083007A1 (en) * 2017-10-27 2020-12-03 住友化学株式会社 Pyridine compound and harmful arthropod control agent containing it
WO2019083008A1 (en) * 2017-10-27 2019-05-02 住友化学株式会社 Pyridine compound and pest control composition containing same
JP2021028298A (en) * 2017-11-30 2021-02-25 日本曹達株式会社 1,3,5,6-tetrasubstituted thieno[2,3-d]pyrimidine-2,4(1h,3h)dione compound, and agricultural and horticultural fungicide
EP3867239A1 (en) * 2018-10-17 2021-08-25 Duke University Quinone reductase 2 inhibitor compounds and uses thereof
CN110642748B (en) * 2019-09-20 2023-03-31 华南理工大学 O- (2-trifluoromethyl-2-hydroxyethyl) oxime ether derivative and synthetic method and application thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4213149A1 (en) * 1992-04-22 1993-10-28 Hoechst Ag Acaricidal, insecticidal and nematicidal substituted (hetero) aryl-alkyl-ketone oxime-O-ether, process for their preparation, compositions containing them and their use as pesticides
JP3874434B2 (en) * 1995-06-21 2007-01-31 日本曹達株式会社 Ketone oxime ether derivative, production method thereof, and agricultural and horticultural fungicide
HUP0203849A3 (en) * 1999-11-05 2003-04-28 Nippon Soda Co Oxime o-ether compounds as fungicides for agricultural and horticultural use
JP2001138166A (en) * 1999-11-08 2001-05-22 Nippei Toyama Corp Tool changing device, and tool changing method
WO2002064566A1 (en) * 2001-02-14 2002-08-22 Nippon Soda Co.,Ltd. Oxime o-ether compounds and fungicides for agricultural and horticultural use
WO2003006432A1 (en) * 2001-07-09 2003-01-23 Nippon Soda Co.,Ltd. Oxime ether compound and agricultural or horticultural bactericide
TW200307669A (en) * 2002-04-15 2003-12-16 Nippon Soda Co Novel oxime o-ether compound, production process thereof, and agricultural or horticultural bactericide
CN100560574C (en) * 2006-03-22 2009-11-18 南开大学 Thiazole oxime ether derivatives and preparation and application thereof
EP2346851A2 (en) * 2008-11-17 2011-07-27 Ishihara Sangyo Kaisha, Ltd. Pyridine derivative or its salt, pesticide containing it and process for its production

Also Published As

Publication number Publication date
WO2015199065A1 (en) 2015-12-30
JP6508540B2 (en) 2019-05-08
JPWO2015199065A1 (en) 2017-04-20

Similar Documents

Publication Publication Date Title
JP7158386B2 (en) Oxadiazole compounds and agricultural and horticultural fungicides
JPWO2019031384A1 (en) 1,3,5,6-Tetra-substituted thieno[2,3-d]pyrimidine-2,4(1H,3H)dione compounds and agricultural and horticultural fungicides
TW201605800A (en) Pyridine compound and use thereof
WO2019065483A1 (en) 1, 3, 5, 6-tetra substituted thieno[2, 3-d]pyrimidine-2, 4(1h, 3h)dione compound and bactericide for agricultural and horticultural use
TWI632127B (en) Guanidine compound and fungicidal agent
JPWO2019065516A1 (en) Quinoline compounds and fungicides for agriculture and horticulture
WO2019107393A1 (en) 1,3,5,6-tetrasubstituted thieno[2,3-d]pyrimidine-2,4(1h,3h)dione compound and agricultural and horticultural fungicide
WO2017155052A1 (en) Pyridine compound and use thereof
TW201609655A (en) Pyridine compound and use thereof
JP6221189B2 (en) Pyridine compounds and uses thereof
WO2021100745A1 (en) Oxadiazole compound and germicide for agricultural and horticultural use
JP2020147544A (en) Quinoline compound and fungicide for agricultural and horticultural use
WO2016047550A1 (en) Agricultural and horticultural fungicide containing aryl amidine compound
JP2020097575A (en) 1,3,5,6-TETRA SUBSTITUTED THIENO[2,3-d]PYRIMIDINE-2,4(1H,3H)DIONE COMPOUND AND HORTICULTURAL BACTERICIDE
JP2019163223A (en) 1,3,5,6-TETRASUBSTITUTED THIENO[2,3-d]PYRIMIDINE-2,4(1H,3H)DIONE COMPOUND, AND AGRICULTURAL AND HORTICULTURAL BACTERICIDE
WO2018097126A1 (en) Guanidine compound and fungicide
WO2018097172A1 (en) Phenylguanidine compound and fungicide
WO2020189525A1 (en) Heterocyclic compound and agricultural or horticultural bactericide
JP2020147545A (en) Oxadiazole compound and fungicide for agricultural and horticultural use
JP2016079175A (en) Germicide for agriculture and horticulture containing amidinopyridine compound
BR112020000992B1 (en) COMPOUND OR A SALT THEREOF, AND, AGRICULTURAL OR HORTICULTURAL FUNGICIDE
JP2023003357A (en) Oxadiazole compound and bactericide for agricultural and horticultural use
JP2022035834A (en) 2,4-dioxo-1,4-dihydrothienopyrimidine compound and bactericide for agricultural and horticultural use
JP2020040947A (en) 1,3,5,6-tetra-substituted thieno [2,3-d]pyrimidine-2,4(1h,3h) dione compound and bactericide for agricultural and horticultural use
JP2022134284A (en) Oxadiazole compounds, and agricultural and horticultural antimicrobial agents